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ABSTRACT
The studies reported here evaluated the role of acute lipid feeding and dietary lipid 
profiles in the regulation of intestinal apolipoprotein B-48 synthesis and secretion using the 
rat model.
Acute fat loading, in vitro and in vivo, resulted in a 2 to 2.5 fold increase in 
apolipoprotein B content of both jejunal enterocytes and mucosal scrapings. A 40 day 
period of dietary manipulation (fat saturation and quantity) showed a significant increase in 
apolipoprotein B-48 content of fasted jejunal enterocytes, but not fasted mucosal scrapings 
when dietary fat energy was increased from 5% to 20%. Manipulation of dietary fat 
saturation was without effect upon apolipoprotein B-48 content of fasted jejunal enterocytes 
and mucosal scrapings.
Chronic change of dietary fat saturation showed no effect upon TAG-rich lipoprotein 
particle size in the mesenteric lymph duct in response to isoenergetic fat loads. However, a 
20% sunflower oil (PUFA rich) diet administered for 40 days was found to be associated 
with reduced blood total cholesterol concentration; and coconut oil (SFA rich) diet was 
associated with raised total blood cholesterol concentration.
Our study suggests that increased transport of fat, during absorption of a dietary fat 
load, is accommodated principally by increased size (about 4 fold) of TAG-rich lipoprotein 
particles with only a small increase in particle number (about 1.45-1.6 fold). Dietary fat 
saturation showed no effect upon the mass of apolipoprotein B-48 secreted during the 
studied period of lipid absorption. However, the average size of the triacylglycerol-rich 
lipoprotein particles, estimated using the lymph apolipoprotein B-48/triacylglycerol ratio,
appears to increase with increased rate of triacylglycerol transport and chain length of 
ingested fatty acids
A final study was conducted to assess the effects of a fat load upon the average size 
of the triacylglycerol-rich lipoprotein particles secreted into the mesenteric lymph duct of 
rats receiving exogenous insulin over a 40 day period. Triacylglycerol-rich lipoprotein 
particle size during peak lipid absorption was unaffected by chronic insulin administration.
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HDL High density lipoprotein
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1. INTRODUCTION
There is little doubt that the nature and quantity of dietary fatty acid intake plays a 
significant role in determining plasma lipid levels through effects on the metabolism of 
both atherogenic and antiatherogenic plasma lipoproteins. The role of dietary fatty acids, 
with respect to both type and amount, in determining plasma lipoprotein levels and 
atherogenic cardiovascular disease risk has been an area of intense investigation for 
several decades.
Plasma lipoproteins are complexes of lipids and proteins with specific roles in 
facilitating exogenous and endogenous lipid transport and metabolism. Lipoprotein 
transport and metabolism are chiefly regulated by the apolipoproteins on the surface of the 
particles, which serve as structural components, ligands for cell receptors, and cofactors 
for enzymes involved in lipoprotein metabolism. Endogenous fat transport is 
accomplished via the synthesis, secretion and catabolism of very low density lipoproteins 
(VLDL) produced in the liver. Exogenous fatty acids are transported from the intestine to 
peripheral tissues and the liver as chylomicrons, large particles rich in triacylglycerols 
(TAG). Produced in the intestine, the chylomicrons transport dietary fat and dietary and 
biliary cholesterol. Nascent chylomicron particles are transported via the lymphatics from 
the enterocytes into the blood where metabolic alteration occurs, initially in peripheral 
tissues where the insulin-sensitive enzyme lipoprotein lipase hydrolyzes the TAG core 
releasing free fatty acids for tissue uptake.
upon loss of its TAG core, the chylomicron particle becomes a very small 
chylomicron remnant The remnant particles are then removed from the circulation via 
the remnant receptor on hepatic membranes (Young, 1990). There is compelling evidence 
that postprandial chylomicrons, and their remnant, are very atherogenic (Weintraub, 
Eisenberg and Breslow, 1987a,b) and increased plasma concentrations levels of these 
particles is regarded as indicative of high risk of atherogenic coronary artery disease 
(Meyer, Westerveld, Deruytermeijstek, Vangreevenbroek, Rienks, Vanrijin, Erkelens and 
Debruin, 1996). Consequently, studying the different factors modulating or regulating the 
synthesis, secretion and catabolism of chylomicron particles and their remnants, is an 
important area for investigation in order further to elucidate the aetiology of atherogenic 
disease states.
Apolipoprotein B48, present on the surface of nascent chylomicrons, has all the 
necessary characteristics to enable it to be used as a marker to trace the chylomicron from 
the enterocytes where it is synthesized until removal from the circulation via the remnant 
receptor on the hepatocytes membrane. Such a marker facilitates study of the synthesis, 
secretion and catabolism of chylomicron particles and their remnant.
1.1 Plasma Lipoproteins
1.2.1 Introduction
Atherosclerosis and associated coronary heart disease (CHD) is a major public 
health problem. Several CHD risk factors including elevated serum total cholesterol, 
elevated serum low density lipoprotein (LDL) cholesterol and low serum high density 
lipoprotein (HDL) cholesterol are influenced by dietary habits. It has been proposed that 
maintenance of appropriate blood cholesterol concentrations may not only reduce risk of 
formation of atherosclerotic plaque (Gordon, Castelli, Hjortland, Kannel and Dawber, 
1977; Castelli, Garrison, Wilson, Abbott, Kalausdian and Kannel, 1986; Stamler, 
Wentforth and Neaton, 1986j ■ , but may also stimulate regression
of atherosclerosis when blood cholesterol concentrations have been reduced (Yamamoto, 
1991). Consequently the potential benefits of changes in both fatty acid type and quantity 
are an area of intense investigation.
Plasma lipoproteins have specific roles in the transport and subsequent 
metabolism of endogenous and exogenous lipids, and each makes its own contribution to 
an individuals CHD risk profile (Ginsberg, 1990). Lipoproteins are complexes of lipids 
and proteins consisting of a hydrophobic core of nonpolar lipids - primarily 
tricaylglycerols and cholesterol esters- with a hydrophilic coat of phospholipid, 
unesterified cholesterol, and apolipoproteins The apoproteins are ligands for cell 
receptors and cofactors for enzymes involved in lipoprotein metabolism. There are four
major classes of lipoproteins; chylomicrons, very low density lipoproteins (VLDL), low 
density lipoproteins (LDL), and high density lipoproteins (HDL). Various subclasses are 
also included such as intermediate density lipoprotein (IDL), a lipoprotein of density and 
composition between VLDL and LDL, and two major classes of HDL, HDLz and HDLg. 
Size heterogeneity and genetically regulated inter-individual variability in the distribution 
of the particles can also exist within each of the major and minor lipoprotein classes 
(Fisher, Blum, Zannis and Breslow, 1983). See Table 1.1
7.7.2 Chylomicrons
Dietary fat and dietary and biliary cholesterol are transported from the intestine to 
peripheral tissues and the liver via large TAG.rich chylomicrons. Apolipoproteins B48, 
A-I and A-IV are present on surface of nascent chylomicrons. Following transport to the 
blood via the lymphatics, chylomicrons acquire apolipoproteins of the C group (C-I, C-II, 
C -m  ) and apolipoprotein E from circulating HDL. In peripheral tissues (principally 
muscle and adipose tissue), after being activated by apolipoprotein C-II on the 
chylomicrons, a capillary endothelial cell surface enzyme, lipoprotein lipase, hydrolyzes 
the core TAG releasing free fatty acid for tissue uptake. The chylomicron becomes 
smaller and is termed a chylomicron remnant. Surface lipids and apoproteins are 
simultaneously released to plasma HDL. The resultant chylomicron remnants are rapidly 
removed from the circulation via remnant receptors recognizing apolipoprotein E
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on hepatic membranes (Young, 1990). They are internalized and digested by the 
hepatocytes.
If prostprandial chylomicrons and their remnant particles are atherogenic in 
normolipidemic individuals (Weintraub et al., 1987a,b), then diets enhancing lower 
concentrations of postprandial chylomicrons and their remnant particles should be 
recommended. Recently, Meyer et al. (1996) observed that fasting apolipoprotein B 48 
levels in women with angiographically proven coronary artery disease were higher than 
their matched controls without coronary artery disease. Also, after a fat load women with 
angiographically proven coronary artery disease showed a greater absolute and 
incremental apolipoprotein B-48 response in the intermediate density lipoprotein fraction.
Nestel and Barter (1973) found that while the quantity of dietary fat did not affect 
the clearance rate of intravenously infused TAGs, dietary fat type had significant effects. 
Patients on raised polyunsaturated fatty acid intake cleared more rapidly the intravenously 
infused TAGs, than patients on high saturated fat or zero fat intakes, both of the latter two 
groups showing similar clearance rates. Recently, Bergeron and Havel (1995) reported 
that after 15 and 29 days of dietary intervention in healthy young men, neither the fatty 
acid composition of the base-line diet nor that of the challenge meal affected chylomicron 
remnant clearance after a fat challenge; however individuals fed a diet rich in saturated 
fatty acids showed prolonged accumulation of hepatogenous TAG-rich lipoproteins. It 
has been recently reported that chylomicron size depends on the fatty acid composition of 
ingested fat and the time course of digestion ( Sakr, Attia, Haourigui, Paul, Soni, Vacher
and Girardgloba, 1997). Chylomicron size was increased by ingestion of polyunsaturated 
fatty acid-rich fats and in the early phase of digestion (4h after ingesting the fat load). 
However, using retinyl ester concentration as a marker, they were unable to demonstrate 
any difference in chylomicron-remnant clearance rates associated with ingestion of 
differing fats.
1.1.3 Very low density lipoprotein (VLDL)
Very low density lipoprotein (VLDL) is synthesized in and released from the liver, 
transporting TAG and cholesterol synthesized in the hepatocytes. Apolipoprotein B-lOO , 
apolipoprotein C (I, H and HI), and apolipoprotein E are present on the surface of these 
VLDL particles. In the circulation, further quantities of cholesterol esters are transferred 
to VLDL from HDL by the action of cholesterol ester transfer protein (CEPT). As in the 
case of chylomicrons, apolipoprotein C n activates endothelial cell lipoprotein lipase that 
in turn hydrolyzes VLDL TAG resulting in the formation of intermediate density 
lipoprotein (IDL). Further hydrolysis of IDL TAG, together with apolipoprotein loss, 
eventually result in the formation of LDL. In fact not all secreted VLDL particles become 
converted to LDL particles. Up to 50% of the newly secreted VLDL can be cleared 
directly via hepatic LDL receptor (Packard, Munro, Lorimer, Gotto and Shepherd, 1984), 
and possibly via the chylomicrons remnant and/or the LDL receptor-related protein 
receptors (Kowel, Herz, Goldstein, Esser and Brown, 1989). IDL can also be cleared via
hepatocyte LDL receptor mechanisms; alternatively conversion to LDL may occur 
following continued intravascular processing.
1.1.4 Low density lipoprotein (LDL)
LDL particles are characterized by the presence of a single apolipoprotein (BlOO), 
on the particle surface with a lipid core containing mainly cholesterol ester. These 
particles are the major cholesterol-carrying lipoprotein in human subjects. Bilheimer, 
Goldstein, Grundy, Stazyl, and Brown, (1984) reported that around 75% of plasma LDL is 
cleared by hepatocytes, and there is a 30-40% turnover of the LDL pool each day. 
Kesaniemi et al. (1983) reported that LDL catabolism occurs chiefly (60-80%) via the 
hepatic LDL receptor-mediated mechanism and the remainder are catabolized in the liver 
by a receptor-independent mechanism(s). Elevated plasma LDL cholesterol level is a 
major CHD risk factor (Stamler et al., 1986). Brown and Goldstein (1986) found that 
expression and activity of the LDL (apolipoprotein B/E/E) receptor, which accounts for 
most of LDL catabolism, is a key regulator for LDL catabolism. Also, numerous studies 
have shown that dietary interventions can affect plasma LDL cholesterol concentrations 
(Mensink and Katan, 1989; Wardlaw and Snook, 1990). Thus, plasma LDL cholesterol 
concentration is determined largely by the relative rates of daily LDL production and 
catabolism. Thus any dietary intervention effecting decreased LDL production and/or 
increased LDL removal is of potential benefit in the avoidance of CHD.
1.1.5 High density lipoprotein (HDL)
Both liver and intestine are involved in the production of HDL which are disk­
shaped particles containing apolipoproteins A-I, E , C-I, n and in, together with 
phospholipid and unesterified cholesterol. HDL particles undergo a cycle of enlargement, 
exchange and contraction. In the circulation, HDL particles acquire phospholipid and free 
cholesterol from lipoprotein lipasejnediated hydrolysis of VLDL and chylomicrons. Free 
cholesterol from cell membranes is also added to HDL particles (McNamara, 1995). 
Further enlargement of the particles may occur because of the presence of an HDL- 
associated enzyme lecithin cholesterol acyltransferase (LCAT). Activated by 
apolipoprotein A-I, LCAT catalyzes the synthesis of cholesteryl ester from free 
cholesterol and phospholipid. Cholesteryl ester is hydrophobic and can move to the core 
of the HDL particles allowing more influx of unesterified cholesterol and phospholipid 
(Tall, 1990). During this cycle of enlargement, particles of the HDL3 subclass enlarge 
forming particles of the HDLz subclass .
Cholesteryl ester formed in HDL particles and TAG from apolipoprotein B- 
containing lipoproteins are exchanged in human and some animal species (Tall,1990). 
HDL cholesteryl esters are turned over at a rate 10-40 times that of major HDL 
apoproteins due to exchange with triacylglycerol-rich lipoproteins and to selective 
removal of HDL cholesteryl esters by the liver and other tissues, (Pittman, Knecht, 
Rosenbaum and Taylor, 1987). In the liver, hepatic TAG lipase hydrolyzes exchanged
TAG and phospholipid reducing the size of enlarged HDL% particles regenerating HDL3 
particles^ the major portion of the plasma HDL subfraction.
1.1.6 Plasma lipoproteins and cardiovascular disease risk
Plasma concentration of both the lipoproteins, and apolipoproteins are strong 
predictors of CHD risk. Some, including apolipoprotein B levels, plasma total cholesterol 
and LDL cholesterol, are positively correlated with disease risk, others such as HDL 
cholesterol (primarily HDLz) (Miller, 1987) and apolipoprotein A-I levels (McNamara, 
1995) are negatively correlated. An important consideration in evaluating dietary 
interventions to lower CHD risk profiles is determination of the ratio of total cholesterol 
to HDL cholesterol or more specifically the LDL cholesterol to HDL cholesterol ratio 
(Gorden gr a l, 1997;Castelli et al., 1986). Also Reinhart, Gani, Arndt and Broste, (1990) 
suggested that apolipoproteins such as apolipoprotein B and apolipoprotein A-I are even 
better discriminators for CHD risk than plasma lipid or lipoprotein levels. It was reported 
that apolipoprotein B levels are elevated while apolipoprotein A-I and apolipoprotein A-II 
are reduced in subjects with diagnosed CHD.
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1.2. Gastrointestinal Lipid Absorption
7.3.7 Introduction.
A large portion of the human dietary intake consists of lipids (about 100 g/day). 
In addition, another 40 to 50 g of lipid enters the gut, mainly from bile together with small 
amounts contributed by bacteria and sloughed mucosal cells (Davidson, Magun and 
Glickman, 1991). A healthy person passes around 4-6g of lipid in the daily stool (Carey 
et al., 1983) indicating that the digestive system absorbs more than 95% of ingested 
lipids. Dietary lipid consists mainly of TAG and small quantities of phospholipids, 
cholesterol and cholesterol esters. Lipolysis of phospholipids and cholesterol esters 
liberates fatty acids of different chain lengths for absorption.
The process of enteric lipid absorption and transport involves four major phases: 
intraluminal digestion and solubilisation; mucosal uptake; intracellular reesterification 
and lipoprotein synthesis and finally export from the enterocyte to lymph and hence to 
circulating blood. Absorption of dietary fat from the intestine is dependent on prior 
lipolysis. In this process four forms of lipolytic enzyme and one coenzyme are secreted 
into the gastrointestinal tract These are acid lipase, pancreatic lipase, carboxyl ester 
lipase and phospholipase A2 together with pancreatic colipase.
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7.2.2 Acid lipase
Acid lipase includes both the lingual and gastric lipases. The former is secreted 
by serous (Ebner’s) glands on the posterior lingual surface in both rat (Hamosh, 1978) and 
man (Hamosh and Bums, 1977), while gastric lipase, secreted from the antral foveoli, is 
found in gastric juice (Tiruppathy and Balasurbramanian, 1982). Stimulation of lingual 
lipase secretion occurs after a diet rich in fat or after a mechanical factor such as suckling 
(Hamosh, 1978). Acid lipase is active against ester bonds of long-chain fatty acid 
triacylglycerols but has greater activity against ester bonds where medium-chain length 
fatty acids and tributyrin contribute to the composition of the TAG. Patton et a / (1982) 
have shown that ester bonds associated with saturated fatty acids such as palmitic acid 
(16:0) and myristic acid (14:0) are not hydrolyzed by rat lingual lipase.
In contrast to pancreatic lipase, which is inhibited by hydrophobic proteins and 
phospholipids, that accumulate at the oil/aqueous phase interface, acid lipase is not 
dependent for its activity on a clean interface (Borgstrom and Patton, 1991). Thus, acid 
lipase initiates lipolysis of dietary TAG in the stomach liberating short and medium chain 
fatty acids that diffuse into the aqueous phase of the dietary TAG.
Although the ingested lipid and lingual and gastric lipases remain in the stomach 
for 2-4 hours, the degree of digestion is trivial (Borgstrom and Patton, 1991). More 
optimal conditions for lipid digestion and absorption are provided by the lumen and 
mucosa of the upper small intestine where the medium is less proton-rich. Pancreatic
12
lipase has greater activity than lingual and gastric lipases and the bile salts have the 
propensity to form micelles which are amphipathic polymolecular aggregates forming 
when bile salt concentration exceeds the critical micellar concentration of about 2 
mmol/L.
1.2.3 Pancreatic lipase
Pancreatic lipase, acts upon dietary fat in the small intestine. In order to allow 
lipase to bind to the substrate interface in the presence of bile salts, colipase is obligatory 
(Borgstrom, 1975; Borgstrom, 1976). Colipase is secreted into the pancreatic juice as 
procolipase, activated by tryptic cleavage of the N-terminal pentapeptide (Borgstrom et 
al., 1979). In the presence of micellar bile salts, colipase binds to fat droplets and serves 
as an anchor for pancreatic lipase at the fat droplet surface. The presence of long chain 
fatty acids in the fat droplets greatly increases the affinity of lipase for its substrates in the 
presence of colipase (Donner et a l, 1976) indicating the role of acid lipase in partially 
hydrolyzing dietary fat in the stomach and thus enhancing the lipase-colipase system 
located more distally in the digestive system.
Carboxyl ester lipase is also secreted into the pancreatic juice and its main 
substrates are 1- and 2-monoacylglycerol, sterol esters, vitamin A and D esters, and 
lysophospholipids (Lombardo et a l, 1980). Although the specific activity of carboxyl 
ester lipase is low, compared with pancreatic lipase, against substrates hydrolyzed by both
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enzymes (Momsen and Brockman, 1977), the former principally hydrolyzes substrates 
containing carboxyl esters (Rudd and Brockman, 1984). Bhat and Brockman (1982) 
suggested a special role for carboxyl ester lipase in the uptake of cholesterol and its esters 
from the lumen. Bile salts are essential activators of carboxyl ester lipase enzyme activity 
when the substrate is water insoluble (Hyun et ah, 1969), however, when the substrate is 
water soluble, the presence of bile salts increases enzyme activity by 7 to 10 fold.
Phospholipase A%, is secreted as an inactive proenzyme into the pancreatic juice, 
and is activated by tryptic cleavage of the N-terminal heptapeptide (Borgstrom and Patton, 
1991). Dietary phospholipids e.g. phosphatidylcholine are hydrolyzed liberating a free 
fatty acid molecule and lysophosphaphatidyl choline which are absorbed as such (Arnesjo 
et al., 1969; Blackberg and Hemell, 1983). Phosphatidylcholine, 
phosphatidylethanolamine, phosphatidylseiine and cardiolipin are all phospholipase A% 
substrates (Borgstrom and Patton, 1991).
1.2.4 Intracellular transport and metabolism o f triacylglycerol, cholesterol and 
phospholipid
1.2.4.1. Triacylglycerol. Short- and medium-chain fatty acids (SCFA), with chain 
lengths less than 14C, differ from long-chain fatty acids (LCFA) in two respects 
(Dietschy, 1978; Thompson and Dietschy, 1981): First, bile salts are not necessary for 
their absorption because these fatty acids have a higher polarity that increases their
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solubility as monomeric dispersions and they are thus easily absorbed without micellar 
involvement (unlike LCFA). Second, once absorbed, SCFA do not undergo intracellular 
activation to their CoA derivatives indicating that these fatty acids are not reassembled 
into complex lipid intracellulary but move directly into the portal vein as free fatty acids. 
This phenomenon is yet unclear but possibly it is related to their low affinity for the 
cytosolic fatty acid-binding proteins (liver- or intestinal-FABP ) within the enterocytes 
(Davidson et a l, 1991). The cytosolic FABPs may serve in targeting the absorbed fatty 
acid to particular compartments within the enterocyte for incorporation into complex 
lipids such as TAG, phospholipid and cholesteryl ester. It has been found that the 
intracellular concentration of FABPs is greater in the jejunum than the ileum, in the villi 
than the crypt and in intestinal mucosa of animals fed a high-fat diet than animals fed a 
low-fat diet (Norum, Helgerud, Petersen, Groot and Dejonge, 1983).
In addition to passive diffusion of LCFA, there is evidence to suggest the 
presence of a ligand with a specific affinity for LCFA, in the intestinal brush border 
membrane. (Stremmel, Strohmeyer and Berk, 1985). This ligand, microvillus membrane 
fatty acid-binding protein (MVM- FABP ), binds to and coelutes exclusively with LCFA 
(Davidson et a l, 1991). The membrane-bound FABP are both spatially and functionally 
distinct from the previously described cytosolic FABPs. While the former have a trans­
membrane transport function, the latter have an intracellular transport function.
Within the enterocyte, TAG is synthesized via two pathways: The 
monoacylglycerol and the glycerol 3-phosphate pathways (Coleman, Walsh, Millington
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and Maltby,1986|.\ _ During fasting, the intestine contributes between 10
% and 40 % of circulating TAG (Ockner, Hughes and Isselbacher, 1969â;Popper, Shiau 
and Reed, 1985) and via the glycerol 3-phosphate pathway i f  Popper et
a l, 1985). The source of lipid substrate in this pathway is either glycerol 3-phosphate 
derived from glucose metabolism (Popper et al., 1985; Parthasarathy, Papasani and 
Ganguly, 1974) or lysolecithin derived from bile (Parthasarathy et a l,  1974). The 
enzymes catalyzing this synthesis are found in the rough endoplasmic reticulum (Higgins 
and Barnett, 1971). A significant amount of intracellular 2-monoacylglycerol inhibits 
TAG synthesis via the glycerol 3-phosphate pathway and this is what happens during the 
fed state (Polheim, David, Schultz, Wylie and Johnston, 1973). With the onset of 
digestion, a TAG molecule is hydrolyzed into 2-monoacylglycerol and fatty acids. Once 
they enter the enterocyte they are resynthesized into t a g  via the monoacylglycerol 
pathway (Kayden, Senior and Mattson, 1967). The enzymes acyl foA  synthetase and 
mono- and diacylglycerol acyltransferase, catalyzing the reacylation of 2- 
monoacylglycerol to % m  TAG within the enterocyte (Kayden et a l, 1967; Mattson and 
Volpenhein, 1964), have been localized to the smooth endoplasmic reticulum (SER) 
(Higgins and Barnett, 1971). It appears that diacylglycerol produced by the 
monoacylglycerol pathway is in a different intracellular pool than diacylglycerol f r o m  
the glycerol 3-phosphate pathway (Johnston, Rao, and Lowe, 1967). Consequently TAG 
synthesis is most probably occurring in two different intracellular compartments within 
the enterocyte depending on the fasting or the fed state.
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L2A.2. Cholesterol The hydrophobic cholesterol molecule is currently believed to 
traverse the lipid bilayer by passive diffusion which process is critically dependent on 
micellar solubilization of cholesterol (Davidson et a l, 1991). In addition to dietary and 
biliary cholesterol, the enterocytes are capable of de novo cholesterol synthesis from 
acetyl-foenzyme A (Davidson et a l, 1991). In the rat model, small intestinal cholesterol 
synthesis account for about 25% of the total daily synthesis (Tso and Gollamudi, 1984). 
Also the enterocytes express specific LDL receptors (Pittman, Attie, Carew and Steinberg, 
1982) and appear to exhibit receptor-mediated endocytosis of circulating plasma LDL. A 
further source of enterocyte cholesterol has been reported to be the internalization of LDL 
by non-receptor mediated pathways (Spady, Turley and Dietschy, 1985).
Intracellular transport of cholesterol to different locations is facilitated by mean of 
a specific carrier protein (Chanderbhan, Nolan, Scallen and Vahouny, 1982) referred to as 
sterol carrier protein 2 (SCP2). Addition of exogenous SCP2 to isolated intestinal 
microsomes enhanced cholesterol estérification (Gallo, Myers and Vamouny, 1984). 
Also, SCP2 facilitates conversion of several microsome-located precursors to cholesterol 
(Noland et a l, 1980). Thus cholesterol synthesis and its metabolic targeting either to 
membrane cholesterol or for estérification is the major function of this protein. 
Cholesterol absorption by the enterocytes appears to be specific, since p-sitosterol (a plant 
sterol resembling cholesterol) is poorly absorbed by normal human subject (Connor and 
Lin, 1981)
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1.2.4.3 Phospholipids. Phospholipid, principally lecithin, is hydrolyzed to lysolecithin 
and fatty acid, which are absorbed and form substrates for lecithin synthesis. 
Phospholipid synthesis within the enterocyte also occurs via two major pathways 
determined by the luminal concentration of phospholipid: either reacylation of absorbed 
lysolecithin (Scow, Stein and Stein, 1967; Nilsson, 1968) or by the phosphatidic acid- 
phosphorylcholine pathway (Nilsson, 1968; Coleman and Bell, 1978; Noma, 1964). At 
high luminal concentration of phospholipid, e.g. with enteric infusion of lecithin, all 
lecithin appearing in chylomicrons is derived from reacylation of absorbed lysolecithin 
(Mansbach, 1977). However, in both fasting and postprandial states, where the luminal 
phospholipid concentration is low, chylomicron lecithin is derived from diacylglycerol 
and cytidine diphosphate (CDP) choline (Mansbach, 1977; Shiau, 198Ï). CDP choline is 
derived from dietary choline, and diacylglycerol from glucose (Noma, 1964).
1.2.5. Intracellular localisation o f lipid processing.
Kessler, Narcessian and Mauldin, (1975) used radiolabeled oleate, leucine and 
glucosamine in order to locate sites of lipid, protein, and monosaccharide synthesis 
relating to formation of the intracellular chylomicron precursor and showed that these 
substrates are synthesized in the smooth endoplasmic reticulum, rough endoplasmic 
reticulum and Golgi apparatus respectively. These organelles which form the 
endomembrane system (Morre, 1977) are closely related; For instance the newly 
synthesized protein is glycated at both endoplasmic reticulum and Golgi apparatus 
(Schachter, 1974).
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Using fasting jejunal biopsies, absorptive cells at the villus apices were shown to 
accumulate apolipoprotein B (the high-molecular weight hydrophobic apoprotein 
synthesized in the intestine as a surface component of TAG-rich lipoproteins) label within 
the rough endoplasmic reticulum and Golgi cistemae (Christensen, Rubin, Cheung and 
Albers, 1983); After fat feeding, apolipoprotein B label was found adjacent to both 
chylomicrons and very low density lipoprotein (VLDL) within the apical smooth 
endoplasmic reticulum (Christensen et al., 1983). The apolipoprotein B label was also 
found at the rough endoplasmic reticulum but less than before (Christensen et a l, 1983). 
This was interpreted as apolipoprotein B synthesis in the rough endoplasmic reticulum, 
transfer to the smooth endoplasmic reticulum followed by addition onto the lipoprotein 
particles. However no explanation was offered for the finding of apolipoprotein B on the 
Golgi vesicle membrane. It has been since been shown that in the liver, t a g  
phospholipid and apoprotein are added to nascent lipoproteins in Golgi apparatus 
(Dolphin, 1985; Higgins and Fieldsend, 1987). More recently. Swift (1996) utilizing rat 
hepatic Golgi apparatus-rich fraction in an in vitro study demonstrated that the Golgi 
apparatus is a site at which phosphorylation of apolipoprotein B occurs, suggesting that 
apolipoprotein B phosphorylation may be a step in the assembly and secretion of 
apolipoprotein B-containing lipoproteins. If similar processes occur in enterocytes, the 
presence of apolipoprotein B in the Golgi membrane vesicles is thus explained.
Pluronic L-81, a non ionic hydrophobic surfactant, inhibits the intestinal formation 
and transport of chylomicron, but not VLDL sized particles (Tso, Balint and Rodgers,
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1980; Tso et a l, 1981; Tso, Buch, Balint and Rodgers, 1982; Tso and Gollamudi, 1984; 
Tso, 1985) resulting in most of the lipid being accumulated in the smooth endoplasmic 
reticulum of the enterocyte. The unaffected VLDL-sized particles pass to the Golgi 
apparatus where they are packaged prior to release from the enterocyte as the ultimate 
VLDL (Sabesin, Frase and Tso, 1985). It thus appears that important modification of the 
chylomicron precursor is taking place in the Golgi apparatus.
Swift, Soule, Gary and LeQuire, (1984), comparing compositions of lymphatic 
VLDL and intestinal Golgi VLDL from chow-fed rats, found significant changes in 
TAG -  rich lipoproteins prior to release by the enterocytes. Consistent with this 
observation, Lambert, Bothan and Mayes, (1996) reported that the predominant fatty acids 
in a fat load, administered to rats, also predominated in their respective chylomicrons, but 
their proportions were reduced during the processes leading to their formation. Thus, 
following acute fat or oil intake, the resulting chylomicrons and chylomicron remnants 
show a more balanced distribution of saturated, mono- and polyunsaturated fatty acids 
than the oils and fats from which they were derived (Lambert et a l, 1996).
1.2.6 Intracellular and extracellular transport o f triacylglycerol-rich lipoproteins
Two mechanisms have been suggested to explain intestinal triacylglycerol-rich 
lipoproteins transport from the endoplasmic reticulum to the Golgi apparatus of 
enterocytes. The first envisages the smooth endoplasmic reticulum giving rise to
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lipoprotein particle-containing vesicles which fuse with the Golgi apparatus (Friedman 
and Cardell, 1977; Jersild, 1966; Lacy and Taylor, 1962). The second envisages physical 
connections in the form of tubules ("boulevard périphérique") between smooth 
endoplasmic reticulum and Golgi apparatus, transporting lipoprotein particles between 
the two organelles (Ovtracht, Morre, Cheetmam and Mollenhauer, 1973; Morré, 
Kartenbeck and Franke, 1979).
After being assembled and processed, the triacylglycerol-rich lipoproteins are 
secreted from the basolateral borders of the enterocytes into the lymphatics. During fat 
absorption the enterocyte exhibits an increase in phospholipid turnover (Hubscheq Smith 
and Gurr, 1964) believed to reflect increased membrane turnover during exocytosis. 
Vesicles containing triacylglycerol-rich lipoproteins are derived from the Golgi apparatus 
of absorbing lipid enterocytes (Sabesin and Frase, 1977).
The triacylglycerol-rich lipoproteins do not contain surface membrane indicating 
that Golgi vesicle membrane is not co-exocytosed during chylomicron secretion (Tso and 
Balint, 1986). However, the membrane vesicles, fused with plasmalemma, are recycled to 
the Golgi apparatus either directly or indirectly via lysosomes (Farguhar, 1983; Farguhar 
and Palade, 1981; Herzog and Farguhar, 1977; Herzog and Herggio, 1980).
Glickman, Perrotto and Kirsh, (1976) demonstrated microtubules involvement in 
intestinal chylomicron secretion. In the rat model, treatment with colchicine (a 
microtubule inhibitor) was followed by a striking decrease in the amount of radiolabeled
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fat appearing in the lymph. At the same time, colchicine was without effect upon fatty 
acid uptake or apolipoprotein and TAG synthesis. Calcium appears to play a role in the 
intestinal transport of lipoprotein . In the everted hamster intestinal sac, Strauss (1977) 
and Strauss and Jacob (1981) reported that calcium was necessary for the formation and 
release 0/  chylomicron-like particles. In < another study Saunders and Sillery (1979), 
using rat jejunum in vitro showed that the presence of 2 mM calcium in the incubating 
medium doubled the rate of transport of radiolabeled triacylglycerol.
In the absence of active fluid and electrolyte absorption, the lateral membranes of 
neighboring enterocytes are closely apposed with separation of 15-30 nm (Dibona, Chen 
and Sharp, 1974). After fluid absorption the intercellular space increases to 2-3 qm (Tso 
et a l, 1980; Dibona et a l, 1974). The enterocytes are in close contact with the basement 
membrane that separates the basal portion of the enterocyte plasmalemma from the lamina 
propria. Tso and Balint (1986) suggest that the basement membrane may be produced by 
both the enterocytes and fibroblasts in the lamina propria. Electron micrography (Trier 
and Madara, 1981) showed the basement membrane as a continuous sheet of amorphous 
or fine fibrillar material. The passage of chylomicron from the intercellular space to the 
lamina propria occurs via occasional gaps in the basement membrane (Tytgat, Rubin and 
Saunders, 1971). Tso and Balint (1986) consider the gaps as stretch-induced breaks 
caused by chylomicron accumulation during active lipid absorption. Consequently the 
breaks may facilitate movement of accumulated chylomicrons from the intercellular space 
to the lamina propria. The lamina propria occupies the central cone of an intestinal villus. 
It is made up of connective tissue that contain numerous types of cells (plasma cells.
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lymphocytes, macrophages, a few mast cells fibroblasts, etc.), unmyelinated nerve fibers, 
blood and lymph vessels, smooth muscle cells, collagen and elastic fibers and hyaluronic 
acid (Tso and Balint, 1986). There appear to be two pathways permitting passage of 
chylomicrons from the lamina propria to the central lacteal of the lamina propria; 
vesicular transport through unfenestrated lacteal endothelial cells (Trier and Madara, 
1981) and transport of chylomicrons through gaps observed between neighboring 
endothelial cells (Tso and Balint, 1986).
In order to reach the lacteal from the intercellular space, the chylomicron particles 
have to migrate around 50 \im (Granger, 1981). Extensive studies have shown that 
chylomicron transport across the lamina propria might not be due only to simple 
diffusion, but could be greatly facilitated by convective fluid movements arising from 
fluid absorption. Studies by Shepherd and Simmonds (1959) and Barona and Lieber 
(1975) suggest that the time required for the chylomicron to migrate from the intercellular 
space to the central lacteal is affected by the rate of lymph formation. Tso, Pitts and 
Granger (1985) reported that when lymph flow is less than 40 pl/minute, the time between 
the introduction of radiolabeled fatty acids into the intestinal lumen and the appearance of 
radiolabeled chylomicrons in the intestinal lymph duct, was inversely proportional to flow 
rate. When the lymph flow rate exceeded 40 pl/min, chylomicron appearance time 
reached a minimum value of 13.6 min which was considered to be the minimum time 
required for reesterification of absorbed fatty acids, formation of chylomicrons and their 
subsequent transport into the intestinal lymphatics.
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To demonstrate that the fluid generating increased lymph flow rate during fat 
absorption is coming mainly from the intestinal lumen, and not deriving from increased 
capillary ultrafiltration as has been suggested (Barrowman, 1978; Borgstrom and Laurell, 
1953; Simmonds, 1955), Tso et a l (1985) infused the rat duodenum with an electrolyte 
solution, consisting of choline chloride and maltose, to reduce luminal water absorption. 
Under these conditions, lymph flow was significantly reduced during fat absorption. This 
observation is correlated with increased luminal fluid absorption leading to increased 
intestinal lymphatic flow reported to occur during fat absorption
It has been shown that in the nonabsorptive state the average pore radius of the 
intestinal interstitial matrix is 25 nm (Granger, 1981). However^ in the absorptive state 
the average pore radius increases up to 100 nm facilitating passage of chylomicrons 
across the lamina propria. Thus, two possible mechanisms for chylomicron transport into 
the lymphatics are proposed. Whether the convective flux effect of lymph flow or the 
modification of the resistance to chylomicron movement within the interstitial matrix, or 
both mechanisms, enable transport of chylomicron into the lymphatic vessels, remains to 
be elucidated.
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1.3 Enterocyte Lipoproteins
1.3.1 Introduction
During lipid absorption, absorbed lipid material combines in specific patterns with 
enterocyte apoproteins to form lipoproteins. The lipoproteins consist of a core o f apolar 
lipids (TAG, cholesterol ester) surrounded by a polar surface coating of phospholipid, 
protein and free cholesterol. Apolipoproteins B48, apolipoprotein A-I, and apolipoprotein 
A-IV, the major apolipoproteins synthesized in the intestine, are assembled into 
lipoprotein particles and secreted as chylomicrons, VLDL and HDL particles (Davidson et 
al., 1991). LDL particles may also be formed (Magun, Mish and Glickman, 1988).
1.3.2 Chylomicron, VLDL and HDL
During fasting periods, the only source of lipid is bile and digested sloughed 
enterocytes. During fasting only VLDL and HDL are formed and secreted by the 
enterocytes into the lymph (Davidson et al., 1991). HDL particles contain 70 % protein 
and 30 % lipid, one half of which is phospholipid (Magun, Brasitus and Glickman 1985). 
These small discoid particles, unlike VLDL and chylomicron, may be secreted directly 
into venous blood (Jones and Ockner, 1971) to reach the hepatic portal vein.
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Fasting combined with bile diversion reduces lymphatic TAG concentration by 
85%, and results in almost complete disappearance of VLDL from the enterocyte Golgi 
bodies (Jones and Ockner, 1971). This has been taken to indicate that intestinal VLDL 
production under fasting conditions provides a mechanism for absorption of lipids 
(sloughed enterocytes and bile lipids) from the intestine and their secretion into the 
lymphatics (Green and Glickman, 1981). About 50 % of TAG and cholesterol in fasting 
rat lymph are transported as VLDL (Green and Glickman, 1981).
In addition to VLDL size particles, chylomicrons, absent in the fasting mucosa, 
appear in huge numbers in the enterocyte and lymph after intestinal lipid infusion. 
Intracellular chylomicrons isolated from Golgi organelles contain 75 % - 85 % lipid (two 
thirds of which is TAG) and 13 %- 25 % protein (Magun et a l, 1988; Green, Tall and 
Glickman, 1978). However, secreted chylomicrons in mesenteric lymph contain 1 % 
protein, 84 % t a g  , 13 % phospholipid and 2 % cholesterol (Green and Glickman, 
1981). This difference in chylomicron composition may be due to modifications during 
intracellular assembly and/or to extracellular postsecretory modifications.
Chylomicrons secreted by the enterocytes are heterogeneous in size. Two factors 
affect the size of chylomicrons (Feldman, Russell, Chen, Johnson, Forte and Bennett 
Clark, 1983): The quantity and type of lipid being absorbed; as the quantity of TAG being 
absorbed increases, chylomicron size increases. TAG composition of newly formed 
chylomicrons affects the size of the chylomicrons. Chylomicron size increases as the 
lipid in the chylomicron become less saturated (Feldman et a l, 1983). For example.
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palmitate (a saturated fatty acid) feeding results in the formation of smaller chylomicrons 
than when unsaturated fatty acids are fed (Ockner et a/., 1969^. The formation of large 
chylomicrons during maximal lipid absorption allows more TAG transport while surface 
constituents (apoproteins and phospholipids) that need active synthesis by the enterocyte 
are conserved (Green and Glickman, 1981; Bishaier and Glickman, 1985). Degrace, 
Caselli, Rayo and Bernard (1996), also reported that, in adult male rats following 
intragastric instillation of a single bolus of butter, com oil, cod liver oil, menhaden oil, or 
ethyl esters of eicosapentaenoic and docosahexaenoic acids, chylomicron size was largest 
with com oil, smaller (but more numerous) with cod liver oil, and smallest with ethyl 
esters of docosahexaenoic acids.
1.3.3 Chylomicron and VLDL as two different lipoproteins
Chylomicron and VLDL are both TAG-rich lipoprotein secreted by the intestine. 
Lipoproteins having Svedberg flotation (Sf) coefficients between 20 - 400 are classified as 
VLDL while those with Sf larger then 400 are regarded as chylomicrons (Lindgren, Jensen 
and Hatch, 1972). Whether those TAG-rich lipoproteins are identical populations of 
different sizes or they are two separate populations, each having its own biosynthetic 
pathway, has been the subject of extensive study.
Intraduodenally infused palmitate caused a marked increase in VLDL transport but 
when oleate and linoleate are infused, only chylomicron output increased markedly; the
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fatty acid composition of chylomicron TAG differed from the VLDL TAG (Ockner et a l, 
1969). This supports the hypothesis that intestinal chylomicron and VLDL are produced 
by separate pathways. Later, it has been reported that intestinal Golgi vesicles contained 
either chylomicron or VLDL particles with little mixing of particle sizes (Mahley, 
Benneti, Morré, Gray, Thistethwaite and LeQuine, 1971). Further supporting evidence 
was provided by Vahouny, Blendermann, Gallo and Treadwell, (1981) who reported that 
puromycin-treated male rats were unable to incorporate radiolabeled leucine into 
chylomicron peptides. By contrast, puromycin had no significant effect on radiolabeled 
leucine incorporation into VLDL-peptides. Intraduodenal infusion of egg 
phosphatidylcholine in the rat resulted in lymphatic VLDL transport unaffected by 
pluronic L-81 administration (Tso et a l, 1981). However, pluronic L-81 administration 
almost completely inhibited lymphatic transport of lipid after triolein infusion suggesting 
that triolein infusion results predominantly in chylomicron formation (Ockner et al., 
1969; Mahley et al., 1971; Vahouny, Blendermann, Gallo and Treadwell, 1981; Tso et al., 
1984). Further experiments are required to characterize the differences in the formation 
and transport of intestinal chylomicron and VLDL in relation to dietary lipid composition.
1.3.4 Fate o f blood-borne enterocyte lipoprotein secretions.
After entering the intestinal lymphatic vessels, the chylomicrons are delivered to 
the bloodstream through the thoracic duct. Chylomicron TAG transported from the 
intestine (in chylomicrons) and hepatic VLDL TAG are hydrolyzed by lipoprotein lipase
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in extrahepatic tissues. Lipoprotein lipase is present principally upon the glycocalyx of 
the capillary endothelium of skeletal muscle and adipose tissue and hydrolyzes 80% - 
90% of the TAG mass (Young, 1990). Hydrolysis releases monoacylgycerols and free 
fatty acids for uptake and subsequent metabolism in tissue cells. Millions of TAG 
molecules forming the bulk of a chylomicron particle can be unloaded in less than 10 min 
leaving a chylomicron remnant particle. The latter can be either removed rapidly from 
plasma via remnant receptors on hepatic membranes (Young, 1990) or remodeled into 
more slowly catabolized LDL and HDL which thus predominate in plasma (Olivecrona, 
1995). Lipoprotein lipase can also serve as a ligand for binding of lipoproteins to cell 
surfaces and to receptors; when the tissue n o a s s i m i l a t e s  the free fatty acids, lipolysis 
is reduced by end-product inhibition and the lipoprotein returns to the circulating blood 
(Olivecrona, 1995).
In blood, the chylomicron remnants are further metabolized by hepatic lipase after 
which they are taken up by a remnant receptor that recognizes apolipoprotein E (Young, 
1990). /apolipoprotein B appears not to be involved in the interaction between the 
chylomicron remnant and its hepatic remnant receptor (Hui, Inneravity, Milne, Marcel and 
Mahley, 1984). After being internalized the remnant particles are digested by hepatic 
lysosomes, and the resulting cholesterol is esterified and stored as cholesterol ester for 
later use for bile acids synthesis or alternatively for synthesis of hepatic lipoproteins 
(Havel and Kane, 1989).
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Normally chylomicrons reside in the plasma for only 5-10 minutes (Grundy and 
Mok, 1976; Stalenhoef, Mallay, Kane and Havel, 1984) and in consequence, 
apolipoprotein B48 concentration in the plasma is very low. In human subjects, Karpe 
and Hamsten (1994) reported that apolipoprotein B48 concentration increases from 0.7 
mg/1 to 2.1 mg/1 after 3h of a meal rich in fat, as determined by relative staining intensity 
of the two bands derived from chylomicrons and VLDL on SDS-polyacrylamide gels.
1.4 Apolipoprotein B
1.4.1 Introduction
Apolipoprotein B is a high-molecular weight hydrophobic apoprotein synthesized 
in mammalian liver and intestine as a surface component of both TAG-rich lipoproteins 
(chylomicrons and VLDL) and low density lipoprotein (LDL) (Bell-Quint, Forte and 
Graham, 1981; Elovson, Huang, Baker and Kannan 1981; Krishnaiah, Walker, 
Borensztajn, Schonfeld and Getz, 1980). Apolipoprotein B occurs in two forms differing 
in molecular mass: apolipoprotein B48 and apolipoprotein B-100. The former is 
synthesized predominantly, in the rat model solely, in the intestine while the latter is 
synthesized in the liver. The name of apolipoprotein B48 comes from the fact that it 
appears to be about 48% the size of apolipoprotein B-100 on sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis (Kane, Hardmans and Paulus, 1980).
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Apolipoprotein B48 is essential for the packaging and secretion of TAG-rich lipoproteins 
and thus has an obligatory role in the intestinal absorption of dietary lipid.
1.4.2 Mechanism o f apolipoprotein B48 formation
In human, the apolipoprotein B gene is located on the chromosome 2 (Mehrabian, 
Sparkes, Mohandas, Klisak, Schumaker, Heinzmann and Zollman, 1986; Huamg, Miller, 
Bruns and Breslon, 1986; Law, Lee, Monge, Brewer Jr., Sakaguchi and Naylor, 1985; 
Knott, Rail Jr., Innerarity and Jacobson, 1985). Spanning about 43KB, the apolipoprotein 
B gene contains 29 exons and 28 introns (Blackhart, Ludwig, Peirotti, Caiati, Onasch, 
Wallis, Powell, Pease, Knott, Chu, Mahley, Scott, McCarthy and Levy-Wilson, 1986). 
Exon 26 (7,572 bases) is longer than any previously reported exon of any mammalian 
gene (Blakhart et a l, 1986). In 1987, three different investigators reported almost 
simultaneously the mechanism of Apolipoprotein B48 formation (Chen, Habib and Yang, 
1987; Powell, Wallis et al., 1987; Hospattankar, Higuchi, Law, Meglin and Brewer Jr., 
1987). They found that both Apolipoprotein B-100 and apolipoprotein B48 are produced 
by the same gene. In contrast to the cytosine residue at nucleotide 6,666 in liver 
apolipoprotein B cDNA clones, a thymidine residue was demonstrated at that same 
position in intestinal apolipoprotein B cDNA Such a substitution yields an in-frame stop 
codon (TAA) instead of CAA codon coding for glutamine at position 2153 in 
apolipoprotein B-100. Consequently apolipoprotein B48 found in plasma contains the N- 
terminal 2,152 amino acids of a  polipoprotein B-100 (Young, 1990). The stop codon
31
present in intestinal apolipoprotein B48 mRNA (Chen et al., 1987) but not in intestinal 
genomic DNA (Powell et ah, 1987) indicates that the primary apolipoprotein B transcript 
undergoes co- or posttranscriptional modification (Young, 1990).
Driscoll, Wynne, Wallis and Scott, (1989) suggested a mechanism for 
apolipoprotein B mRNA editing. They proposed that a tissue-specific enzyme, 
recognizing a specific sequence within the apolipoprotein B mRNA deaminates cytosine- 
6,666 at position 4, creating a uracil residue. Another study (Davidson, Powell, Wallis 
and Scott, 1988a) suggested the possibility of hormonal regulation since after 
triiodothyronine administration to the rat liver, which synthesizes both forms of 
apolipoprotein B, only apoHpoprotein B48 was synthesized by the hepatocyte
Fetal human intestine appears to synthesize both forms of apolipoprotein B with a 
developmentally regulated switch to apolipoprotein B48 occurring late in gestation 
('Goodman&Blana:1984)j . It has been shown (Demmer, Levin, Elovson, Reuren, Lusis and 
Gordon, 1986) that apolipoprotein B gene expression increases at birth with a decline 
until day 8 after which a second increase occurs followed by an another decline to a 
minimum. Apolipoprotein B gene expression then increases to adult levels. The 
mechanism involved in the developmental changes in apolipoprotein B gene expression is 
still unknown. Recently, it has been demonstrated that human fetal colonic explants 
elaborated most of the major lipoprotein classes but showed a lower efficiency than 
jejunal explants in exporting chylomicrons, VLDL and HDL into the medium (Levy, 
Loirdighi, Thibault, Nguyen, Labuda, Delvin and Menard, 1996a).
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1.4.3 Dietary regulation o f apolipoprotein B48 synthesis
Although apolipoprotein B has an obligatory role in the assembly and secretion of 
TAG-rich lipoproteins, it has been found that neither acute nor chronic dietary TAG 
augmentation has a regulatory function on apolipoprotein B synthesis (Davidson, Kollmer 
and Glickman, 1986). Another study by Davidson, Magun, Brasitus and Glickman, 
(1987) on rats fed either butter fat or com oil (30-35 % by weight) indicated that dietary 
fat saturation has no effect on apolipoprotein B48 synthesis by the intestine. However, 
Davidson, Drewek, Gordon and Elovson, (1988a) have revealed that various components 
of bile may regulate apolipoprotein B gene expression. Specifically, bile diversion 
reduces apolipoprotein B synthesis which is reexpressed following introduction of fatty 
acids and bile salts. Apolipoprotein B synthesis regulation appears to be dependent upon 
the presence of a fatty acid substrate for microsomal TAG assembly. Thus, when a 
threshold level is reached, intestinal apolipoprotein B synthesis is re-expressed but any 
increase above the threshold level produces no further change in apolipoprotein B 
synthesis (Davidson etal., 1991).
In contrast to fatty acids, cholesterol seems to have an important effect upon the 
regulation of apolipoprotein B synthesis. Sorci-Thomas, Wilson, Johnson, Williams and 
Rudel, (1989a) reported that African green monkeys fed a diet moderate in cholesterol 
showed a 30 % increase in intestinal apolipoprotein B mRNA compared to animals fed a 
low cholesterol diet The increased intestinal apolipoprotein B mRNA abundance could
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be due to an increased cholesterol transport in chylomicrons resulting in more 
chylomicrons and apolipoprotein B production (Sorci-Thomas et a l, 1989a).
lA A  Intracellular apolipoprotein B48 distribution
If intracellular protein synthesis is inhibited, immunofluorescence measurements 
of intracellular apolipoprotein decrease (Glickman, Kilgore and Khorona, 1978), the 
lymph chylomicron size and the lymph chylomicron t a g  -  to-phospholipid ratio 
increases (Glickman, Kirsch and Isselbasher, 1972), and t a g  droplets accumulate 
within the enterocyte (Sabesin and Isselbacher, 1965). Studies on intracellular 
distribution of apolipoproteins have shown that during lipid absorption, apolipoproteins 
from a large nonlipoprotein-associated pool are shifted onto nascent forms of lipoproteins 
(Magun et a l, 1988; Alpers, Lock, Lancaster, Poksay and Schonfeld, 1985). Although 5 
% -10 % of apolipoprotein B are mobilized onto nascent form of lipoproteins under such 
conditions, the percentage of apolipoprotein B moved onto nascent chylomicron is tripled 
(Magun et a l, 1988). During fasting, more than 90% of intracellular apolipoprotein B is 
found in the non-associated form in the microsomal fraction (Magun et a l, 1988).
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1.5 Dietary Fatty Acids And Cardiovascular Disease Risk
1.5.1 Introduction
Numerous epidemiological studies demonstrate a positive relationship between 
saturated fat intake and incidence of CHD mortality (Keys, Menotti, Karvonen, Aravanis, 
Blackburn, Buzina, Djordjevie, Dontas, Fidanza, Key, Fromhout, Nedeljkovic, Punsar, 
Seccareccia and Toshima, 1986; Kagan, Harris, Winkelstien Jr., Johnson, Kato, Syme, 
Rhoads, Gay, Nichaman, Hamilton and Tillotson 1974; McGee, Reed, Stemmerman, 
Rhoads, Yanok and Feinleib, 1985; Kushi, Lew, Stare, Ellison, Ellozy, Browkeg, Daly, 
Graham, Hickey, Mulcahy and Kevaney, 1985). However the data do not consistently 
support the presence of polyunsaturated fatty acids (PUFA) and monounsaturated fatty 
acids (MUFA) in the diet as being protective against CHD. Also, although dietary 
saturated fatty acids (SFA) have been generically regarded as hypercholesterolaemic, they 
have various chain length and exert different effects on plasma lipoprotein constituents 
and concentrations. For this reason, it is necessary to take into consideration the chain 
lengths of SFAs used in any study.
1.5.2 Saturated fatty acids
Keys, Anderson and Grande, (1965) and Hegsted, McGandy, Myers and Stare 
(1965) in their early studies of dietary fat effects on plasma cholesterol suggested that
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cocoa butter, rich in stearic acid (C l8:0), did not raise cholesterol levels to the same 
extent as lauric (C12:0) , myristic (C14:0), or palmitic acids (C l6:0) when used 
isoenergetically to replace either PUFAs or carbohydrates in the diet. Similar findings in 
human subjects, demonstrated an increase in plasma total and LDL cholesterol when 
palmitic acid -  containing TAG was isoenergetically substituted for PUFA or 
carbohydrates. (Mattson and Grundy, 1985; Grundy and Vega, 1988; Bonanome and 
Grundy ,1988). Studies by Hayes, Pronezuk, Lindsey and Diersen-Schade, (1991) in non 
human primates and by Lindesy, Benattar, Pronezuk and Hayes, (1990) in hamsters 
suggested that intake of palmitic acid is not as hypercholesterolaemic as lauric and 
myristic acid. Bonanome and Grundy (1988), also demonstrated clearly that not all SFA 
have the same cholesterol-raising potential since subjects fed large (40% of dietary 
energy) quantities of stearic or oleic acids showed similar LDL and HDL cholesterol 
levels that were both significantly lower compared to subjects fed palmitic acid at the 
same energy level. Thus, SFAs are consistently hypercholesterolaemic where lauric and 
myristic acids have the maximum effect followed closely by palmitic acid; however 
stearic acid has little effect possibly because it can be converted in vivo to oleic acid 
(McNamara, 1995).
With reference to medium to short chain fatty acids (C<8), absorbed directly via 
the portal circulation, there appears to be no contribution to the production of 
chylomicrons, and studies in humans or animal models (Hashim, Arteaga and Van Itallie, 
1960; Beveridge, Connell, Haust and Mayer, 1959; Grande, 1962) did not show any 
changes in plasma cholesterol levels after the intake of these fatty acids.
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1.5.3 Polyunsaturated fa tty acids
The plasma hypocholesterolaemic action of dietary PUFA is well established 
(Ahrens Jr., Hirsh, Insull, Tsaltas, Blomstrand and Peterson 1957; Hegsted et a l, 1965; 
Keys, Anderson and Grande, 1957). Compared to SFA, PUFA has no effect on 
cholesterol absorption (McNamara, Kolb, Parker, Batwin, Samuel, Brown and Ahrens Jr.,
1987), endogenous cholesterol synthesis (Shephered, Packard, Grundy, Yeshurun, Gotto 
Jr. And Taunton, 1980), or bile acid synthesis (Shephered et a l, 1980). Numerous 
mechanisms have been suggested for the cholesterol lowering effect of chronic intake of 
PUFA-rich diets. The majority of data suggest modifications of both synthesis and 
catabolism of plasma lipoproteins rather than any effect on endogenous cholesterol 
metabolism (McNamara et a l, 1987; Grundy and Denke, 1990). The recent report by 
Bravo, Cantafora, Marinelli, Avella, Mayes and Botham, (1996) may offer some 
explanation of the hyper- and hypocholesterolaemic effects of some saturated and 
polyunsaturated fatty acids in that chylomicron remnants of different fatty acid 
composition were shown to have differential effects on cholesterol metabolism in liver 
cells. Incubation of hepatocytes with chylomicron remnants derived from com oil 
increased bile acid production while lipid secretion in VLDL remained unchanged; 
however, addition of palm oil remnants to the medium resulted in the secretion of 
cholesterol-rich VLDL while bile acid synthesis was not affected.
Studies on rats fed either butter fat or com oil failed to show any effect of dietary 
fat saturation on rates of apolipoprotein A-I or apolipoprotein B synthesis by the
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intestine(Davidson et a l, 1987). Similar data have been reported in African green 
monkeys (Sorci-Thomas et al., 1989a; Sorci-Thomas, Parck, Dashti, Johnson, Rudel and 
Williams, 1989b) where enterocyte apolipoprotein B and apolipoprotein A-I mRNA 
levels were unaffected by a change in the nature of dietary fat from SFA to PUFA. Groot, 
De Boer, Haddeman, Houstsmuller and Hulsman, (1988) reported that fat saturation had 
no effect on chylomicron TAG synthesis rate in rats, however, chylomicrons from PUFA- 
fed animals were catabolized faster than chylomicrons from SFA-fed animals. Similar 
data have been reported by Green, Massaro and Green, (1984) where chylomicron 
metabolism was more rapid in rats fed PUFA compared to SFA. Also, Coiffier, Paris and 
Lecerf, (1987) demonstrated that chylomicrons from rats fed SFA were hydrolyzed more 
slowly in vitro compared to chylomicrons from rats fed PUFA. In the same study 
(Coiffier et al., 1987), it was reported that unsaturated fat intake was associated with 
higher lipoprotein lipase activity than that seen following SFA feeding , whereas hepatic 
TAG lipase was higher in SFA-fed animals than those fed an unsaturated fat diet.
The increased rate of chylomicron catabolism in PUFA-fed animals appears to 
depend upon chronic fat feeding. Nestel and Scow (1964) reported that acute fat feeding 
on either cream fat or com oil showed a faster removal of cream-derived chylomicrons 
when tested in control rats and dogs. Similar findings have been reported by Renner, 
Samuelson, Rogers and Glickman, (1986) where chylomicrons containing palmitate 
(C l6:0) were slightly more rapidly cleared compared to chylomicrons containing 
linoleate (C l8:2) in recipient rats. Green et al. (1984) reported that the quality of fat fed 
to donor rats had less effect on chylomicrons metabolism than did the metabolic state of
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the recipient, especially with regard to plasma TAG levels. It has been demonstrated that 
normolipidemic men fed a diet containing 42 % fat energy, with P:S ratio 1.39, decreased 
postprandial chylomicron concentrations by 67 % in comparison with subjects fed the 
same fat energy regime but with P:S ratio 0.07, (Weintraub, Zechner, Brown, Eisenberg 
and Berslow, 1988). This response was found to be more related to the chronic intake of 
PUFA than to the fatty acid content of the acute fat challenge. Also, the same 
investigators reported that in vitro hydrolysis of PUFA-containing chylomicrons was 
faster than SFA-rich chylomicrons. Thus the increased catabolism of chylomicrons and 
their remnants, observed during intake of PUFA, may be partly explained by increased 
LPL activity resulting in a more rapid conversion of chylomicrons to remnant particles 
which in turn can be removed via hepatic receptor uptake mechanisms.
1.5.4 Monounsaturated fatty acids
MUFAs were long considered to have a neutral effect on plasma cholesterol 
concentrations until Mattson and Grundy (1985) demonstrated that intake o f oleic acid 
(C l8:1) was as effective as linoleic acid (C l8:2) in reducing LDL cholesterol and, more 
interestingly, did not lower HDL cholesterol concentrations in normolipidemic patients. 
The effect o f a low fat diet (28 % of dietary energy as fat) containing either olive oil or 
com oil on plasma lipids, apoproteins and lipoprotein has been investigated in 
hypercholesterolaemic subjects (Sirtoli, Termoli, Gratti, Montanari, Sirtoli, Colli, 
Gianlfanceshi, Madema, Dentonewazzu, Testolin and Galli, 1986). They observed
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similar lowering effects on plasma total and LDL cholesterol and apolipoprotein B 
concentrations, but olive oil intake had a smaller effect on plasma HDL cholesterol and 
apolipoprotein A-I levels and was associated with a higher apolipoprotein A-I to 
apolipoprotein B ratio, indicative of a less atherogenic lipoprotein profile (McNamara, 
1995).
Studies using formula diets (Grundy, 1986) or solid food diets (Grundy and Vega,
1988) have shown that high-MUFA diets and low-fat diets significantly reduce plasma 
total and LDL human cholesterol levels when compared with high-SFA diets. However, 
only the low-fat diets raised plasma TAG and lowered HDL cholesterol concentrations. 
Similar findings have been reported by Mensink and Katan (1987) where subjects were 
fed test diets rich in either complex carbohydrates ( low fat diet containing 22 % of 
dietary energy as fat) or olive oil (MUFA diet containing 40 % of dietary energy as fat). 
Switching from a SFA diet (38 % of dietary energy as fat) to either a low-fat diet or a 
MUFA diet in normolipidemic men and women resulted in a lower plasma total and LDL 
cholesterol levels in both diets (Mensink and Katan, 1989). However, intake of the low- 
fat diet increased plasma TAG concentration and lowered levels of total HDL and HDLg 
cholesterol and plasma apolipoprotein A-I and apolipoprotein A-II levels. Compared to 
the high-SFA diet phase, the ratio of apolipoprotein A-I: apolipoprotein B increased 
during the intake of the MUFA diet, whereas it decreased in subjects on the high- 
carbohydrates, low fat diet (Mensink et a l, 1989).
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Wardlaw and Snook (1990) reported that both MUFA or PUFA-rich diets, 
administered to men, had similar lowering effect on plasma total and LDL cholesterol and 
apolipoprotein B concentrations, while HDL cholesterol and apolipoprotein A-I 
concentrations were unaffected. Similar findings have been reported by Becker, 
Illingworth, Alaupovic, Connor and Sundberg, (1983); McDonald, Gerrard, Bruce and 
Comer, (1989); and Dreon et al., (1990). Under more modest conditions of fat intake 
Berry, Eisenberg, Haratz, Friedlander, Norman, Kaufmann and Stein, (1991) reported that 
the PUFA-rich diet was more effective than the MUFA-rich diet in lowering plasma total 
and LDL cholesterol in human subjects; HDL levels were unchanged.
The above studies on human subjects clearly demonstrate that substituting dietary 
SFA with MUFA or PUFA results in a comparable lowering effects on plasma LDL 
cholesterol concentrations. Decreased in plasma HDL cholesterol concentrations were 
reported with extremely high (about 29% fat energy (Mattson and Grundy, 1985) intake 
of PUFA. Reducing total fat calories in the diet decreases both plasma LDL and HDL 
cholesterol. However, Jeppesen, Schaaf, Jones, Zhou, Chen and Reaven, (1997) reported 
recently that healthy postmenopausal women fed a high carbohydrate low fat (60 % 
carbohydrate, 25 % fat energy) diet showed a higher fasting plasma TAG, VLDL TAG, 
and VLDL cholesterol concentrations compared to postmenopausal women feeding on a 
low carbohydrate high fat diet (40 % carbohydrate, 45 % fat).
The importance of MUFA intake does not only reside in reducing plasma LDL 
cholesterol. Steinberg, Parthasarathy, Carew, Khoo and Witzum, (1989) reported that
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oxidative modification of LDL may generate LDL particles with enhanced atherogenic 
potential. Studies in rabbits (Parthasarathy, Khoo, Miller, Barnett and Steinberg, 1990) 
and in humans (Berry et a l, 1991) revealed that LDL particles isolated after a high- 
MUFA diet were found to be less susceptible to oxidative stress than LDL isolated after a 
high-PUFA diet.
Animal studies have shown a fundamental difference between rodents and humans 
in term of plasma cholesterol response to dietary MUFA. Intake of MUFA compared to 
PUFA resulted in increased plasma cholesterol levels in rats (Kris-Etherton and Fosmire, 
1984; Beynen, 1987), hamsters (Spady and Dietschy, 1988), rabbits (Beynen, 1987) and 
guinea pigs (Fernandez, Yount and McNamara, 1990; Fernandez and McNamara, 1989), 
and it significantly reduced hepatic sterol synthesis (Spady and Dietschy, 1988; Fernandez 
et ah, 1990).
MUFA intake has no effect on apolipoprotein B/E receptor-mediated LDL 
catabolism. In vitro binding studies in guinea pigs (Fernandez and McNamara, 1989) 
have shown that lard or olive oil-containing diets (19% or 30% fat energy) did not affect 
the number of hepatic receptors; similar studies in hamsters (Spady and Dietschy, 1988) 
have revealed that feeding on either olive oil or coconut oil showed the same rate of 
hepatic clearance of plasma LDL.
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1.6 Hyperinsulinaemia
Insulin is the primary factor which controls the storage and metabolism of ingested 
metabolic fuels. Nutrient regulation of insulin secretion involves the direct action of 
nutrients on the pancreatic beta cells plus indirect effects mediated by autonomic nerves, 
and the release of the various entero-insular hormones and islet peptides.
The most common hyperinsulinaemic condition encountered in humans is obesity 
where obese individuals show a high plasma insulin levels in the basal as well as after 
meal ingestion (Felig and Bergman, 1995). The hypersecretion of insulin in obesity is 
associated with beta cells hyperplasia and enhanced activity of the entero-insular axis 
(Morgan, 1992). This appears to provide an adaptive compensation for the additional 
insulin resistance incurred by obesity. Hyperinsulinaemia is also common in non-insulin- 
dependent diabetes mellitus (NIDDM) where a reduced clearance of insulin is observed in 
the peripheral tissue (Warram, Martin, Krolewski, Soeldner and Khan, 1990).
Studies examining the relationship between fasting and post-prandial 
apolipoprotein B48 in NIDDM patients and healthy non-diabetic control subjects have 
shown that diabetic patients had significantly higher concentrations of apo B48 and apo 
BIGG in both the fasting (p<G.G5) and the post-prandial (p<G.Gl) TAG -rich 
lipoprotein samples (Curtin, Deegan, Owens, Collins, Johnson, Tomkin, 1996). Curtin . et 
a l (1996) suggested that the raised fasting TAG -rich lipoprotein, often found in 
diabetes, are associated with apo B48 and may be derived from increased intestinal
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chylomicron production. Studies on cultured jejunal explants from human fetuses 
indicated an insulin-stimulated decline in TAG _ and chylomicron production and in 
apolipoprotein B48 and apoliporotein BlOO secretion (Levy, Sinnett,Thibault, Nguyen, 
Delvin, Menard, 1996).
1.7 Aims And Scope Of The Research Project
The survey of the literature indicates that there is evidence linking dietary fats, in 
term of degree of saturation and quantity ingested, to serum lipid levels and other factors 
influencing coronary heart disease risk (apolipoproteins, low density lipoprotein 
concentration). Apolipoprotein B48, secreted by enterocytes as an obligatory surface 
constituent of the triacylglycerol-rich lipoproteins (chylomicrons and VLDL), has been 
implicated as a coronary heart disease risk factor In plasma, the concentration of 
apolipoprotein B48 has been shown to be positively correlated with the development of 
arteriosclerosis and coronary heart disease. The increased apolipoprotein B-48 
concentration in plasma could be the result of either an increased apolipoprotein B-48 
secretion from the enterocytes or a decreased apolipoprotein B-48 catabolism and removal 
from plasma.
Thus the aims of this study were:
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1. To investigate the in vitro and in vivo effects of fat loading on 
apolipoprotein B-48 content in rat jejunal enterocytes and mucosal 
scrapings.
2. To assess the long-term effect of dietary fat manipulation, in terms of 
saturation and fat energy ratio, upon apolipoprotein B-48 content in 
fasted rat jejunal enterocytes and mucosal scrapings.
3. To investigate the effect of dietary fat saturation (using either 
coconut oil, olive oil or sunflower oil) in rats upon:
- Lymph apolipoprotein B-48, cholesterol, and triacylglycerol 
secretion
- Blood cholesterol and triacylglycerol concentration
- Estimated triacylglycerol-rich lipoprotein particle size
4. To investigate the long-term effect of changed dietary fat saturation 
upon the size of triacylglycerol-rich lipoproteins secreted in response 
to a standard fat load.
5. To examine the estimated size of the TAG-rich lipoprotein particles 
secreted during lipid absorption from the enterocytes of rats after 40 
days of insulin treatment.
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2. MATERIALS AND METHODS
This chapter describes the materials and methods employed in the investigations 
reported, together with experiments validating those procedures. Modifications of 
methods required for specific study designs are described in the relevant experimental 
chapters.
2.1. Materials
2.1.1. General reagents
All general reagents, listed in Appendix 1, were Analytical Reagent grade unless 
otherwise stated.
2.1.2 Assay systems, kits etc
Nor-Partigen apolipoprotein B plates for radial immunodiffusion (Behring, Germany). 
Cholesterol assay kit (Biolabo, France).
Donkey anti-rabbit antibody (Chfmar, University of Surrey, UK).
Glucose assay kit (Biolabo, France).
Human apolipoprotein control serum (Behring, Germany).
Specific anti apolipoprotein B-48 antisemm (GfflofDrBJGould,UniversityofSuney). 
Triacylglycerol assay kit (Amico Lab. Inc., Nashville, USA)
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2.1.3 Pharmaceuticals
Chloramphenicol (Roussel, UK).
Gentamycin sulphate (Roussel, UK).
Insulin (Insulin Monotard, Novo Nordisk, Denmark).
2.1.4 Dietary components
Bledine (Danone, France)
Coconut oil (Vegetahne, Netherlands).
Com flakes (Oteker, Germany)
Lentils (Amigo, Metro Superstores, Lebanon) 
Olive oil (Sigma, Poole, UK).
Olive oil (Amioun, Lebanon).
Starch (Merck, Germany)
Sunflower oil (Lesieur, France).
Wheat flour (Amigo, Metro Superstores, Lebanon)
2.1.5 Method-specific materials
Disposable spectrophotometer cuvettes (1 ml), (Cole-Parmer, USA). 
Disposable microcentrifuge tubes (1.5 ml), (Cole-Parmer, USA).
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2.2 Methods
2.2.1 In vitro studies
Fasted rats were anaesthetised by sodium pentobarbital (50 mg/kg body wt i.p). 
The abdomen was opened by a midline incision, a 25-30 cm segment of the small intestine 
representing the jejunum (5-7 cm after the ligament of Treitz) removed and immediately 
placed in 100 ml of oxygenated ice-cold phosphate-buffered saline (PBS) solution (0.14 M 
NaCl, 0.01 M K2HPO4; pH adjusted to 7.4 with IM  KH2PO4). Fat and mesenteric 
attachments were removed from the segment which was then cut into one centimeter 
segments. The intestinal segments were opened along the mesenteric line thereby exposing 
the mucosal villi to the bathing medium and washed extensively with three changes (75 
ml) of the PBS solution. The intestinal strips were randomly divided into groups each 
containing 5 strips. In the control groups, each group of 5 intestinal strips was incubated in 
20 ml of oxygenated modified Ringer solution (pH 7.4, consisting of 140 mM NaCl, 10 
mM KHCO3, 1.2 mM K2HPO4, 0.2 mM KH2PO4, 1.2 mM MgCh, 1.2 mM CaCk), while 
in the oleic acid group every group of 5 intestinal strips was incubated in 20 ml of 
oxygenated oleic acid emulsion (pH 7.4 consisting of modified Ringer solution as above, 
2.5% oleic acid and 1.25% Tween 80j y/\/).
The emulsions were prepared using an ultrasonic homogenizer (Coleparmer 500 
W, USA) where each 60 ml of the oleic acid solution was sonicated (using the 13 mm 
diameter tip) intermittently at 90% amplitude for a total sonication period of 1 minute. 
The oxygenated incubating solutions were kept at 37°C and were shaken at 60 rpm (Grant 
instrument, Cambridge Ltd., England). After 2h of incubation, the intestinal strips were 
removed, washed in ice-cold PBS solution (pH 7.4), and the mucosa was scraped and 
stored in about 1 ml of PBS at -20°C for later analysis.
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2.2.2 In vivo study
Conscious ovemight-fasted animals received either 4 ml olive oil (Sigma, Pool, 
UK) emulsion (20 % v/v olive oil and 1 % v/v Tween 80 in 153.8 mM NaCl) 
(Experimental group), or 4 ml 153.8 mM sodium chloride solution (Control group) via a 
gastric tube. Otherwise, fasted rats were anaesthetised with diethyl ether, a small incision 
made in the upper abdominal wall and either 4 ml of an oleic acid emulsion (10 % v/v 
oleic acid and 1 % v/v/ Tween 80 in 153.8 mM sodium chloride solution, pH adjusted to
7.4 using 0.2 M NaOH) (Experimental group), or 4 ml of 153.8 mM sodium chloride 
solution (Control group) was then injected through a syringe needle passed into the 
duodenum just after the pyloric sphincter. The incision was sutured and the animals were 
returned to their cages, the entire procedure taking less than 5 min for each animal. An 
oleic acid emulsion was instilled intraduodenally instead of an olive oil emulsion in order 
to avoid the unphysiological conditions resulting from the single bolus instillation of a 
very large fat load that needs digestion into the duodenum. The above emulsions were 
prepared as described previously with the exception that 10 ml volumes were sonicated 
with a 3 mm diameter microtip at 40 % amplitude (maximum power for the microtip 
used).
At 90 min and 3 h after intragastric instillation and 90 min after intraduodenal 
instillation of either the saline or fat load, the animals were sacrificed, the abdomen 
opened and a 30 cm segment of the small intestine representing the jejunum (5-7 cm after 
the ligament of Treitz) was removed and immediately placed in oxygenated ice-cold 
phosphate-buffered saline (PBS) solution (pH 7.4). Fat and mesenteric attachments were 
carefully removed from the intestinal segment which was then everted exposing the 
mucosa to the bathing medium. The intestinal segment was washed with four changes of
the ice-cold PBS solution (100 ml for each PBS change) by gently swirling for 20 seconds 
after each PBS change, after which three intestinal segments, 2 cm in length, (representing 
the first, the middle and the last part (starting at about 10 cm, 25 cm and 38 cm distal to 
the pylorus) were cut, mucosae scraped and the scrapings stored in about 1ml of PBS at - 
20°C for later analysis. The remaining intestinal segments were used for isolation of 
enterocytes
2.2.2.7 Preparation o f jejunal enterocytes. . The following procedures were carried out at 
5°C. The remaining everted intestinal segments were tied at each end and incubated in a 
50 ml beaker containing 20 ml of 0.257'4'/EDTA in PBS (Waynforth and Flecknell, 1992)) 
(pH=7.4). After 30 min of incubation, they were shaken for Imin in an orbital shaker 
(ROSI 100, Thermolyne) at 100 /min to remove dead enterocytes from the everted 
intestinal segments. The resulting supernatant was discarded and a further 20 ml ice cold 
PBS-EDTA solution added to the intestinal segments which were incubated for a further 
25 min. following which they were stirred using a magnetic stirrer (5 min; ca 200-250 
rev/min). The resulting supernatant was examined using light microscopy (1000 X 
magnification) and was very rich in jejunal enterocytes. The supernatant was centrifuged 
in a refrigerated centrifuge (Labofuge I, Bestell) at 1500 g for 5 min in order to harvest the 
enterocytes. The pellet was washed three times with ice cold PBS solution and placed in 
0.5-1 ml of ice cold PBS and stored at -20°C for further analysis. To ensure maximal 
harvest of enterocytes, the intestinal segments were further incubated in another 20 ml 
of the ice cold PBS-EDTA solution. After 25 min incubation, the remaining enterocytes 
were isolated as described; the resulting pellet was added to the previous one and stored at 
-20 ^C. Repeating the same procedure a third time on the same intestinal segments 
showed no appreciable enterocyte yield confirming maximal harvesting.
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2.22.2 Preparation o f jejunal enterocytes and mucosal scraping supernatants for  
immunoprécipitation. Within 24 hours of harvesting, jejunal enterocytes and mucosal 
scrapings were homogenized (Pyrex Brand Ten Broek tissue grinder, 2 ml, model 7727) 
on ice in a solution containing PBS, disodium ethylene-diamine-tetraacetic acid 
(NazEDTA) 1.2 mg/ml, chloramphenicol 80 mg/1, gentamycin sulphate 80 mg/1, 
benzamidine 1 mM, phenylmethyl-sulfonylfluoride (PMSF) lmM,ÜfÿVj Triton X-100 and 
i lM  sodium deoxycholate at pH 7.4.
Aliquots of the homogenates were taken for total protein determination (Lowry et 
f l /1951) as described below, and the remaining homogenates were centrifuged for 10 min 
at 15680g in a refrigerated centrifuge (Biofuge 13R, Heraeus, Sepatech) at 2°C. The 
resulting supernatants were used for apolipoprotein B estimation.
2.2.2.3 Apolipoprotein B estimation by radial immunodiffusion. Aliquots of the 
homogenate supernatants were assayed for apolipoprotein B content by radial 
immunodiffusion (RID) using Nor-Partigen apolipoprotein B plates for (Behring, 
Germany). Apolipoprotein B concentration in the homogenates was calculated by 
reference to the criteria of the IFCC (International Federation of Clinical Chemistry) 
However, since the antibody used was standardized using human apolipoprotein B-lOO, 
the values were corrected by reference to a specific enzyme-linked immunosorbent assay 
(ELISA) (Lovegrove et al., 1996) for apolipoprotein B48. Correction was made according 
to the formula shown below:
Apo B content of a sample using RID X Apo B content of the standard sample using ELISA 
Apo B content of the standard sample using RID
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Aliquots of the homogenate supernatants used for radial immunodiffusion 
contained 25 to 50 g of protein per liter. Diameters of the immunoprecipitate complex 
formed on radial immunodiffusion were estimated after 96 hours of incubation at ambient 
temperature. Values were accepted only when the diameter fell between 5 mm and 9 mm. 
Apolipoprotein B content was estimated as mg apolipoprotein B/g protein of the 
homogenate.
2.2.2.4 Confirmation o f absence o f contamination o f mucosal scrapings with blood. This 
investigation confirmed the absence of contamination with blood borne apolipoprotein B 
of the intestinal mucosal scrapings
Three groups of fasted rats were used. In the first group, jejunal mucosal scrapings 
were collected immediately after sacrifice, as described above. The same procedure was 
followed for the second and third groups except that the intestinal blood vessels of the 
animals were immediately flushed with either ice-cold PBS (pH=7.4), group 2, or ice-cold 
isotonic sucrose solution (group 3) at 4 ml/min for 10 min immediately after sacrifice. The 
inlet cannula was inserted into the hepatic portal vein and the outlet was through an 
incision in the dorsal aorta. Mucosal supernatant was then prepared for apolipoprotein B 
estimation as described above.
Apolipoprotein B content in the jejunal mucosal scrapings of fasted rats, without 
flushing and following flushing the intestinal blood vessels with either ice cold sucrose or 
PBS, was determined. The results are shown in Figure 2.1 with the values given in 
Appendix 2, Table l.A. Oneway analysis of variance of apolipoprotein B/mg protein 
revealed no significant differences (Fs[2,12] = 0.27; NS) in apolipoprotein B content in 
the absence of flushing and after flushing the intestinal blood vessels with either solutions.
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Figure 2.1. Apolipoprotein B content of jejunal mucosal scrapings without
flushing (n = 5) and following flushing with PBS (n = 5) or isotonic 
sucrose (n = 5). Data presented as mean ± SEM.
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Thus, the possibility of blood apolipoprotein B-lOO contamination of the intestinal 
mucosal preparations was eliminated.
2.2.3 Enzyme-linked immunosorbent assay (ELISA)
The inner 60 wells of Nunc Maxisorp microtitre plates (Nunc, Roskilde, 
Denmark) were coated with 100 pi of coating conjugate, prepared as described by 
Lovegrove et al. (1996), at a final dilution of 1:8000 in 0.1 M bicarbonate/carbonate 
buffer (pH 9.4). After incubating the plates overnight at 4°C in a humid container, the 
plates were washed with 0.05 M phosphate-buffered (pH 7.6) saline (PBS) containing
0.05% (v/v) Tween 20 and 0.1% (w/v) gelatin (PBSGT), and then blocked by incubation 
with 120 pi of PBSGT at 37°C for 1 h. The wells in the microtitre plates were emptied to 
receive the preincubated samples as described below. Subsequent incubations were at 
37°C unless otherwise stated; all washing steps used PBSGT.
Serial dilution of original human standard lymph samples were prepared in order 
to construct a 9-point standard curve. The human lymph was diluted with human serum 
albumin (HSA; Sigma, Poole, UK) at 35 mg HSA/ml in PBS. The 9-point standard curve 
and enterocyte supematents were pre-incubated with equal volumes of specific anti- 
apolipoprotein B-48 antibody (final dilution 1:250000) at ambient temperature for 1 h. 
Following this, 100 pi of the human lymph standards or enterocyte supematents were 
added in duplicate and the plates incubated at ambient temperature for 2 h. The plates 
were washed and 100 pi of the secondary antibody-enzyme conjugate consisting of 
donkey anti-rabbit antibody (Clifmar, University of Surrey, Guildford, UK) conjugated to 
horse radish peroxidase (Boehringer Mannheim, Lewes, UK), were added to the plates at 
a final dilution of 1:30000. After a further 2 h of incubation (ambient temperature), the
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plates were washed and 100 pi of 3,3',5,5'-tetramethylbenzidine (Boehringer Mannheim, 
Lewes, UK) substrate added. The plates were incubated for 30 min (ambient temperature) 
after which the reaction was stopped by adding 50 pi of IM  HCl. Absorbance was read 
using an automated ELISA plate spectrophotometer (Labsystems, Basingstoke, UK) at X 
= 450 nm. A standard curve was constructed and the amount of apolipoprotein B-48 
within the enterocytes samples estimated. The ELISA had an intra- and inter-assay 
coefficients of variation of 3.8% and 8.6% respectively.
2.2.4 Protein determination
Protein determination was done according to the method of Lowry et al. (1951). 
All samples were run in duplicate.
Solutions:
Solution A. 0.5 g CuS04.5 H2O and 1 g NasCëHgO? (2H2O) were dissolved (distilled 
water) to a final volume of 100 ml. This solution may be stored indefinitely at room 
temperature.
Solution B. 20 g of Na2C03 and 4 g of NaOH were dissolved in distilled water to a final 
volume of 1 litre. This solution may be stored indefinitely at room temperature.
Solution C. Just before protein determination, 1 ml of solution A was mixed with 50 ml 
of solution B.
Solution D. Just before protein determination, 10 ml Folin-Ciocalteau phenol reagent was 
diluted with 10 ml distilled water.
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Assay:
Enterocyte and mucosal scraping homogenates were diluted either 50 or 100 times to fall 
within the assay range of sensitivity (5 pg/ml -100  pg/ml protein).
1. 100 pi diluted homogenate sample was mixed with 400pl distilled water to a final 
volume of 0.5 ml.
2. 2.5 ml of solution C was added.
3. The solution was vortex mixed and left at room temperature for 5-10 min.
4. 0.25 ml of solution D was added and the solution was vortex mixed.
5. After 20 - 30 min, absorbance was read in a spectrophotometer (Jenway 6105, U.K.) at 
X = 750 nm
The assay blank solution was prepared in exactly the same manner except that 100 pi of 
the homogenate sample (step 1) was replaced by an equal volume of distilled water.
The amount of protein in the samples to be assayed was determined by comparing the 
absorbance of every unknown sample to a bovine serum albumin standard curve (BSA). 
The standard curve was constructed by including 10, 20, 40,60 and 80 pg BSA/ml 
standards in the assay. As used here, total protein estimation showed intra-assay variation 
of between 1.4% and 5.1%; between assay variation was 1.6% using quality control 
samples at BSA concentration of 30 pg/ml.
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2.2.5 Mesenteric lymph
To collect lymph from the rat mesenteric lymph duct, the animal was anaesthetized 
rapidly with diethyl ether, and placed on its back on a heating mantle to maintain 
homeothermy. Anaesthesia was maintained by allowing the animal to breathe from a small 
container containing a diethyl ether soaked gauze.
A midline abdominal incision was made for about two-thirds of the length of the abdomen 
posterior to the xiphoid cartilage. The intestine was exteriorised, wrapped in gauze soaked 
in saline at 37°C and placed on the left side of the animal. This enabled ready 
visualisation of the mesenteric lymph duct (white-coloured after lipid absorption) 
accompanying the superior mesenteric artery and attached to it by connective tissue. The 
mesenteric lymph duct and surrounding mesentery was wiped with cotton wool soaked in 
warm saline, dried with a gauze, and carefully cut. Oozing lymph was collected into a 1.5 
ml Eppendorf tube using a 100 pi pipette. A preservative cocktail solution containing 
disodium ethylene-diamine-tetraacetic acid (NazEDTA) 1.2 mg/ml, chloramphenicol 80 
mg/1, gentamycin sulphate 80 mg/1, benzamidine 1 mM, phenylmethyl-sulfonylfluoride 
(PMSF) ImM (Black and Rhower-Nutter, 1991) was added to the collected lymph in the 
proportion of 5%(v/vj. Lymph was collected for a period ranging from 7 to 9 minutes but 
not more than 9 minutes (collecting a total volume of 120-200 pi lymph). The entire 
procedure took not more than 11 to 13 minutes depending on lymph flow rate. Lymph 
flow rate was then estimated by the procedure described below. Collected lymph samples 
were stored at -20°C for subsequent analysis
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2.2.6 Validation o f  the lymph collection method
To avoid the unwanted and uncontrolled effects of trauma, this procedure for 
collecting lymph was used in preference to prior surgical cannulation of the lymph duct 
with subsequent recovery a day or so before experiment. The aim was to minimise the 
effect of potential unidentified and hence uncontrolled confounding factors on the studied 
parameters, hence reducing the robustness of the results.
Tso et al. (1985) reported that when the lymph flow rate is less then 40 pl/min, the 
time between introduction of radiolabeled fatty acids into the intestinal lumen and 
appearance of radiolabeled chylomicrons in the intestinal lymph duct appeared inversely 
proportional to the lymph flow rate. However, when lymph flow was exceeded 40 pl/min 
chylomicron appearance time reached the minimum value of 13.6 minutes. Hence the 
short duration of experiment here (11-13 minutes), should ensure that most of the 
collected lymph chylomicrons would have been formed under almost completely normal 
physiological conditions.
The short duration of the experiment permits collection of only a small volume of 
lymph. This could be a limitation for experimental procedures necessitating larger 
volumes of lymph samples. However, this small volume was sufficient for the procedures 
employed here where 40pl lymph samples sufficed adequately for cholesterol and 
triacylglycerol determinations. Sufficient lymph remained for apolipoprotein B-48 
quantitation by SDS-PAGE.
Although haemorrhage near the mesenteric lymph duct led to automatic 
termination of the experiment, it was necessary to establish that collected lymph was not 
contaminated with unseen blood or any other fluids from the neighbouring tissues which
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might generate unrecognised artefacts in the data. To establish absence of extra­
lymphatic contamination the following experiments were performed:
Four hours after intragastric instillation of 2 ml olive oil, the animal’s abdomen 
was opened, the mesenteric lymph duct exposed and lymph was collected for 7 minutes, 
as described above. Following this, using a binocular dissecting microscope, connective 
and fat tissue around the mesenteric lymph duct was cleared. The duct was cannulated 
with polyethylene tubing (i.d. 0.5 mm, o.d. 1.0 mm), cut diagonally at the tip with a 
scalpel and the point blackened with a black marker. The cannula was filled with heparin- 
saline solution (20 lU heparin/ml) and attached to a 2.5 ml syringe and needle filled with 
heparin-saline. The catheter was held with fine forceps a few millimeters behind the tip 
which was advanced along the duct until it entered at the point of section. On entry into 
the mesenteric lymph duct, the cannula was advanced about 6 mm and two ligatures were 
placed around the duct and the catheter. The first and second ligatures were placed 
respectively at points below and above where the duct was sectioned. After the first half­
hitch of the first ligature was tied, it was important to ascertain that the catheter was 
correctly placed and lymph flow was proceeding. The needle and syringe were removed 
from the cannula and if drops of saline-heparin emerged the second half-hitch was tied 
completing the first ligature followed by tying the second ligature. After discarding the 
saline-heparin solution and the first two drops of lymph leaving the catheter, lymph was 
collected for 7 minutes. The entire experiment took around 30 minutes. Aliquots of the 
collected lymph samples were taken for cholesterol and triacylglycerol determination and 
the remaining lymph was used for apolipoprotein B-48 estimation by SDS-PAGE as 
described below.
Results are respectively shown in Figures 2.2a, b and c below (tabular data in 
Appendix 1; Table 2.B, 2.C and 2.D). Analysis of data presented in Figures 2a, b and c
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(paired t-test, having confirmed normal distributions and data homeoscedasity) indicated 
no significant difference in the concentrations of cholesterol, triacylglycerol and 
apolipoprotein B-48 in the lymph samples collected from the same animal using either of 
the two methods. Consequently, the ratio of lymph apolipoprotein B-48 (mg/l)/lymph 
TAG (g/1) shown in Figure 2.3 below (See Appendix 1, Table 2.E for tabular data) show 
that the average size of the TAG-rich lipoprotein (intestinal chylomicrons and VLDLs) 
particles was not affected by the different methods used thus validating the method 
adopted in this study.
Differences between paired data (cannulated and non-cannulated) for each of the 
analytes are shown in Table 2.1 below
Analyte Mean concentration difference 
(Non-cannulated - 
cannulated).
95% Confidence Interval of 
Mean difference
Triacylglycerol
(mg/dl)
-54 (-100.4 ; 7.6)
Cholesterol
(mmol/L)
-0.002 (-0.0303 ; 0.0263)
Apolipoprotein B-48 
(mg/L)
-0.66 (-4.17 ; 2.85)
Apolipoprotein B-48 
TAG 0.038 (-0.0943 ; 0.1703)
Table 2.1 Mean differences, with their 95% Confidence Intervals, of analytes in lymph 
from cannulated and non-cannulated animals.
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Figure 2.2c: Apo B-48 (mg/1)
Analyte concentrations in lymph samples collected from the mesenteric lymph 
duct of the same animals with and without cannula and 4 h after intragastric 
instillation of 2 ml olive oil (values denote mean ± S.E.M. (n = 5)).
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Figure 2.3 Apolipoprotein B-48(mg)/TAG (g) ratios determined in lymph 
samples collected from the mesenteric lymph duct of the same 
animals with and without a cannula 4 hours after intragastric 
instillation of 2 ml of olive oil (values denote mean ± S.E.M. (n=5)).
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All of the 95% Confidence Intervals shown in Table 2.1 pass through zero. Hence 
there are no significant method-related differences in the analyte concentrations thereby 
validating the method used for lymph collection
It is also noteworthy that as triacylglycerol and apolipoprotein B-48 concentrations 
in the rat blood are both ca 50 to 100 fold less than those in the mesenteric lymph, any 
blood contamination of collected lymph samples will result only in dilution of the 
concentration of lymph apolipoprotein B-48 and triacylglycerol without effect upon the 
concentration ratio (lymph apolipoprotein B-48 (mg/l)/lymph TAG (g/1)) or estimates of 
average TAG-rich lipoprotein particle size.
2.2.7 Measurement o f lymph flow rate
Measurement of lymph flow rate was carried out immediately after lymph 
sampling. Double-ended cotton buds were weighed to 0.1 mg (Précisa 150 M balance, 
USA.) Lymph oozing from the sectioned mesenteric lymph duct was collected with the 
pre-weighed cotton buds over 15 minutes. Usually, 3 double-ended cotton buds were 
required for 15 minutes lymph collection, one every 5 minutes. Each of the lymph- 
saturated cotton buds was weighed immediately after lymph collection to reduce 
evaporative water loss. Lymph mass was calculated from the cotton-bud weight 
difference over the 15 minutes period and expressed as g/h. Volumetric conversion was 
made by assuming lymph density as 1.0000 and hence Ig = 1 ml lymph. Data were thus 
expressed as ml lymph/h.
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2.2.8 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
2.2.8.1 Principle: Proteins carry a net charge at any pH other than their isoelectric point. 
Since any charged ion or group migrates when placed in an electric field, any charged 
protein will migrate at a rate dependent upon its charge density (the chargeimass ratio). 
The speed of migration is linearly related to the charge density. In SDS-PAGE, a porous 
gel, where the pore size is similar to the size of the protein molecules, is used. Thus a 
molecular sieve effect occurs and separation is dependent on both molecular size and 
charge density of protein molecules. In polyacrylamide gels, the effective pore size is 
inversely related to acrylamide concentration in the polymerization mixture. In a gradient 
polyacrylamide gel, acrylamide concentration increases as the proteins migrate from the 
origin resulting in the separation of a wide range of protein sizes into sharper bands than 
is usually possible with single concentration gel (Hames 1990).
Most proteins bind to SDS at a constant weight ratio (1.4 g SDS/g polypeptide). 
Adding excess SDS to the protein renders the intrinsic charge of the polypeptide 
insignificant. Hence SDS-polypeptide complexes migrate in the polyacrylamide gel 
according to polypeptide size only. In addition to SDS, denaturing buffer systems contain 
a thiol reagent (dithiothreitol) cleaving disulphide bonds and urea to disrupt hydrogen 
bonds. In such a buffer system proteins dissociate into their individual polypeptide 
moeities.
Following SDS-PAGE separation, the protein bands are visualized directly on the 
polyacrylamide gel by staining with Coomassie Blue. Usually 0.2-0.5 pg of any protein 
can be detected in a sharp band using this dye and staining is quantitative up to 15-20 pg 
for at least some proteins (Hames 1990). Not all proteins have the same chromogenicity 
with this dye since different proteins bind Coomassie Blue to different extents. Hence it
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is essential to run standards concurrently and to construct a standard curve for the protein 
to be assayed. This applies whether sample quantitation is by elution or scanning.
22.8.2 Materials: Stock solutions:
Sample buffer (Two-fold concentrated). 20 ml glycerol was added to 1.5 g Tris dissolved 
in 35 ml of distilled water and pH adjusted to 6.75 with 12 M HCl following which 10 ml 
of 2-mercaptoethanol, 4 g of SDS and 2 mg of bromophenol blue were added and diluted 
with distilled water to a final volume of 100 ml.
3 M  Tris buffer (pH 8.8). 36.3 g Tris was dissolved in about 80 ml distilled water; the pH 
was adjusted to 8.8 with 12 M HCl. Distilled water was added to a final volume of 100 
ml. This solution is stable for several weeks at 4°C.
0.5 M  Tris buffer (pH 6.8). 6.02 g Tris was dissolved in approximately 90 ml distilled 
water. The pH was adjusted to 6.8 with 12 M HCl and the final volume was made up to 
100 ml with distilled water. This solution is stable for several weeks at 4°C.
Urea/SDS/dithiothreitol solution. 38.4 g urea, 24.6 mg dithiothreitol and 0.16 g SDS 
were dissolved in 50 ml of distilled water and the final volume was made up to 80 ml.
1.5 % ammonium persulfate solution. 0.15 g of ammonium persulphate was dissolved in 
10 ml of distilled water.
Electrode buffer (pH 8.3). 42.6 g glycine, 9.18 g Tris and 3 g SDS were dissolved in 3 L 
distilled water.
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Proto gel. 30 g acrylamide and 0.8 g N,N'-6A-methylene acrylamide were dissolved in 
approximately 70 ml of distilled water; the final volume was adjusted to 100 ml.
2.2.8.3 Procedure.
Preparation o f SDS-PAGE: Linear gradient (5-20 %) polyacrylamide gels were prepared 
following the method of Hames (1990) according to the original method of Laemmli 
(1970). A 5X^W/j|acrylamide resolving gel and a 2Q?|ÿ^) acrylamide resolving gel were 
prepared as shown in Table 2.2.
Resolving gel Stacking gel
5% Kv) 20%(ty/ÿ)
Sucrose 0-00 6.75 g o . o o
Tris-HCl 5.55 ml 5.55 ml 3.75 ml
Protogel 7.50 ml 30.0 ml 1.85 ml
Urea/SDS/dithiothreitol 4.50 ml 0.45 ml 0.30 ml
1.5% Ammonium persulphate 
(w/v)
1.05 ml 1.05 ml 1.15 ml
Water 30.30 ml 4.05 ml 7.50 ml
Table 2.2 Gel mixtures for 5-20 % gradient gel
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The formulations presented in Table 2.2 provided final gel concentrations as shown in 
Table 2.3 below
Resolving gel Stacking gel
5% 20%
Sucrose 0.438 M
Tris-HCl 0.340M pH 8.8 0.370M pH 8.8 0.123M pH 6.8
Dithiothreitol 0.149mM 0.016mM ImM
Urea 0.588M 63.3mM 4mM
SDS 0.52mM 0.055mM 3.5mM
Ammonium 1.4mM 1.5mM 4.4mM
persulphate
Table 2.3: Final concentrations of Resolving and Stacking gels used in SDS-PAGF
Immediately before pouring the resolving gels, 34.5 pi tetramethylethylenediamine 
was added to initiate polymerization.
The 5 % and the 20 % gels were poured into two different chambers in a gradient 
forming apparatus (Coleparmer, USA). The 20 % solution was placed in the mixing 
chamber and the 5 % solution in the reservoir chamber. The mixing chamber outlet was 
connected to a peristaltic pump (Watson Marlow 503U, U.K.) discharging between the 
glass plates of the electrophoresis apparatus (Labconco vertical slab, Coleparmer, USA). 
As the gels were poured into the chambers, stirring commenced and the valve outlet of the 
mixing chamber was opened. Simultaneously, the peristaltic pump and the valve between 
the two chambers was opened, forming a 5-20 % concentration gradient. The gel was then 
overlayered with water-saturated butanol and left for 45 min to allow polymerization to
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take place. After 45 min the water-saturated butanol was discarded and the gel top rinsed 
several times with distilled water. Remaining water droplets were removed with a filter 
paper. The volumes shown in Table 2.2 provided sufficient material for two 1.5 mm 
thickness slab gels.
Immediately before pouring the stacking gel, 11.25 pi tetramethylethylenediamine 
was added. The stacking gel was placed on top of the resolving gel. Immediately, a 
twenty-well comb was inserted and the gel left for polymerization. After 30 min ,the 
upper and lower electrode chambers were filled with electrode buffer and the comb was 
carefully removed.
Preparation o f samples for electrophoresis: One volume of sample (lymph or 10 fold 
diluted standardized serum sample) was mixed with three volumes of sample buffer (two­
fold concentrated) in an Eppendorf tube and heated at 95°C for 4 min to denature the 
proteins. The tubes were then centrifuged at 15,680 g for 4 min to separate any insoluble 
material. Molecular weight markers (Sigma Chemical Co. Ltd.) were dissolved in sample 
buffer according to the supplier's instructions, aliquoted and stored at -20°C. Just before 
use, the molecular weight aliquots were thawed and treated as for samples described 
above. 20 pi of molecular weight marker solution was loaded into the first gel lane with a 
gel loading tip. 10, 20 and 40 pi of standardized serum samples were loaded in duplicate 
into the following lanes. The remaining lanes were loaded with 25 pi of the lymph 
samples under examination.
Electrophoresis: After loading the samples, the lid of the upper chamber was fitted and 
the water cooling system switched on. The power supply (Consort E455, Belgium) was 
turned on and electrophoresis was carried out at 30 mA for one gel or 60 mA for two gels 
until the bromophenol blue marker reached the resolving gel after which the current was
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raised to twice the values reported above. 4 hours later, the power was switched off, the 
gel removed and stained with Coomassie Blue.
2.2.8A Staining o f proteins in the gel: . The protein staining solution was prepared by 
dissolving Coomassie Blue R-250 (0.1 % w/v)) in waterimethanol: glacial acetic acid 
(5:5:2 by volume). The solution was filtered (Whatman No.l filter paper) to remove any 
insoluble material before use. The gel slabs were rinsed in distilled water for a few 
seconds (to remove excess SDS) and placed in a plastic tray containing 500 ml of the 
staining solution. The gel slabs were stained overnight at room temperature with 
constant shaking (SS40-2 orbital shaker. Grant Instruments Ltd, Cambridge.) at 80 
rev/min.
In the morning of the following day, the gel slabs were rinsed with distilled water 
to remove excess stain adhering to the gels. The gel slabs were then destained in the 
plastic trays using 250 ml 30%^ methanol, 10'/(v/yjacetic acid with shaking at 60 rev/min. 
Destaining solutions were replaced every 90 min four to five times.
2.2.8.5 Quantitation o f stained proteins. After destaining, the gel slabs were placed 
between two transparencies, and then scanned using a desk top scanner (Scanjet 6100c, 
Hewlett Packard). The image saved on the computer diskette was used for quantitation of 
the apolipoprotein B bands using 1-D Advanced software (Advanced American 
Biotechnology, 1166E Valencia Dr, #6C, Fullerton CA. 92831). To quantitate the 
apolipoprotein B-48 bands of rat lymph samples, it was necessary to include, in every gel 
slab, human serum samples previously standardized for their apolipoprotein B-lOO 
content using Nor-Partigen apolipoprotein B plates for radial in^munodiffusion (Behring). 
Zilversmit and Shea, (1989) and Kotite et al. (1995) reported that when using Coomassie
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brilliant blue R-250 the chromogenicity of apolipoprotein B-lOO obtained from human 
blood samples was the same as that of apolipoprotein B-48 from rat lymph chylomicrons. 
Similar results were reported recently by Van Beek, Van Barlingen, De Ruijter-Heijstek, 
Jansen, Erkelens, Dallinga-Thie and De Bruin (1998). This indicates that the method 
employed here was a satisfactory means of quantitating rat apolipoprotein B48.
The concentration of the standardized human serum samples (3 different 
concentrations) included in every gel slab were selected so that the concentration of 
apolipoprotein B-lOO in the three samples was respectively around one half, equal, and 
double the expected concentrations of apolipoprotein B-48 in the rat lymph samples. A 
standard curve was constructed for every gel slab and the quantities of apolipoprotein B- 
48 in the rat lymph samples were estimated accordingly. There was a linear relationship 
between the volume of standard serum sample applied to the gel and the corresponding 
amounts of apolipoprotein B-lOO as determined by this procedure (Figure 2.4). The 
absorbance of apolipoprotein B-lOO and apolipoprotein B-48 bands was determined with 
subtraction of background absorbance estimated from an adjacent similar-sized area of 
gel.
2.2.8.6 Estimation o f relative chylomicron size. Two methods were used to estimate the 
relative increase in chylomicron size during lipid absorption. The first method considers 
the ratio of lymph triacylglycerol transport rates during the fasted and fat fed state. 
However, two major points were taken into consideration, i) the composition of 
triacylglycerol-rich lipoproteins (% by weight) where triacylglycerol constitutes 
respectively in the fasted and fat fed state 64.0% and 85.9% (Martins et al., 1994); ii) the 
change in particle number with lipid absorption which is mirrored by the change in apo B- 
48 secretion.
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In the second method, the ratio lymph apo B-48/lymph TAG was determined in 
both the fasted and the fat fed state, after taking into consideration the composition of 
triacylglycerol-rich lipoproteins in both the fasted and fat fed state (Martins et a l, 1994). 
After that, the obtained ratios are divided in order to compare how many times the size 
have changed. The two methods gave similar results with less than 1% difference.
2.2.9 Measurement o f plasma glucose
Blood was collected in fluoride-oxalate tubes, centrifuged at 2000 g for 5 minutes 
and the plasma removed and stored at -20°C prior to assay. The glucose assay (Biolabo, 
France) was a colorimetric method where the enzymatic reaction sequence employed in 
the assay was as follow:
Glucose oxidase
1) Glucose + 2H2O 4- O2 —^ Glucuronic acid + 2H2O2
Peroxidase
2) H2O2 + o-Dianisidine —^ o-Dianisidine (oxidized)
(colourless) (brown)
Samples were run in duplicate and the absorbances of the unknown and the 
standard samples were measured against reagent blank at X = 510 nm (Jenway 6105
u.v./vis. spectrophotometer, U.K.).
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As the concentration/absorbance relationship is linear (see Figure 2.5), plasma 
glucose concentration was estimated using a duplicated glucose standard at 0.56 mmol/L.
^  , . Absorbance of unknown x concentration of standardConcentration of unknown = [ r t  "i Absorbance of standard J
As used here, plasma glucose estimation showed intra-assay variation of between 
1.2% and 2.7%; between assay variation was 0.7% using quality control samples at 
glucose concentration of lOmM.
2.2.10. Measurement o f serum triacylglycerol
Blood samples were collected in glass clotting tubes and left at ambient temperature for 1 
h to clot before centrifugation at 2000 g for 5 minutes. Serum was then removed with a 
pipette and stored in an Eppendorf tube at -20 °C prior to assay. The triacylglycerol assay 
kit (Amico Laboratories Inc, Nashville, USA) used is a colorimetric method where the 
enzymatic reaction sequence employed in the assay was as follow:
Lipase
1) Triacylglycerol Fatty acids + Glycerol
Glycerol Kinase
2) Glycerol + ATP —^ Glycerol 3-phosphate + ADP
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Glycerol-3-Phosphate Oxidase
3) Glycerol 3-phosphate -f- 0% —^ Dihydroxyacetone-phosphate +
H 2 O 2
4) H2O2 + 4-Aminoantipyrine-3,5-Dichloro-2-hydroxybenzene sulfonate
Peroxidase
Quinoneimine dye + 2H2O 
(red)
Samples were run in duplicate and the absorbances of the unknown and the 
standard samples were measured against reagent blank at X = 520 nm (Jenway 6105 
spectrophotometer, U.K.).
Lymph samples were diluted 10 fold before taking aliquots for triacylglycerol 
determination in order to obtain concentrations within the range of sensitivity of the assay. 
The values obtained were then multiplied by ten to correct for dilution of the original 
lymph samples.
As the concentration/absorbance relationship is linear over the range of interest in 
this study (see Figure 2.6), plasma TAG concentration was estimated using a duplicated 
triacylglycerol standard at 200 mg/dl.
_ . .c 1 r  Absorbance of unknown x concentration of standard nConcentration of unknown = I ------------------------------------------------------------------------  I
L Absorbance of standard J
As used here, serum TAG estimation showed intra-assay variation of between
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1.2% and 2.1%; between assay variation was 0.5% using quality control samples 
at TAG concentration of 200mg/dl.
2.3.11 Measurement o f serum cholesterol
Blood samples were collected in glass clotting tubes and left for 1 h to clot at 
ambient temperature before centrifugation at 2000 g for 5 minutes. Serum was removed 
with a pipette and stored in an Eppendorf tube at -20 prior to assay. The cholesterol 
assay kit (Biolabo, France) used is a colorimetric method where the enzymatic reaction 
sequence employed in the assay was as follow:
Cholesterol Esterase
1) Esterified cholesterol —> Free Fatty acids + Cholesterol
Cholesterol Oxidase
2) Cholesterol + 0% —^ Cholesten 4 one 3 + H2O2
Peroxidase
3) 2H2O2 + 4-Aminoantipyrine + Phenol Quinoneimine + 4H2O
(pink)
Samples were run in duplicate and the absorbances of the unknown and the 
standard samples were measured spectrophotometrically (Jenway Model 6105, U.K.) 
against reagent blank at A, = 505 nm
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As the concentration/absorbance relationship is linear over the range of serum 
cholesterol encountered here (see Figure 2.7), serum cholesterol concentration was 
estimated using a duplicated cholesterol standard at 5.2 mmol/L.
^  , . Absorbance of unknown x concentration of standardConcentration of unknown = [ t t  ~i Absorbance of standard J
As used here, serum cholesterol estimation showed intra-assay variation of 
between 1.6% and 2.5%; between assay variation was 0.5% using quality control samples 
at cholesterol concentration of 2.5mM.
2.4 Data handling and statistical methods
Normal distributions of data were confirmed using the Kolmogorov-Smimov one- 
sample goodness of fit test. For parametric tests, homogeneity of variances was assessed 
using the! Levene test. Unacceptable heteroscedasity was eliminated, where possible, 
by the logarithmic transformation of data. Where data were normally distributed, 
comparisons between fewer than three groups were made using paired or unpaired r-tests 
as appropriate. Where data distributions where not normal or could not be appropriately 
transformed, the Mann-Whitney ‘U ’ test was used for between-group comparisons. 
Comparisons between more than two groups were made using oneway analysis of 
variance with localisation of differences being achieved with an appropriate range test. 
Where data were not normally
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Figuren 2.7 Cholesterol standard curve (each value denotes the mean of three 
determinations)
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distributed and could not be transformed to achieve normal distribution, the 
Kruskall-Wallis nonparametric analysis was used and differences located using the Mann- 
Whitney ‘U ’ test with appropriate adjustment to the critical value of p. Unless otherwise 
stated, statistical significance was assumed at/» < 0.05.
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3. Fat Loading and Apolipoprotein B Content of Rat Jejunal 
Enterocytes and Mucosal Scrapings
3.1. Introduction
A large proportion (100 g/day, providing some 40% of total energy intake) of the 
Western diet consists of lipids, largely TAG (97%) together with small amounts of 
phospholipids and cholesterol. These components are important in cell membrane 
composition, fluidity, peroxidation, synthesis of prostaglandins and leukotrienes and in 
cellular metabolic processes. Lipids have been implicated in mechanisms of brain 
development, inflammatory processes, atherosclerosis, carcinogenesis, aging and cell 
renewal (Shiau, 1986).
Dietary lipids and lipids of the enterohepatic circulation are efficiently absorbed 
(95%) into the enterocytes where they are incorporated or reincorporated into lipoproteins 
and secreted into mesenteric lymph. The intestine secretes two major classes of 
lipoprotein, chylomicrons and very low density lipoproteins (VLDL), both of which are 
triacylglycerol-rich and are predominantly secreted in both fed and fasting states (Green, 
Glickman, Saudek, Blum and Tall, 1979).
During fasting periods, VLDL particles (20-80 nm in diameter) and high density 
lipoprotein (HDL) are present in the mesenteric lymph. VLDL particles carry 50% of
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lymph cholesterol and TAG in the fasting state and are the absorptive route for 
endogenous intestinal and biliary lipids (Davidson et a l, 1991). VLDL secreted by 
enterocytes are similar in size to liver VLDL, but their apolipoproteins (specifically apo 
B-48 in enterocytes VLDL and apo B-lOO in liver VLDL) are different. During higher 
rates of lipid absorption, particle size increases to accommodate the increased lipid flux 
across the intestinal mucosa, and chylomicrons then become the predominant 
triacylglycerol-rich lipoprotein in lymph (Davidson et a l, 1991).
Chylomicrons are spherical triacylglycerol-rich particles (75-600 nm diameter) 
synthesized within enterocytes during TAG absorption. Particle size appears to be largely 
determined by the magnitude of TAG flux through the intestinal cell; large chylomicrons 
are formed during the peak of lipid absorption (Martins, Sainsburry, Mamo and Redgrave, 
1994). This may reflect conservation of surface constituents (apolipoprotein and 
phospholipids) requiring active synthesis by the enterocytes. Lymph chylomicrons are 
composed mainly of TAG (86-92%), cholesteryl ester (0.8-1.4%), free cholesterol (0.8- 
1.6%), phospholipids (6-8%) and protein (1-2%) (Bisgaier and Glickman, 1983).
Structurally, lipoprotein particles (chylomicron and VLDL) are spherical 
complexes with a hydrophobic lipid core (TAG, cholesteryl ester) surrounded by a polar 
surface coating of phospholipid, free cholesterol and apolipoproteins. Apolipoprotein B- 
48 is essential for the packaging and secretion of t a g  -rich lipoprotein, and has an 
obligatory role in the intestinal absorption of dietary lipid. Apolipoprotein B-48 is a 
truncated form of apolipoprotein B-lOO produced through the post-transcriptional
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modification of apolipoprotein B-lOO mRNA by a single base change, producing a stop 
codon at position 2153 (Chen et a l, 1987; _ , , . - ; Hospattankar et a l, 1987).
Synthesized in the liver, apolipoprotein B-lOO is a component of plasma VLDL and LDL, 
and contains the LDL receptor binding domain (Knott, Pease, Powell, Wallis, Rail, 
Innerarity, Blackhart, Taylor, Marcel, Milne, Johnson, Fuller, Lusis, McCarthy, Mahley, 
Levy-Wilson and Scott, 1986). In the rat, apolipoprotein B-48 is synthesized solely in 
the intestine, and is found in intestinal chylomicrons (Davidson et a l, 1986). It does not 
contain the LDL receptor binding sequence (Hui et a l, 1984).
Defective assembly and secretion of apolipoprotein B-containing lipoproteins in 
affected patients with abetalipoproteinemia was found to be associated with mutations in 
the gene encoding a 97-kDa protein, microsomal TAG transfer protein (MTP) large 
subunit (Wetterau, Aggerbeck, Bouma, Eisenberg, Munck, Hermier, Schmitz, Gay, Rader 
and Gregg, 1992). MTP is a heterodimer that consists of a 97-kDa large sub-unit and a 
smaller sub-unit of 58 kDa , identified as protein disulfide isomerase (PDI) (Wetterau, 
Aggerbeck, Laplaud and McLean, 1991; Wetterau, Combs, Spinner and Joiner, 1990). In 
vitro studies (Wetterau and Zilversmit, 1984; Atzel and Wetterau, 1993) showed that 
MTP efficiently catalyzes the transfer of TAG and other lipids from donor membranes to 
acceptor membranes. MTP is present in the lumen of the endoplasmic reticulum of 
enterocytes and hepatocytes and physically interacts with apolipoprotein B during 
lipoprotein assembly (Wu, Zhou, Huang, Wetterau and Ginsberg, 1996). The large sub­
unit either possesses, or confers lipid transfer activity (mainly TAG but also 
phospholipids and cholesterol esters) on the complex (Jamil, Dickson, Chu, Lago,
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Rinehart, Biller, Gregg and Wetterau, 1995). In the absence of MTP, no lipidation of 
apolipoprotein B occurs on the endoplasmic reticulum membrane and apolipoprotein B 
will consequently be rapidly degraded (Wetterau et a l, 1992).
Neither acute nor chronic dietary t a g  augmentation appear to have a 
regulatory function on intestinal apolipoprotein B synthesis (Davidson et a l, 1986; 
Hayashi, Fujimoto, Cardelli, Nutting, Bergstedt and Tso, 1990). However, bile 
components were shown to regulate apolipoprotein B gene expression since bile diversion 
reduces intestinal apolipoprotein B synthesis which can be re-expressed following 
intraduodenal instillation of fatty acids and bile salts (Davidson et a l, 1988b). Lipid 
feeding was found to increase enterocyte apolipoprotein B content in intestinal mucosal 
scrapings from the rat (Schonfeld, Bell and Alpers, 1978; Alpers et a l, 1985) and the 
newborn piglet (Black and Rhower-Nutter, 1991; Black, 1992). However, conflicting 
results were reported from enterocytes. In human subjects (Rachmilewitz, Albers and 
Saunders, 1976) in and the rat (Davidson et a l, 1986) cells lipid feeding was reported to 
result in apolipoprotein B depletion. These reports conflict with those of Green, 
Lefkowitch, Glickman, Riley, Quinet and Blum, (1982) and Glickman, Green, Lees, Lux 
and Kilgore, (1979) who reported apolipoprotein B enrichment in human enterocytes and 
with Schonfeld et al (1978), Alpers et a l  (1985) and Glickman et a l  (1978) ) who 
reported apolipoprotein B enrichment in rat enterocytes following lipid feeding
In view of this conflict, the present investigation sought to ascertain the effects of 
lipid feeding upon apolipoprotein B content in the rat jejunum. The rat was selected as an
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appropriate model because only apolipoprotein B-48, and not apolipoprotein B-lOO, is 
secreted by the enterocytes of this species (Davidson et a l, 1986).
3.2 Study Design
Male Sprague Dawley rats weighing 250-325 g (Lebanese American University 
stock) were used in all experiments. All animals received the same rat chow diet ad 
libitum until 24 hours prior to use and had free access to water at all times.
3.2.1 In vitro study
Jejunal strips were prepared from fasting animals as described in Chapter 2. The 
intestinal strips were randomly divided into two groups (each of 5 strips) and incubated in 
20 ml of either oxygenated (by bubbling air into the solution) modified Ringer solution 
(control group) or oxygenated oleic acid emulsion (oleic acid group) as described in 
Chapter 2.2.1 at page 48. The oxygenated incubating solutions were shaken at 60/min 
(Grant instrument, Cambridge Ltd., England) at 37°C. After 2h incubation, the intestinal 
strips were removed, washed in ice-cold phosphate buffered saline (PBS) at pH 7.4 . 
The mucosa was scraped and homogenized as described in Chapter 2. Samples from the 
homogenate and homogenate supernatant were taken for protein determination and 
apolipoprotein B content respectively as also described in chapter 2. Apolipoprotein B 
content was estimated as mg apolipoprotein B/g protein.
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3.2.2 In vivo study
Fasted rats were divided into three groups of 14 animals each. Animals from the 
same group were further subdivided into a control group and an experimental group. In 
the first group, the experimental group received 4 ml of olive oil emulsion (20% olive oil 
and 1% Tween 80 in 153.8 mM saline) intragastrically; the control group received 4 ml of 
153.8 mM saline intragastrically. After 90 minutes, the animals were anesthetised with 
ether and the jejunal enterocytes and mucosal scraping supernatants were prepared for 
apolipoprotein B estimation as described in Chapter 2 (see page 49).
In the second group, experimental and control groups were treated similarly to 
those in the first group but the animals were sacrificed 3 h after intragastric instillation of 
fat or saline. Apolipoprotein B contents were estimated in jejunal enterocytes and 
mucosal scrapings supernatants as above.
The third group received the test material by intraduodenal rather than intragastric 
installation in order to avoid unexpected effects of gastric emptying rates. Following 
ether anaesthesia, a small incision was made in the upper abdominal wall and the 
proximal duodenum exposed. 4 ml oleic acid emulsion (10% oleic acid and 1% Tween 
80 in 153.8mM saline, pH 7.4) (Experimental group), or 4 ml of 153.8 mM saline 
(Control group) was injected, via a hypodermic (20 gauge) needle into the duodenum 
immediately distal to the pyloric sphincter. Apolipoprotein B content of jejunal mucosal 
scrapings and enterocyte supernatants were estimated (as described in Chapter 2) 90 min 
after instillation.
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3.3 Results
The method of estimating apolipoprotein B content in the present study is used 
clinically for quantitatively determination of human apolipoprotein B-lOO content in 
plasma. Estimation of rat apolipoprotein B-48 therefore necessitated a new calibration of 
the Nor-Partigen apolipoprotein B plates for radial immunodiffusion. This was done using 
a specific enzyme-linked immunosorbent assay (ELISA) (Lovegrove et al. 1996) using 
lymph samples, standardized by Karpe and Hamsten, (1994) as standards. Values 
reported are thus based upon the calibrated lymph standard. Results obtained as mg/L 
apolipoprotein B in solution were expressed as mg apolipoprotein B/g protein of the 
homogenate following protein estimation (Chapter 2.2.4 at page 55)
To elucidate the effect of lipid feeding upon apolipoprotein B-48 content of 
enterocytes and mucosal scrapings, one in vitro and three in vivo studies were conducted. 
For data analyses, normality of distributions of the data were confirmed (Kolmogorov- 
Smirnov goodness of fit test). Comparisons between groups were made using two-tailed 
unpaired f-tests.
3.3.1 In vitro study.
Apolipoprotein B contents in the jejunal mucosal scrapings of fasted rats (278 g ± 
18 g) were estimated after 2 h of incubation in either modified Ringer solution or oleic 
acid emulsion in modified Ringer solution. The data are shown in Figure 3.1 (see also
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Appendix ni. Table 3.A). Oneway analysis of variance of the data revealed significant 
heteroscedasity of the data (Levene test: p  = 0.03). The data were therefore 
logarithmically transformed and variance homogeneity was substantially improved 
(Levene test: p  = 0.05). Analysis of variance of the transformed data showed significant 
difference between the control and 2.5% oleic acid groups (Fs [1,8]= 6.82; p  = 0.03) 
showing that incubation of jejunal segments in an oleic acid emulsion resulted in 
increased apolipoprotein B-48 concentration in the mucosal scrapings.
3.3.2 In vivo studies.
Apolipoprotein B content of jejunal enterocytes and mucosal scrapings of fasted 
rats (274 g ± 16 g), 90 min after intragastric instillation of fat or saline load, are shown 
respectively in Figures 3.2 and 3.3 (see also Appendix m . Tables 3.B and 3.C). 
Differences were located using Duncan’s multiple range test at a  (pre-set probability) = 
0.05. Compared to the control group receiving the saline load, there was significant 
increase (p<0.05) in apolipoprotein B content in both the jejunal enterocytes and mucosal 
scrapings 90 min after instillation of the fat load.
Data for apolipoprotein B contents jejunal enterocytes and mucosal scrapings of 
fasted rats (284 g ± 15 g), 3 h after intragastric instillation of the fat or saline load, are 
shown respectively in Figures 3.4 and 3.5 (values in Appendix II, Table 3.D and 3.E). As
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before, apolipoprotein B contents in both the jejunal enterocytes and mucosal scrapings 
were significantly (p<0.05) higher after fat load than after saline load.
An increase of apolipoprotein B content was also observed 90 min after 
intraduodenal instillation of fat or saline in fasted rats (269 g ± 20 g). The data are shown 
in Figures 3.6 and 3.7 respectively (values in Appendix IE, Table 3.F and 3.G). 
Apolipoprotein B content in both the jejunal enterocytes and mucosal scrapings were 
higher (p<0.05) in animals receiving the fat load than those receiving the saline load.
3.4 Discussion
The present study was undertaken to assess the effect of lipid feeding upon 
apolipoprotein B content in jejunal enterocytes and mucosal scrapings of the fasting rat. 
The jejunum, rather than the ileum was used in the light of the report (Black et a l,  1991) 
that, following 24 hours of intraduodenal infusion of Vivonex (a low fat elemental 
formula) or TAG emulsion in newborn piglets, jejunal mucosal TAG content was an order 
of magnitude greater in the TAG infused group compared to the V/von^Jc-infused 
group while ileal mucosal TAG content was unchanged.
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Figure 3.1 Apolipoprotein B content of jejunal mucosal scrapings (In vitro study) after 2 
h of incubation in either a modified (Unger solution (control) or an oleic acid 
emulsion (oleic acid) in modified Ringer solution. Mean ± S.E.M. (n = 7).
* = Oleic acid vs Control group (p < 0.03).
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Figure 3.2 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
90 minutes of instilling intragastrically 2 ml of either 153.8 mM NaCl or 
olive oil. Mean ± S.E.M. (n = 5).
* = Olive oil vs Fasted and 153.8 mM NaCl groups (p < 0.05).
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Figure 3.3 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting 
and after 90 minutes of instilling intragastrically 2 ml of either 153.8 mM 
NaCl or olive oil. Mean ± S.E.M. (n = 5).
* = Olive oil vj Fasted and 153.8 mM NaCl groups (p < 0.05).
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Figure 3.4 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
3 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl or olive 
oil. Mean ± S.E.M. (n = 5).
* = Olive oil vj Fasted and 153.8 mM NaCl groups (p < 0.05).
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Figure 3.5 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting 
and after 3 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl 
or olive oil. Mean ± S.E.M. (n = 5).
* = Olive oil vs Fasted and 153.8 mM NaCl groups (p < 0.05).
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Figure 3.6 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
90 minutes of instilling intraduodenally 4 ml of either 153.8 mM NaCl or 
oleic acid emulsion. Mean ± S.E.M. (n = 5).
* = Olive oil vj" Fasted and 153.8 mM NaCl groups (p < 0.05).
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Figure 3.7 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting
and Oafter 90 minutes of instilling intraduodenally 4 ml of either 153.8 mM 
NaCl or oleic acid emulsion. Mean ± S.E.M. (n = 5).
* = Olive oil vs Fasted and 153.8 mM NaCl groups (p < 0.05).
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During fasting periods, the only source of lipid in the intestinal lumen is bile 
and sloughed digested enterocytes and only intestinal VLDL and HDL are formed and 
secreted by the enterocytes into the intestinal lymph (Davidson et a l, 1991). 
Following feeding and consequent lipid absorption, in addition to VLDL-sized 
particles, chylomicrons, absent in the fasting mucosa and lymph, appear in great 
numbers in both enterocytes and lymph.
Rat enterocytes synthesize and contain apolipoprotein B48; there is no 
apolipoprotein BlOO formed (Davidson et a l, 1986). Hence the present results 
specifically report apolipoprotein B-48 content in the jejunal enterocytes. hnmunoblot 
techniques [Black and Rhower-Nutter^ ,1991) show the major proportion of 
apolipoprotein B found in newborn piglet jejunal mucosal scrapings to be 
apolipoprotein B-48; there was no contamination with plasma apolipoprotein B-100. 
Similar results are shown in the present study where extensive washing of the 
intestinal blood vessel with either ice-cold PBS or sucrose, before scraping the jejunal 
mucosa (Chapter 2), did not affect the jejunal mucosal apolipoprotein B content. 
Hence, the apolipoprotein B content reported in both the jejunal enterocytes and 
mucosal scraping in the present study is considered to be specifically apolipoprotein 
B-48.
Rachmilewitz et a l  (1976) reported a 77% reduction in enterocyte 
apolipoprotein B content 45 min after intraduodenal instillation of a fat load in human 
subjects. The content fell from 1.3 to 0.3 pg/mg cell protein. Since a change in
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apolipoprotein B synthesis rate is very unlikely to occur over such a short time 
interval (Davidson et a l, 1986, Hayashi et a l, 1990), this observation suggests that 
after an hour or more of acute lipid absorption there would be insufficient enterocyte 
apolipoprotein B for further lipid absorption, leading in turn to reduced apolipoprotein 
B secretion into lymph. This does not accord with the finding reported here (Chapter 
5) or with others (Martins et a l  1994; Krause, Sloop, Castle and Roheim, 1981) in 
which apolipoprotein B48 secreted from rat enterocytes into the lymph increased 3h to 
6h after acute lipid absorption. Also, Magun et a l  (1988) suggested that rat 
enterocytes contain a large intracellular apolipoprotein B pool, and that lipid 
absorption mobilizes only a small fraction of this pool. Thus, it is very unlikely to 
show the acute depletion of enterocyte apolipoprotein B reported by Rachmilewitz gr 
a l  (1976) during the very short time after lipid absorption. The latter observation 
could represent incomplete recovery of intracellular apolipoprotein B, since data for 
their method showed failure to recover 25-30% of a known amount of apolipoprotein 
B added to the cell homogenate. This suggests that most of the intracellular 
apolipoprotein B, which is non-lipoprotein-bound and tightly membrane associated 
(Magun et a l, 1988), and a quite large amount of the lipoprotein-bound 
apolipoprotein B remained unextracted and was not accounted for in their assay 
procedure. The report of Rachmilewitz et al (1976) may therefore be discounted for 
the purpose of the present study.
More recently, Davidson et a l  (1986) reported inconsistent depletion of rat 
enterocyte apolipoprotein B content associated with increased triacylglycerol flux.
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The intestinal samples were pulse labelled with radiolabeled leucine in the last 9 min 
of lipid absorption and only radiolabelled apolipoprotein B was considered in the 
study of both apolipoprotein B48 synthesis rate and content. The latter method is 
appropriate for synthesis rate studies e.g. that of Black and Rhower-Nutter (1991). 
However, the method does not permit inference about changes in total intracellular 
apolipoprotein B content during lipid absorption, as it accounts only for newly 
synthesized apolipoprotein B while neglecting the pre-existing large intracellular 
apolipoprotein B pool (Magun et al., 1988). Hence, the inconsistent depletion 
observed with active TAG flux, does not exclude the possibility of overall increase in 
intracellular apolipoprotein B content.
Using immunofluorescence techniques, Glickman et al. (1978) and Glickman 
et al., (1979) respectively reported increased enterocyte apolipoprotein B content after 
lipid feeding in rats humans and humans. Using the same technique, Schonfeld et al. 
(1978) reported increased apolipoprotein B content of rat enterocytes after lipid 
feeding, and the data suggested a close correlation between immunofluorescence and 
apolipoprotein B content of rat intestinal mucosa estimated by radioimmunoassay. 
Thus changes in immunofluorescence during lipid feeding are a true reflection of 
increased content, rather than an altered intracellular distribution of apolipoprotein B. 
The same study reported a 2.5 fold increase in rat intestinal mucosal apolipoprotein B 
content 4h after intragastiic instillation of 1.5 ml of com oil. Comparable increases 
are reported in the present study in both enterocytes and intestinal mucosal scrapings. 
Unlike Rachmilewitz et al. (1976), Schonfeld et al. (1978) were able to recover more
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than 95% of apolipoprotein B added to the cell homogenate, probably because of the 
use of Triton X-100. Davidson et al. (1986) showed Triton X-100 to be very 
effective in enabling recoveries of 84% - 94% of total apolipoprotein from cell 
homogenates, with no discernible effect of the lipid flux state. Thus, the use of Triton 
X-100 in the present study enables reliable estimates of total intracellular 
apolipoprotein B changes after lipid feeding.
Using column chromatography, Alpers et al. (1985) were unable to use 
detergents to solubilise membrane bound apolipoprotein, but they studied the pattern 
of distribution of more than 50% of the intracellular apolipoprotein B pool (using 
radioimmunoassay). They reported that acute fat feeding for 3h not only produced a 
shift in the distribution of intracellular apolipoprotein B, but also that there was a 
considerable increase in the absolute amount of apolipoprotein B in all isolated 
fractions studied. Under the same conditions, the lamina propria showed a 
pronounced increase in apolipoprotein B content but without a change in its 
distribution, hence indicating an enhanced secretion of apo B48 towards the serosal 
sides of the enterocytes as part of the secretion process.
Green et al. (1982), using immunoperoxidase techniques, reported overall 
increase in apolipoprotein B staining accompanying redistribution within the human 
enterocytes after lipid feeding. Also, using competitive ELISA, Black and Rhower- 
Nutter (1991) and Black (1992) reported around 2.4 fold increase in intestinal mucosal 
apolipoprotein B48 content following 24 h intraduodenal infusion of TAG emulsion
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in the newborn piglet. The order of magnitude of increase is comparable with that 
reported in the present study supporting the contention that previously reported 
depletion of enterocyte apolipoprotein B during lipid absorption (Rachmilewitz et al. 
1976; Davidson et al 1986) results from flawed methodologies.
Intestinal mucosal apolipoprotein B content represents the intracellular 
apolipoprotein B content in addition to the newly secreted apolipoprotein B molecules 
into the intercellular spaces up to the lamina propria. Findings by other investigators 
(Martins et a l,  1994) and in the present study (Chapter 5 at page 147) have shown 
that during the peak of lipid absorption increased lipid transport is accomplished 
mainly by increased chylomicron particle size with only a small increase in particles 
number (around 50 % increase) in intestinal lymph. This, and the finding of Magun et 
al. (1988) that rat enterocytes contain a large intracellular apolipoprotein B pool of 
which only a small fraction is mobilised by lipid absorption, is of relevance. It 
indicates that the consistently observed increase in intestinal mucosal apolipoprotein 
B content after fat intake not only results from accumulation of apolipoprotein B in 
intercellular spaces, but also from concurrently increased intracellular apolipoprotein 
content, as reported here
While apolipoprotein B48 has an obligatory role in the assembly and secretion 
of triacylglycerol-rich lipoproteins, lipid feeding has no effect upon apolipoprotein B 
synthesis rate in either the rat (Davidson et a l,  1986, Hayashi et a l, 1990) or the 
neonatal piglet (Black, 1992). Previous studies have demonstrated that apolipoprotein
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B secretion is regulated post-translationally (Pullinger, North, Teng, Rifici, Ronhid de 
Brito and Scott, 1989; Moberly, Cole, Alpers and Schonfeld, 1990; Dashti, William 
and Alaupovic, 1989; Sorci-Thomas et al., 1989^ Kroon, DeMartino, Thompson and 
Chao, 1986; Kushwaha, McMahan, Mott, Carrey, Reardon,Getz and McGill, 1994; 
Leighton, Joyner, Zamarripa, Deines and Davis, 1990; White, Graham, LeGros, Pease 
and Scott, 1992). Studies on HepG2 cells have shown that the availability of newly 
synthesized TAG may be the most important among factors affecting secretion of 
apolipoproteinB-containing lipoprotein (Boren, Graham, Wettesten, Scott, White and 
Olofsson, 1992; Dixon, Furukawa and Ginsberg, 1991; Sakata, Wu, Dixon and 
Ginsberg, 1993; Wu, Sakata, Dixon and Ginsberg, 1994a; Wu, Sakata, Lui and 
Ginsberg, 1994b). Thus, when lipid availability is increased, rapid intracellular 
degradation (Borchardt and Davis, 1987; Bostrom, Boren, Wettesten, Sjoberg, 
Bondjers, Wiklund, Carlsson and Olofsson, 1988) of newly synthesized 
apolipoproteinB is apparently inhibited (Wu et al., 1996).
It is presently accepted that the general mechanism of intracellular assembly of 
apolipoprotein B-containing lipoproteins in enterocytes and hepatocytes includes 
association of apolipoprotein B with lipid in a multi-step process. The first step in the 
assembly is the co-translational lipidation of apolipoprotein B (mediated by MTP) at 
the endoplasmic reticulum (Innerarity, Boren, Yamanaka and Olofsson, 1996). This 
protects the protein from early intracellular degradation and results in the formation of 
a primordial intracellular lipoprotein (Hussain, Kancha, Zhou, Luchoomun, Zu and 
Bakillah, 1996; Innerarity et a l, 1996) with HDL size and density (Innerarity et a l.
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1996). In enterocytes, the primordial lipoproteins are converted to large TAG-rich 
apolipoprotein B-48-containing VLDL/chylomicron particles (Innerarity et a l, 1996). 
Thus, the major amount of lipid is added in the second step (Boren, Rustaeus and 
Olofsson, 1994). Recent studies in Caco-2 cells (Van Greevenbroek, Robertus- 
Teunissen, Erkelens and De Bruin, 1998) suggest that MTP is not only involved in 
the first step of lipoprotein synthesis whereby apolipoprotein B degradation is avoided 
by the co-translational lipidation referred to above, but also in further steps involving 
the association of hpoproteins with TAG.
Studies on HepG2 cells (Wu et al., 1996) indicated that cells treated with oleic 
acid showed a dramatic increase (3-5 fold) in MTP-apolipoprotein B binding which 
was eliminated when a TAG inhibitor (triacsin D, a fatty acyl-CoA synthetase 
inhibitor) was added to the media with oleic acid. These results indicate that MTP- 
apolipoprotein B interaction was closely coupled with, or dependent upon, TAG 
synthesis. In the same study, it was further demonstrated that oleic acid-treated cells 
showed increased MTP-apolipoprotein B interaction. It is suggested that prolonged 
MTP-apolipoprotein B interaction protects apolipoprotein B from intracellular 
degradation by facilitating its translocation across the endoplasmic membranes and 
targeting it for secretion (Sakata et al., 1993). Thus, during lipid absorption protection 
of apolipoprotein B from rapid intracellular degradation occurs mainly via an increase 
in both the degree and the duration of association between MTP and apolipoprotein B.
103
Since increased lipid transport appears to be accomplished principally by 
increased chylomicron particle size, with only a small increase (around 50 %) in 
particle number in intestinal lymph, two further reasons may be adduced for the 
increased intracellular apolipoprotein B content reported here. First, consistently 
increased secretion of chylomicrons or apolipoprotein B-48 particles for as long as 
active TAG absorption occurs (even after 24h of lipid absorption (Black and Rhower- 
Nutter, 1991)), would necessitate an increase (of about 50 %) in the mobilisation of 
intracellular apolipoprotein B-48 into formed chylomicrons, thereby reducing 
intracellular degradation of apolipoprotein B. Secondly, formation of very large 
chylomicrons during lipid absorption could require longer intracellular residence for 
packaging. It is unlikely that the surface apolipoprotein B-48 of such nascent 
chylomicrons within the enterocytes would be degraded. These two reasons, together 
with the protection of apolipoprotein B from rapid intracellular degradation via an 
increase in both the degree and the duration of association between MTP and 
apolipoprotein B, could explain the intracellular accumulation of and raised content of 
apolipoprotein B reported here.
The present study thus confirms an overall increase in apolipoprotein B 
content in both jejunal mucosal scrapings and enterocytes after lipid feeding. Also, 
the present data, in conjunction with previous reports (Black and Rhower- 
Nutter, 1991; Schonfeld et al., 1978) support the contention that during lipid 
absorption, mucosal apolipoprotein B content increases, to a maximum of 2-2.5 fold, 
and the increase persists as long as there is active TAG absorption.
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4. LONG-TERM DIETARY FAT-LOADING. FAT TYPE AND 
INTESTINAL APOLIPOPROTEIN B CONTENT
4.1 Introduction
The role of both type and quantity of dietary fatty acids as determinants of both 
nature and quantity of plasma lipoproteins and of cardiovascular disease risk is 
currently an area of intense investigation. Lipids such as TAG and cholesterol are 
transported in the body as lipoproteins which are lipid-proteins complexes based upon 
the apolipoproteins. After absorption, exogenous lipids, comprising the dietary fat, 
are assembled and processed within the enterocytes and secreted as TAG-rich 
lipoproteins (chylomicrons and VLDL) from the intestine into the blood via the 
cistema chyli and the thoracic lymph duct.
In blood TAG-rich lipoproteins are hydrolyzed by lipoprotein lipase present 
mainly in the vascular endothelium of skeletal muscle and adipose tissue capillaries. 
The chylomicron particles become smaller after losing their TAG core and new 
particles called chylomicron remnants are formed. These particles are enriched in 
cholesteryl ester and fat-soluble vitamins and contain apo B48 and apo E (Cooper, 
1997). Chylomicron remnant particles are rapidly removed from the circulation by the 
liver. Apo E is the moiety required for rapid hepatic removal (Young, 1990; Cooper,
1997). Recently it has been hypothesised that the periphery could be of importance
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for removal of the largest chylomicron remnants, as their size might partially exclude 
them seiving through the endothelial fenestre to reach the hepatic chylomicron 
remnant receptors (Karpe, Humphreys, Samra, Summers and Frayn, 1997). Having 
achieved a size that allows them k penetrate the fenestrated hepatic sinusoidal 
epithelium and enter the space of Disse, these remnant particles can then be removed 
by several overlapping mechanisms (Cooper, 1997): They may 1) be removed directly 
by LDL receptors; 2) acquire additional apo E that is secreted free into the space of 
Disse, and then be removed directly by the LDL receptor-related protein (LRP); or 3) 
they may be sequestered in the space of Disse where apo E binds to heparan sulfate 
proteoglycans and/or apo B binds to hepatic lipase, then the sequestered particles may 
further be metabolised allowing apo E and lysophospholipid enrichment, followed by 
transfer to one of the above receptors for hepatic uptake.
Weintraub et al. (1987a,b) suggested that postprandial chylomicrons and their 
remnant particles may be atherogenic in normolipidemic individuals. Simons et al. 
(1987) examined the amount of apolipoprotein B-48 relative to apolipoprotein B-100 
on stained gels of the postprandial lipoproteins of control subjects and subjects with 
coronary artery disease. The apolipoprotein B-48lapolipoprotein B-100 ratio was 
significantly increased in patients with coronary artery disease even when age and 
other lipid discriminators, such as TAG and cholesterol were included in the analysis. 
Similarly, Meyer et al (1996) observed that fasting apolipoprotein B-48 levels in 
women with angiographically proven coronary artery disease were higher than 
disease-free matched controls. Women with angiographically proven coronary artery
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disease showed also greater absolute and incremental apolipoprotein B-48 response in 
the intermediate density lipoprotein fraction after a fat load.
Apolipoprotein B-48 is an obligatory surface component of both TAG-rich 
lipoproteins (chylomicron and VLDL) secreted by the intestine. It has been used as a 
marker molecule as it remains as a part of secreted chylomicron and VLDL particles 
until they are digested by the hepatocytes after being internalized. Thus, tracing 
apolipoprotein B-48 molecules from the enterocytes, where they are synthesized, until 
they are removed by the hepatocytes can aid understanding of the metabolism of these 
TAG-rich particles. The number of apolipoprotein B-48 particles in blood is assumed 
to reflect the number of postprandial chylomicron and remnant particles as the 
apolipoprotein B-48 molecule/chylomicron particle ratio appears to remain constant at 
unity (Martins et a l, 1994; Elovson et a l, 1988).
Increased plasma apolipoprotein B-48 content, in subjects at high risk of 
coronary artery disease, is the result of either increased secretion from the enterocyte 
or decreased catabolism and removal from the blood or possibly both mechanisms 
occurring simultaneously. The intestine, where apolipoprotein B-48 molecules are 
synthesized, is a good starting point to consider the metabolism of chylomicrons. 
Quantitation of apolipoprotein B-48 mRNA abundance can not detect potentially 
important co- and posttranslational regulatory mechanisms. This is illustrated by 
studies on cultured hepatocytes (Borchardt et a l, 1987) and Hep G2 cells (Bostrom et 
a l, 1988) which showed that significant amounts of newly synthesized apolipoprotein
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B are immediately degraded intracellularly. Hence, direct determination of actual 
apolipoprotein B-48 content changes in enterocytes may provide a more reliable 
representation of all the transcriptional, translational and other regulatory mechanisms 
involved in the formation and secretion of the end-product, apolipoprotein B-48.
During fasting periods, bile and sloughed digested enterocytes are the only 
source of lipid info the intestine. _ Under these conditions only
intestinal VLDL and HDL are formed and secreted into lymph by the enterocytes
(Davidson et a l, 1991). Under such conditions, the intestine contributes 
between 10 % and 40 % of circulating TAG (Ockner et a l, 1969a; Popper et a l, 
1985), mainly utilising the glycerol 3-phosphate pathway (Kennedy, 1961; Popper et 
al., 1985). After a fat load, increased intracellular 2-monoacyglycerol concentration 
inhibits TAG synthesis via the glycerol 3-phosphate pathway and stimulates TAG 
synthesis via the monoacylglycerol pathway (Kayden et al., 1967). During lipid 
absorption, in addition to VLDL, chylomicrons that were absent in fasting mucosa 
appear in huge numbers in the enterocytes and lymph. After a fat load, increased lipid 
transport is accomplished mainly by increased chylomicron particle size with only 
small increases (around 50%) in particle numbers in intestinal lymph (Martins et a l, 
1994; Krause e ta l,  1981).
Analysis of chylomicron TAG synthesis rates in rats fed palm oil principally 
palmitic acid; C l6:0) versus sunflower seed oil (principally linoleic acid; €18:2 n-6) 
suggested no effect of fat saturation (Groot et a l, 1988). Studies by Davidson et al.
108
(1987) of rats fed either butter fat (mainly C16:0) or com oil (C18:2 n-6) (30-35 % by 
weight) indicated that dietary fat saturation had no effect on the rate of apolipoprotein 
B-48 synthesis by the intestine. These data are consistent with the report of Sorci- 
Thomas et al. (1989a,b), that intestinal apolipoprotein B mRNA levels of African 
green monkeys were not affected by a change in dietary fat quality from TAG 
consisting of saturated fatty acids (SFA) to TAG consisting of polyunsaturated fatty 
acids (PUFA). Further studies by Davidson et al. (1986) showed neither acute nor 
chronic dietary TAG augmentation to have a regulatory function on apolipoprotein B- 
48 synthesis rate in rats. Thus, the literature consistently favours the absence of an 
effect of dietary fat manipulation on apolipoprotein B-48 synthesis rate in the 
intestine.
The observation that fasting plasma apolipoprotein B-48
concentration^ in women with angiographically proven coronary artery disease 
were higher than their matched controls without coronary artery disease (Meyer et al., 
1996) reveals the importance of the fasting state in studies of atherogenic (ly. 
Also, Sureda et al. (1995) reported that a six week period of hypercaloric cafeteria diet 
reduced jejunal and ileal absorption of palmitic acid (per unit intestinal mass) after 
obesity had developed. In view of these observations this Chapter reports the long 
term effect of dietary fat manipulation of fat quantity and saturation on
apolipoprotein B-48 content in fasted rat jejunal enterocytes and mucosal scrapings.
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4.2 Study Design
Male Sprague Dawley rats weighing 220-250 g (Lebanese American 
University Stock) were used in all experiments. Six series of diets were administered 
to six groups of animals over a period of 40 days. Fatty acid composition of the major 
oils used in the present study is shown in Table 4.1 while diet formulations are shown 
in Table 4.2. The diets were prepared to contain either 5% or 20% fat energy. All 5 
% fat energy diets contained the same ingredients in terms of protein and carbohydrate 
composition and the only difference was in the type of fat used. The 20 % fat energy 
diets were similarly formulated. Three major types of oils were used: coconut oil 
(primarily lauric acid C l2:0) for the saturated fat diets (5% and 20% SAT groups), 
olive oil (primarily oleic acid C l8:1 n-9) for the monounsaturated fat diets (5% and 
20% MONO groups) and sunflower oil (primarily linoleic acid C l8:2 n-6) for the 
polyunsaturated diets (5% and 20% POLY groups). The percentage macronutrient 
compositions of the diets are shown in Table 4.3
Starch was used in the 5% fat energy diets to compensate for the increased fat 
content in the 20% fat energy diets.
Each experimental group of 7 animals was caged in groups of three or four 
and were given equal dietary energy on a body mass basis, every morning. The mass 
of food administered to the animals in the same cage was decided on the first day of 
every week
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Fatty acids (%
Fat________ Coconut oil_______ Olive oil_______ Sunflower oil
Total
SFA 86.5 13.5 10.3
08:0 7.5 _  _
010:0 6 _ _
012:0 44.6 _  _
014:0 16.8 __  _
016:0 8.2 11 5.9
018:0 2.8 2.2 4.5
Total
MUFA 5.8 73.7 19.5
016:1 _  0.8 _
018:1 5.8 72.5 19.5
020:1 0.3
Total
PUFA 1.8 8.4 65.7
018:2 1.8 7.9 65.7
018:3 _  0.6 _
Ratio
PUFA 0.02 0.62 6.38
MUFA 0.07 5.46 1.86
SFA 1 1 1
Table 4.1 Fatty acid composition of the major oils used in the present study 
(McNamara, 1995)
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5 % Fat energy diet 20 % Fat energy diet
mass (2 ) carb^(s) vrot**(£) fat(£) mass(s) carb^(e) vrot^^ts) fat(g)
Food Mixture
Lentils 100 60.1 24.6 1.1 100 60.1 24.6 1.1
Wheat 100 71 13.3 2 100 71 13.3 2
Rice 100 80.4 6.7 0.4 100 80.4 6.7 0.4
Cornflakes 33.5 24.5 2.6 0.23 33.5 24.5 2.6 0.23
Olive oil 3.95 0 0 3.95 27 0 0 27
Starch 53.4 53.4 0 0 0 0 0 0
Daily food intake 50 37 d.04 0.9& 46.1 30.2 d.04 3.94
g/kg body weight
Daily caloric intake
172.3 140.7 22.9 172.3 114.7 22.9 34.7
kcal/kg body weight
carb*= carbohydrate 
prot^^= protein
Table 4.2 Dietary composition of the food mixtures (5% and 20% fat energy) 
administered to the rats.
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5 % Fat 20% Fat
Protein
Daily caloric intake 
kcal/ks/day
22.94
Percent daily 
caloric intake
13.3%
Daily caloric intake 
kcaUke/day
22.94
Percent daily 
caloric intake
13.3%
Carbohydrate 140.7 81.7% 114.7 66.7%
Fat 8.64 5.0% 34.67 20%
Table 4.3: Percent (by energy) macronutrient composition of the diets used.
after measuring the body mass of all the animals. For the 5% and 20% fat energy 
groups 50 g and 46.1 g of food were respectively administered per kg body weight. 
Dietary energy inputs for the six groups was 172.3 kcal/kg/day. Greater food mass/kg 
body weight was administered to the 5% fat energy groups compared to the 20% fat 
energy groups to compensate for the higher caloric value of the diet administered to 
the latter group. The palatability of the diets appeared to be similar as all the 
previously administered diet had been consumed at re-feeding. Animals were 
maintained on the same diet until 24 h prior to use where they had free access to water 
only.
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Because of the large number of animals to be tested, commencement of feeding 
the different groups with the test diet was staggered among the groups. Each day, one 
cage containing three or four animals was started upon the appropriate diet avoiding 
simultaneous testing of all animals at day 40.
After 40 days of dietary intervention, followed by a 24h fast, jejunal mucosal 
scrapings and enterocyte supernatants were prepared for apolipoprotein B estimation 
as described in Chapter 2. Apolipoprotein B content in the mucosal scrapings and 
enterocytes supernatants was determined as mg apolipoprotein B/g protein of the 
homogenate.
Normal distributions of data were confirmed using the Kolmogorov-Smimov 
goodness of fit test. Data were analysed using oneway analysis of variance of 
apolipoprotein B48 concentrations against treatment group.
4.3. Results
Apolipoprotein B-48 content in fasted rat jejunal enterocytes and mucosal 
scrapings was determined after 40 days period of dietary fat manipulation. The test 
diets administered to the different experimental groups allowed the effects of both fat 
saturation and fat quantity to be examined.
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The effects of both fat saturation and fat quantity upon percent weight gain
defined as (start weight - end weight)^ X 100 was also studied. Fat quantity showed a
start weight
significant effect upon weight gain (p = 0.015). Figure 4.1 shows the 95% confidence 
interval of weight gain in relation to fat quantity. However, fat saturation did not 
show any effect upon weight gain (p = 0.231). Further, there was no interaction 
between saturation and quantity of fat regime - which means that dietary fat level 
alone determines weight gain.
4.3.1 Dietary fa t saturation effect.
The changes in apolipoprotein B-48 content in the fasted jejunal enterocytes 
and mucosal scrapings after 40 days period of following a 20% fat energy test diet 
(either 20% SAT or 20% MONO or 20% POLY) are shown respectively in Figures
4.2 and 4.3 with the values given in Appendix IV, Table 4.A and Table 4.B. 
Similarly, Figures 4.4 and 4.5 (with the values given respectively in Appendix IV, 
Table 4.C and Table 4.D) represent the same effects but after feeding on a 5% fat 
energy test diet (either 5% SAT or 5% MONO or 5% POLY). Dietary habits (over a 
40 days period) relying on fat saturation had no effect upon apolipoprotein B-48 
content in either the enterocytes or the mucosal scrapings when the fat energy content 
of the diet was either 5% or 20%.
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4.3.2 Dietary fa t quantity effect.
Increasing the fat content from 5% fat energy to 20% fat energy in the different 
test diets showed significant increase in enterocyte apolipoprotein B-48 content 
among the treatment regimes (FJ5,36] = 4.7224; p  = 0.002). Duncans multiple range
test (a  = 0.05) revealed that apolipoprotein B48 content of enterocytes from animals 
fed 20% fat energy was consistently higher than that of enterocytes from animals fed 
5% fat energy.
However, the observed increase in apolipoprotein B content in the enterocytes 
with increasing the percent fat energy in the diet seems to be masked when 
determining apolipoprotein B-48 content in the intestinal mucosal scrapings. The data 
indicated no change in apolipoprotein B-48 of the jejunal mucosal scrapings with no 
significant change among the different groups (FJ5,36] = 0.97; NS). Figure 4.6 and
figure 4.7 respectively, with the values given in Appendix IV (Table 4.E and Table 
4.F), represent the changes in apolipoprotein B-48 content in the jejunal enterocyte 
and mucosal scrapings after feeding for 40 days on either a 5% or a 20% fat energy 
test diets.
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Figure 4.1 95% confidence intervals of weight gain in relation to fat quantity.
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Figure 4.2 Fasted rat jejunal enterocytes apolipoprotein B content after 40 days of 
feeding on a 20% fat energy diet rich in either coconut (20% SAT), olive 
(20% MONO) or sunflower (20% POLY) oil. Means ± SEM. (n = 7). 
(F [2,18] =0.36; NS)
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Figure 4.3 Apolipoprotein B content in fasted rat jejunal mucosal scrapings after 40 
days of feeding on a 20% fat energy diet rich in either coconut (20% 
SAT), olive (20% MONO) or sunflower (20% POLY) oil. Mean ± SEM. 
(n = 7). (Fr2,18] = 0.17; NS)
119
0.4 X
0.35--
0.3 --
IQ. 0.25
î
C0)D)O£ 0.2 
Os:
f
E
CÛ
o
Q.<
0.15 -■
0.1 - -
0.05 - -
5% SAT 5% MONO 5% FOLY
Experimental group
Figure 4.4 Fasted rat jejunal enterocytes apolipoprotein B content after 40 days of 
feeding on a 5% fat energy diet rich in either coconut (5% SAT), olive 
(5% MONO) or sunflower (5% POLY) oil. Means ± SEM. (n = 7). 
(F [2,18]= 0.0168; NS)
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Figure 4.5 Apolipoprotein B content in fasted rat jejunal mucosal scrapings after 40 
days of feeding on a 5% fat energy diet rich in either coconut (5% SAT), 
olive (5% MONO) or sunflower (5% POLY) oil. Mean ± SEM. (n = 7). 
(F [2,18] = 0.607; NS)
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4.4 Discussion
The reported increased atherogenicity with increased postprandial (Simons et 
a l, 1987; Meyer et a l, 1996; Weintraub et a l, 1987a,b) and fasting (Meyer et al., 
1996) plasma apolipoprotein B-48 is consistent with long-standing theories that 
hyperlipoproteinaemia may be atherogenic. The metabolic basis of increased plasma 
apolipoprotein B-48 observed in patients suffering from coronary artery disease - 
whether the finding is due to increased secretion or decreased catabolism of 
apolipoprotein B-48 - is not fully understood.
During fasting periods, the only source of lipid in the intestine is bile and 
sloughed digested enterocytes resulting in the formation and secretion only of 
intestinal VLDL and HDL into the lymph (Davidson et al., 1991). If a change in 
intestinal apolipoprotein B content occurs in the fasting state in the present study, this 
change should be attributed to a direct regulatory effect of the long-term use of the test 
diet. Determination of enterocyte apolipoprotein B content reflects the intracellular 
stores of apolipoprotein B in addition to the newly synthesized and packaged 
molecules forming the TAG-rich lipoprotein particles (chylomicron and VLDL). On 
the other hand, mucosal apolipoprotein B content represents intracellular as well as 
the newly secreted apolipoprotein B molecules in the intercellular spaces up to the 
lamina propria.
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In the present study it has been shown that a 40 day period of feeding a diet 
rich in either coconut, olive or sunflower oil as fat sources respectively rich in 
saturated, monounsaturated or polyunsaturated fats does not have any differential 
regulatory effect on apolipoprotein B content in either jejunal enterocytes or mucosal 
scrapings. Consequently, dietary fat saturation, as opposed to quantity, appears not to 
have any regulatory effect on enterocyte apolipoprotein B synthesis or on any other 
regulatory mechanism known to have effect on the intestinal content of this 
molecule. Thus, dietary fat habit as regards fat saturation appears not to have any 
effect on the intracellular stores combined with the newly synthesized and secreted 
apolipoprotein B molecules in the fasting state.
Studies on HepG2 cells have shown that the availability of newly synthesized 
TAG may be the most important among factors affecting secretion of apolipoprotein 
B-containing lipoprotein (Boren et a l, 1992; Dixon et a l, 1991; Sakata et a l, 1993; 
Wu et a l, 1994a; Wu et a l, 1994b). Since the administered diets were isocaloric in 
term of fat energy and the fact that changing fat saturation in the diet results in a 
similar increase in intestinal apolipoprotein B-48 secretion (shown later in this 
dissertation chapter 5) we expect a similar degree of mobilization of apolipoprotein B- 
48 molecules with both saturated and unsaturated fat feeding. Consequently, it is very 
unlikely that changing dietary fat saturation would significantly affect apolipoprotein 
B-48 content in fasted jejunal enterocytes and mucosal scrapings over the 40 days 
period utilised in the present study.
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This finding is also consistent with data reported by Davidson et al. (1987) 
from rats fed butter fat or corn oil (30-35% by weight). In this study, it was inferred 
that dietary fat saturation had no effect on rate of apolipoprotein B-48 synthesis by the 
intestine. Similar findings were also reported by Sorci-Thomas et al. (1989a,b) where 
intestinal apolipoprotein B mRNA levels of African green monkeys were not affected 
by a change in dietary fat quality from SFA to PUFA. These reports would then 
indicate that fat saturation has no effect on either apolipoprotein B-48 gene expression 
(transcription) or translation (apolipoprotein B synthesis) and making unlikely any 
change in the apolipoprotein B-48 content of fasted jejunal enterocytes and mucosal 
scrapings after prolonged dietary fat saturation manipulation. The present data thus 
further extend the above findings and confirm that fat saturation has no effect on co- 
and post-translational regulatory mechanisms affecting the final content and 
availability of apolipoprotein B in the intestinal mucosa when a 40 days study-period 
is utilised.
The present study shows that increasing the percentage caloric value of dietary 
fat in the different test diets from 5% to 20%, for a period of 40 days, resulted in 
significant increases in apolipoprotein B content in the enterocytes in all groups. 
However, determination of apolipoprotein B content in the jejunal mucosal scraping 
showed no significant change in apolipoprotein B content with increasing percentage 
caloric value of dietary fat. Thus, the increased apolipoprotein B content of jejunal 
enterocytes with increased fat in the test diet was not seen in jejunal mucosal 
scrapings. This could be due to the fact that jejunal mucosal scrapings, compared to
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the enterocytes, represent a larger apolipoprotein B pool (the intracellular and the 
newly secreted extracellular apolipoprotein B pools). Also, since bile and sloughed 
digested enterocytes are the only source of lipid in all tested groups in the fasting 
state, it is very likely that a similar number of apolipoprotein B molecules are newly 
secreted and these are assayed with the mucosal scrapings. Consequently, the increase 
in apolipoprotein B-48 content observed in the enterocytes with high fat intake would 
be expected to be reduced in the mucosal scrapings where both the intracellular and 
the newly secreted apolipoprotein B pools are included in the assay.
Although apolipoprotein B48 has an obligatory role in the assembly and 
secretion of triacylglycerol-rich lipoproteins, Davidson et al. (1986) and Hayashi et al. 
(1990) have shown that neither acute nor chronic dietary TAG augmentation 
has a regulatory function on apolipoprotein B48 synthesis rate. Similar studies by 
Black et al. (1991) and Black (1992) have shown that despite an increase in jejunal 
mucosal apolipoprotein B content with TAG absorption in newborn piglet, the rate of 
synthesis of apolipoprotein B-48 remained unchanged. Thus, a change in 
apolipoprotein B-48 synthesis rate with increased fat intake, resulting in a change in 
apolipoprotein B content was unlikely to have been revealed in the present study.
Studies on cultured hepatocytes (Borchardt et al., 1987) and HepG2 cells 
(Bostrom et a l, 1988; Wu et a l, 1996) suggested that significant amounts of newly 
synthesized apolipoprotein B are degraded intracellularly. The rapid intracellular 
degradation of newly synthesized apolipoprotein B is inhibited when lipid availability
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is increased (Wu et a l, 1996). This is consistent with studies showing that lipid 
feeding can result in increased intracellular apolipoprotein B content (Glickman et a l, 
1978; Glickman et a l, 1979; Schonfeld et a l, 1978; Alpers et a l, 1985; Green et a l  
1982 and the data presently reported in Chapter 3) and secretion from the enterocytes 
(about 50% increase) (Martins et a l, 1994; present data reported in Chapter 5). 
Possibly, the increased intracellular mobilization and reduced intracellular degradation 
of apolipoprotein B with high (20%) fat energy diets over 40 days resulted in a 
regulatory effect on the rate of intracellular apolipoprotein B degradation. This is 
consistent with studies demonstrating that apo B secretion is regulated 
posttranslationally (Pullinger et a l, 1989; Moberly et a l, 1990; Dashti et a l,  1989; 
Sorci-Thomas et a l, 1989bjKroon et a l, 1986; Kushwaha et a l, 1991; Leighton et a l, 
1990; White et a l, 1992). The observed increase of apolipoprotein B content in the 
fasted enterocytes from animals previously exposed to high fat energy diets may have 
been attributable to decreased rate of intracellular degradation.
The presently reported increase in apolipoprotein B content with increased fat 
intake in enterocytes, but not in mucosal scrapings, could indicate that dietary habits 
relying on decreased fat intake may exert a modest post-translational effect on total 
intracellular apolipoprotein B content in the fasted state which is probably effected via 
regulation in the rate of intracellular apolipoprotein B degradation. These same 
dietary habits showed no effect on newly secreted apolipoprotein B molecules from 
the enterocytes in the fasted state. Since atherogenicity appears to be related to net 
secretion of apolipoprotein B from enterocytes, forming blood-borne chylomicron and
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chylomicron remnants, it is reasonable to conclude that dietary habits relying on 
reducing caloric intake from fat are unlikely to produce benefit in terms of reduced 
apolipoprotein B secretion in the fasted state.
The present study has confirmed that long-term dietary habits relying on either 
changed fat saturation or reduced fat quantity have neutral effects in term of intestinal 
contribution to blood apolipoprotein B-48 in the fasted state. Consequently, any 
expected benefit from these dietary habits in reducing fasting plasma apolipoprotein 
B-48 is likely to be the result of effects upon the catabolism of chylomicrons and 
chylomicron remnants rather than alteration of chylomicron synthesis and secretion 
rates in the intestine.
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5. Effects of Dietary Fat Saturation upon Size And Number Of TAG- 
Rich Lipoprotein Particles Secreted During Lipid Absorption
5.1 Introduction
Following intestinal digestion and absorption the majority of dietary TAG and 
cholesterol, together with biliary lipids, is transported in mesenteric lymph. Transport is 
principally in the form of TAG-rich particles; chylomicrons and VLDL, composed mostly 
of lipids but also containing a number of different apolipoproteins. Apolipoprotein B48 
(241 kDa), the largest of these proteins, is synthesized in the enterocytes and is an 
essential component of TAG-rich lipoproteins.
Chylomicrons (S /400-10,000) are heterogeneous, ranging in diameter from 75 nm 
to 600 nm with a mean diameter of about 120 nm (Lossow, Lindgren, Murchio, Stevens 
and Jensen, 1969; Fraser, 1970). Chylomicron size is largely determined by the rate of 
flux of TAG through the enterocytes. Chylomicrons are small at the beginning, and larger 
during the peak, of lipid absorption (Martins et a l, 1994). During maximal lipid 
absorption the formation of large chylomicron particles allows increased TAG transport 
and conserves surface constituents, the apolipoproteins. At low rates of lipid absorption, 
such as in the fasting state, intestinal VLDL predominate in lymph (Davidson et a l, 
1991). The composition of intracellular and lymph lipoproteins is shown in Table 5.1.
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The increased transport of fat after digestion and absorption of a dietary fat load 
could be accommodated by increasing the size of chylomicron particles, or by increasing 
the number of particles or both. If more particles were produced, this would be reflected 
in increased apolipoprotein B48 concentration in the lymph since there is only one 
apolipoprotein B48 molecule per chylomicron particle (Elovson et a l,  1988; Martins et 
a l, 1994). Biosynthesis of apolipoprotein B48 in the intestinal mucosa of rats (Davidson 
et a l, 1986) and newborn piglets (Black and Rower-Nutter, 1991) was reported not to be 
increased during acute lipid absorption, hi rats, apolipoprotein B output in whole lymph 
and in TAG-rich lipoprotein fractions of lymph did not change from fasting values during 
the absorption of a triolein emulsion (Hayashi, Funjimoto, Card, Nutting, Bergstedt and 
Tso, 1990). However, studies by Renner et a l  (1986) have shown around two fold 
increase in rat mesenteric lymph apolipoprotein B transport during steady state lipid 
absorption, indicating around two fold increase in the number of chylomicrons. Other 
studies on rats by Martins et a l  (1994) and Krause et a l  (1981) indicated around 50% 
increase of apolipoprotein B output in lymphatic TAG-rich lipoproteins during fat 
absorption.
A variety of studies have examined the effect of saturated and unsaturated lipids 
on the secretion and composition of mesenteric lymph lipoproteins. In some studies, 
saturated lipid feeding resulted in the secretion of smaller chylomicrons than when 
unsaturated lipid was fed (Ockner et a l, 1969i>^-Ockner et a l, 1970), but with greater 
saturated fatty acid transport in the VLDL fraction (Ockner et a l, 1970). Feldman et a l  
(1983) reported that chylomicron size increased progressively as the chylomicron lipids
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became less saturated. However, intestinal VLDL were largest with the diets with high 
saturated fat content and smallest with diets with low saturated fat content. Other studies, 
however, failed to show any particle size differences between saturated and unsaturated 
lipids (Zilversmit et a l, 1966; Fraser et a l, 1968; Renner et a l, 1986). Renner4jl-Cl3&) 
and other previous studies (Parks, Atkinson, Small and Rudel, 1981; Bennett, Atkinson, 
Hamilton, Forte, Russel, Feldman and Small, 1982) have shown that low temperatures 
result in partial crystallization of saturated core lipids with resultant changes in the size, 
shape, and density of these lipoproteins. These findings raise the possibility that reported 
differences in chylomicron size, when comparing saturated and unsaturated lipids at low 
temperatures and with the use of electron microscopy, may be artefacts resulting from the 
effect of cooling on chylomicrons carrying saturated lipid.
Weintraub et a l  (1987a,b) suggested that postprandial chylomicrons and their 
remnant particles may be atherogenic in normolipidemic individuals. Simons et a l  
(1987) found that the postprandial apolipoprotein B48 to apolipoprotein BlOO ratio was 
significantly increased in patients with coronary artery disease compared with control 
subjects, even when age and other lipid discriminators, such as TAG and cholesterol were 
taken into account. Similarly, Meyer et al (1996) reported that women with 
angiographically proven coronary artery disease showed greater absolute and incremental 
apolipoprotein B48 responses in the intermediate density lipoprotein fraction after a fat 
load.
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In view of the increased atherogenicity apparently associated with high 
postprandial apolipoprotein B48 (resulting from either an increased secretion or decreased 
catabolism of the apolipoprotein or possibly to both mechanisms operating 
simultaneously) the study now reported was undertaken to investigate the following: First, 
a time study showing the effect of dietary fat saturation upon TAG-rich lipoprotein 
particle size and apolipoprotein B48 secretion in mesenteric lymph during lipid 
absorption. The fat load consisted of 2 ml of either olive oil, coconut oil, or sunflower oil 
instilled intragastrically. Second, to ascertain the above effects of dietary fat saturation 
upon chylomicron size when a solid “physiological” diet is given, rather than a lipid load 
consisting only of oil.
5.2 Study Design
5.2.1 Dietary fa t saturation effects
5.2.1.1.After instilling 2 ml o f lipid intragastrically: Time study. Male Sprague Dawley 
rats weighing 300-350 g (Lebanese American University stock) were used in all 
experiments. Animals were maintained on the same rat chow diet until 18 hours prior to 
use where they had free access to water only. Fasted animals received intragastrically, 
using a stomach tube, 2 ml of either coconut oil, olive oil, or sunflower oil as fat sources 
respectively rich in SFA, MUFA, or PUFA. Control animals received 2 ml of 153.8 mM 
sodium chloride intragastrically.
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Blood and lymph samples were collected at 0 h (control group only), 1.5 h, 3 h 
and 6 h after intragastric instillation and concentrations of plasma TAG, plasma 
cholesterol, lymph TAG, lymph cholesterol and lymph apolipoprotein B48 were 
measured. Lymph flow rate was determined in all groups. All experimental procedures 
were as previously described (Chapter 2). From the these data, the ratio of lymph 
apolipoprotein B48 (mg)/lymph TAG (g), reflecting chylomicron size, was determined. 
The rates of apolipoprotein B48 (as pg/hr), cholesterol (as pg/hr) and TAG (as mg/hr) 
secretion by the intestine into the mesenteric lymph duct were also determined.
5.2.7.2 After administering a solid “physiological” diet rich in the tested oils. Groups of 
male rats of body weight 300-350 g were used to investigate if solid “physiological” diets, 
rich in the tested oils, can give results consistent with the effects observed when only 2 ml 
of the tested oils is used. For this purpose, fasted rats, maintained on the same rat chow 
diet until 18 hours prior to use with free access to water only, received a solid diet 
(Bledine 5 cereals, Bledina, Danone, France) to which either coconut oil, olive oil, or 
sunflower oil was added to provide 35 % fat energy contents of the diets. The 
composition of the solid diets are shown in Table 5.2. In order to receive similar fat loads 
fasted rats caged as one animal per cage received exactly 10 g of the prepared diet. All 
diets showed similar palatibility, and food was usually completely consumed 15 to 20 min 
after introducing the diet. Five hours after introducing the diet (five hours was chosen 
since it falls within the steady state period of maximal lipid transport), blood and lymph 
samples were collected and concentrations of plasma TAG, plasma cholesterol, lymph
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TAG, lymph cholesterol and lymph apolipoprotein B48 were measured as previously 
described (Chapter 2). Lymph apolipoprotein B48(mg) / lymph TAG (g) ratios were 
derived from these data.
5.3 Results
5.3.1 Time study
After intragastric instillation of 2 ml of either 153.8 mM sodium chloride (control group) 
or one of the tested oils (coconut oil, olive oil, or sunflower oil) blood and lymph samples 
were collected at the time intervals specified above. Data obtained from each oil tested 
group were compared with the control group receiving 153.8 mM sodium chloride. All 
data were shown to be normally distributed (Kolmogorov Smirnov goodness of fit test) 
and were assessed at each time point by single factor (the oil) analysis of variance. 
Differences were localised using Duncan’s multiple range test (a  = 0.05). Where 
significant heteroscedasity was found (Levene test), logarithmic transforms were 
employed. If such transforms failed to alleviate heteroscedasity, non parametric methods 
were employed. These consisted of, a priori, the Kruskall Wallis analysis of variance 
followed, in the case of significant difference(s) among the groups being indicated by 
multiple pairwise comparisons using the Mann Whitney U test. To control Type 1 error, a 
Bonferroni correction was employed. In this experiment, with four pairwise comparisons.
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Ecrit by Bonferroni would be 0.05/4 or 0.0125. However, as the Bonferroni 
correction is regarded as overconservative (e.g. Campbell and Machin 1993), significance 
was assumed, in the case of multiple pairwise comparisons, at E<  0.02.
5.3.1.1 Serum cholesterol. Serum cholesterol concentrations, in control and oil tested 
groups, are shown in Figure 5.1 (actual values given in Appendix V, Table 5.A). 
Compared to the control group, the mean serum cholesterol concentrations showed an 
apparent downward trend in all oil tested groups. However, the maximum Fs[3,19] of 
1.62 ip = 0.2) was achieved at 6 hours after instillation indicating no significant 
differences among the groups.
5.3.1.2 Serum TAG. The serum TAG concentrations in both the control and the oil tested 
groups are shown in Figure 5.2 with the values given in Appendix V, Table 5.B. In 
comparison to the control group, the mean serum TAG concentrations of the fat loaded 
animals showed significant increases at 1.5 hr (Fs[3,19] = 3.6; p  = 0.0327), 3 hr (Fs[3,19] 
= 4.1; p  = 0.0225) and 6 hr (Fs[3,19] = 6.2; p  = 0.004), after instilling the fat load. There 
were no differences among the oil-loaded groups.
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5.3.1.3. Lymph Cholesterol. The concentrations of lymph cholesterol in both the control 
and the oil tested groups are shown in Figure 5.3 with the values given in Appendix V, 
Table 5.C. Compared to the control group, lymph cholesterol concentrations decreased 
significantly (p<0.01) in all of the oil tested groups at 1.5 h (Fs[3,19] = 13.5; p  = 0.0001),
3 h (Fs[3,19] = 22.0; p  < 0.0001) and 6 h (Fs[3,19] = 11.9; p  = 0.0001) after instilling the 
fat load. The data at 1.5 h were significantly heteroscedastic (Levene Test = 3.4613; p = 
0.037 ) ; heteroscedasity was alleviated by logarithmic transformation of the data 
(Levene Test = 1.4923; p = 0.249) and analyses at this time point were made upon log- 
transformed data.
However, the net flux of cholesterol from the intestine into the lymph, determined 
as mg per hour (Figure 5.4; Appendix V, Table 5.D), did not show significant effect 
associated with oil loading.
No differences were apparent between the oil-loaded groups.
5.3.1.4 Lymph TAG. The concentrations of lymph TAG in both the control and the oil 
tested groups are shown in Figure 5.5 with the values given in Appendix V, Table 5.E. 
Lymph TAG concentrations showed large increases with time after instilling the fat load 
compared with the control group (minimum Fg[3,19] = 31.9; p  < 0 .0 0 0 1 ) . The maximum 
value reached in all oil tested groups was 6 hr after instillation of the fat load (Fs[3,19] = 
44.3; p  < 0.0001). No differences were observed between the oil-loaded groups.
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Determination of the TAG output in lymph (Figure 5.6; Appendix V, Table 5.F) revealed 
expectedly large increases in TAG transport associated with lipid absorption (minimum 
Fs[3,19] = 35.2; p  < 0.0001 at 3 h). The maximal TAG transport in all oil tested groups 
was reached 3 h after introducing the fat load and remained steady at 6 hr, the maximum 
time period used in the present study. No significant differences in TAG output in lymph 
of the oil-loaded groups were observed.
5.3.L5 Lymph apolipoprotein B48. The concentrations of lymph apolipoproteinB48 in 
both the control and the oil tested groups are shown in Figure 5.7 with the values given in 
Appendix V, Table 5.G. Compared to the control values, the concentrations of lymph 
apolipoprotein B48 showed inconsistent changes, apparently decreased 3 hr after fat load 
then appearing to increase slightly 6 hr after the same fat load. However, no significant 
differences were noted either between the fat loaded group and the saline loaded control 
group or within the fat loaded group.
The net amount, as ng/hr, of apolipoprotein B48 secreted into the mesenteric lymph duct 
is shown (Figure 5.8) (Data in Appendix V, Table 5.H). The mass of apolipoprotein B48 
output in lymph increased significantly during lipid absorption in all oil tested groups 
compared with the control group. At 1.5 h Fs[3,19] = 20.5; p  < 0.0001 with Duncans test 
showing apolipoprotein B48 output to be greater in the oil-loaded groups than in the 
control group. At 3 h, irresolvable heteroscedasity required use of the Kruskall Wallis 
test where = 9.4150 for 3 df; p = 0.0243. Here, Mann Whitney
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pairwise comparisons showed that apolipoprotein B48 output was always greater in oil- 
loaded groups than in the control group (p always < 0.0105). At 6h, Fs[3,19] = 56.4; p  < 
0.0001 with Duncans test again confirming greater apolipoprotein B48 output in the oil- 
loaded groups. Increases of apolipoprotein B48 secretion following oil-load ranged from 
45% to 63 % . No differences in apolipoprotein B48 secretion attributable to specific oil 
load were shown. Although the maximum increase of secretion occurred 3 to 6 hr after 
the fat load, apolipoprotein B48 outputs after 1.5 hr in the oil loaded groups was not 
significantly lower than the maximum increase observed after longer periods of lipid 
absorption.
5.3.1.6 Lymph flow rate. Lymph flow rate in both the control and the oil tested groups are 
shown in Figure 5.9 with the values given in Appendix V, Table 5.1. Oneway analysis of 
variance, followed by Duncan’s test, showed increased lymph flow rates in all oil tested 
groups compared with controls {p always <0.0001). Maximum values were reached 3 h 
after instillation of the fat load. No differences in flow rate were observed between the 
oil-loaded groups.
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5.3.1.7 Lymph apolipoprotein B48Aymph TAG ratio. From these data the lymph 
apolipoprotein B48 (mg)/lymph TAG (g) ratios were calculated (reflecting the average 
size of theTAG-rich lipoprotein particles) and are shown in Figure 5.10 (values in 
Appendix V, Table 5.J). In comparison with the control values, all groups showed a 
significant decrease (minimum Fs[3,19] = 15.65; p  < 0.0001 at 6 h) of this ratio associated 
with lipid absorption. As is evident from Figure 5.10, the ratio was lowest 3 to 6 hours 
after intragastric instillation of the fat load. Comparison of the different oil tested groups 
showed no significant effect of dietary fat saturation on the studied lymph 
apolipoproteinB48 (mg)/lymph TAG (g) ratio during steady state maximal lipid 
absorption.
Estimation of TAG concentration (Chapter 2) actually measures the number of 
glycerol molecules generated after hydrolyzing fatty acids from the TAG molecules and 
the final results may be expressed as either mg/dl or mmol/L. Such methods do not 
consider that differences in the chain lengths of fatty acids esteiified to the glycerol 
molecule can exist. Since extensive studies have shown that the composition of TAGs 
found in chylomicrons closely resemble the TAGs present in the intestinal lumen (Whyte 
et a l, 1965; Zilversmit, 1965; Feldman et a l, 1983; Levy et al., 1991; Lambert et a l, 
1996) we have recalculated the TAG concentrations (as mg/L) of all groups (SAT, 
MONO, POLY) taking into consideration the average mass of the TAG molecules in the 
oil used. The average TAG masses in the coconut, olive and sunflower oils were 
respectively 732.9, 928.1 and 928.7 (Lidc, D.R. and Frederikse, H.P.R. (Eds) (1997-1998) 
CRC Handbook o f Chemistry and Physics New YorkiCRC Press Ltd pp 7-5). The new
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lymph apolipoprotein B48 (mg)/lymph TAG (g) ratios were also déterminai and the results 
are shown in Table 5.3. Oneway analysis of variance indicated significant differences 
among the groups. At 1.5 h (Fs[2,15] = 4.61; p = 0.0275) Duncan’s test confirmed that 
the new lymph apolipoprotein B48 (mg)/lymph TAG (g) ratios in the POLY group was 
significantly reduced (p<0.05) compared to the SAT group. At 3 h (Fs[2,15] = 12.02; p = 
0.0008), both POLY and MONO groups were significantly reduced (p<0.05) compared to 
the SAT group. Also, at 6 h (Fs[2,15] = 17.1; p = 0.0001) the POLY and MONO groups 
were significantly reduced (p<0.05) compared to the SAT group.
5.3.2 Solid physiological diet.
Dietary fat saturation effects were also studied using solid ‘physiological’ diets 
rich in the tested oils. Blood and lymph samples were collected 5 hr after food 
administration. Data so obtained were examined using oneway analysis of variance 
followed by localisation of differences using Duncan’s test for assessment of differences 
attributable to the type of oil load. Normal distributions of all data were confirmed by 
Kolmogorov Smirnov analysis.
5.3.2.1 Serum cholesterol. The serum cholesterol concentrations in control and solid 
‘physiological’ diet groups are shown in Figure 5.11 (see also Appendix V, Table 5.K). 
Oneway analysis of variance indicated significant differences among the groups (Fs[3,19] 
= 6.30; p  = 0.0038). Duncan’s test confirmed that serum cholesterol concentrations were
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significantly reduced (p<0.05) in all groups fed the solid ‘physiological’ diet compared to 
fasted animals. There were no effects attributable to fat saturation of the diets tested.
5.5.2.2 Serum TAG. The circulating concentrations of serum TAG in both the control and 
the solid physiological diet groups are shown in Figure 5.12 (see also Appendix V, Table 
5.L). In view of marked heteroscedasity of the data in this analysis (Levene test = 4.2747; 
p  = 0.018), data were logarithmically transformed. This successfully alleviated the 
heteroscedasity (Levene test = 0.8728; p  =.018), Oneway analysis of variance indicated 
significant differences among the groups (Fs[3,19] = 6.0; 0.0002).
Duncan’s test, using log-transformed data revealed that, compared to the control group, 
blood TAG was significantly increased after feeding on the solid physiological diets. No 
significant effect of dietary fat saturation on serum TAG concentrations among groups 
receiving the solid ‘physiological diet’ was indicated by Duncan’s test.
5.3.2.3 Lymph Cholesterol. The concentrations of lymph cholesterol in both the control 
and the solid ‘physiological’ diet groups are shown in Figure 5.13 (see also Appendix V, 
Table 5.M). Oneway analysis of variance indicated significant difference among the 
groups (Fs[3,19] = 11.6; p  = 0.0002). Duncan’s test showed that lymph cholesterol 
concentrations in the different solid diet groups were similar but significantly less than the 
control group.
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5.3.2.4 Lymph TAG. The concentrations of lymph TAG in both the control and the solid 
physiological diet groups are shown in Figure 5.14 (see also Appendix V, Table 5.N). 
Data were found to be significantly heteroscedastic (Levene test = 3.4667; p = 0.037). 
Following logarithmic transformation of the data, heteroscedasity was adequately 
alleviated (Levene test = 0.8763; p = 0.471). Oneway analysis of variance of log- 
transformed data indicated significant difference among the groups (Fs[3,19] = 57.17; ;? < 
0.0001). Duncan’s test showed that, in compared with control values, lymph TAG 
concentrations were greatly increased after feeding the solid physiological diet in all 
groups. All groups showed similar TAG concentrations without effect of fat saturation.
5.3.2.5 Lymph Apolipoprotein B48. The concentrations of lymph apolipoproteinB48 in 
both the control and the solid physiological diet groups are shown in Figure 5.15 (see also 
Appendix V, Table 5.0). While lymph apolipoprotein B48 concentrations appeared 
slightly increased compared to the control group, significance was not achieved (Fs[3,19] 
= 0.95; NS). Dietary fat saturation was without effect upon apolipoprotein B48 
concentrations in the lymph.
5.3.2.6. Lymph apolipoprotein B48Aymph TAG ratio. Using data from above, the ratio 
lymph apolipoproteinB48 (mg)/lymph TAG (g) was calculated. As the data showed 
significant heteroscedasity, (Levene test = 6.2042; p  = 0.004), logarithmic transformation 
was used successfully (Levene test = 1.1656; p = .349). The data in Figure 5.16, (see
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also Appendix V, Table 5.P) show that, in comparison with control values, all groups 
showed a drastic fall in the ratio with lipid absorption (oneway analysis of variance; 
Fs[3,19] =13.91', p <  0.0001) but dietary fat saturation was without effect on the lymph 
apolipoproteinB48 (mg)/lymph TAG (g) ratio.
5.4 Discussion
The present report extends earlier studies and confirm the effect of dietary fat 
saturation on the average size of the TAG-rich lipoprotein particles secreted by the 
enterocytes during lipid absorption. TAG-rich lipoprotein particles are small at the 
commencement and larger during the peak of lipid absorption, as indicated by 
apolipoprotein B48/TAG ratios. Consequently, it was important to reach a steady state of 
maximal lipid absorption properly to compare the size of TAG-rich lipoproteins resulting 
from the different tested oils. For this reason, a time study was performed and the time 
needed to reach a steady state of maximal TAG transport was determined.
The present data show that TAG output in lymph reached a steady state of 
maximal TAG transport three hours after intragastric instillation of the fat load. 
Comparison of lymph TAG concentration at 3 h and 6 h after fat instillation showed 
increased TAG concentration at 6 hr. It is inferred that this difference is due to reduced 
water content of lymph resulting in greater TAG concentration and lower lymph flow 
rates, rather than to an increase in the net absorption and transport of TAG.
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Figure 5.11 Rat serum cholesterol (mmol/L) concentrations as collected after fasting or 
after 5 hours of feeding on a solid physiological diet rich in either olive 
(MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 
6). * = MONO, SAT and POLY groups vj" Fasted group (p < 0.05).
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Figure 5.12 Rat serum triacylglycerol (TAG) (mg/dl) concentrations as collected after 
fasting or after 5 hours of feeding on a solid physiological diet rich in either 
olive (MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. 
(n = 6). * = MONO, SAT and POLY groups vs Fasted group (p < 0.05).
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Figure 5.13 Rat mesenteric lymph duct cholesterol (mmol/L) concentrations as collected 
after fasting or after 5 hours of feeding on a solid physiological diet rich in 
either olive (MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± 
S.E.M. (n = 6). * = MONO, SAT and POLY groups vj Fasted group (p < 
0.05).
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Figure 5.14 Rat mesenteric lymph duct triacylglycerol (TAG) (mg/dl) concentrations as 
collected after fasting or after 5 hours of feeding on a solid physiological 
diet rich in either olive (MONO), coconut (SAT), or sunflower (POLY) oil. 
Mean ± S.E.M. (n = 6). * = MONO, SAT and POLY groups vs Fasted 
group (p < 0.05).
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Figure 5.15 Rat mesenteric lymph duct apolipoprotein B-48 (apo B-48) (mg/1)
concentrations as collected after fasting or after 5 hours of feeding on a 
solid physiological diet rich in either olive (MONO), coconut (SAT), or 
sunflower (POLY) oil. Mean ± S.E.M. (n = 6).
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Figure 5.16 Lymph apolipoprotein B-48 (apo B-48) (mg) /  lymph triacylglycerol (TAG) 
(g) in the rat mesenteric lymph duct as collected after fasting or after 5 
hours of feeding on a solid physiological diet rich in either olive (MONO), 
coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 6). * = 
MONO, SAT and POLY groups va’ Fasted group (p < 0.05).
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Since there is one apolipoprotein B48 molecule per chylomicron particle (Elovson 
et al., 1988; Martins et a l, 1994) the average size of the TAG-rich lipoprotein particles 
(chylomicrons and VLDL) in the collected lymph samples was estimated by determining 
the ratio lymph apolipoprotein B48(mg)/lymph TAG(g). The average size estimated using 
this method would then represent the average size of both chylomicron and VLDL 
particles.
On this basis, compared to the fasting state and taking into consideration the 
increase in chylomicron number and the percentage composition of TAG in the TAG-rich 
lipoprotein that occur with lipid absorption (from 64% in the fasting state to 85.9% during 
acute lipid absorption) (Martins et al., 1994), the average size of the TAG-rich lipoprotein 
particles increased about 4 fold during steady state of maximal lipid absorption with only 
about 1.45-1.6 fold increase in number as estimated from net apolipoprotein B48 flux. 
This is consistent with previous findings showing that increased transport of fat after 
digestion and absorption of a dietary fat load is accommodated mainly by increased 
chylomicron size (Green and Glickman, 1981; Bishaier and Glickman, 1983; Martins et 
a l,  1994) with only a small increase in number of particles (1.5 fold) (Krause et a l,  1981; 
Martins et al., 1994).
Data from one rat not included in the analysis showed very high lymph TAG 
concentration (about 3 times the average lymph TAG concentration) collected 6 h after 
instilling the fat load. Interestingly, the concentration of lymph apolipoprotein B48 from 
the same rat showed also about 3 fold increase of apolipoprotein B48 concentration when
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compared with the average in lymph 6 h after fat load. Unfortunately, lymph flow rate in 
that particular animal was not determined to ascertain whether the high TAG 
concentration was the result of /j a drastic fall in water content of lymph or ii) abnormal 
lipid absorption rate. In either case, this observation is consistent with the present finding 
that the particle size reached was maximal at 6 h. If this was the result of an abnormal 
lipid absorption rate, the observation may also indicate that, after reaching a maximum 
particle size, TAG-rich particles should increase in number to accommodate all the lipid 
absorbed during high rates of lipid absorption. Such a mechanism could explain why, 
during maximal lipid transport, an approximately 1.6 fold increase in the particle number 
was observed, reflected in the increase in apolipoprotein B48 output in lymph.
The present study achieved comparable TAG secretion rates with all of the tested 
oils and minimized the effects of variable TAG absorption. Steady state TAG absorption 
and secretion was reached after 3 h and persisted up to 6 h after instilling 2 ml of the 
tested oils intragastiically. Consequently, when using the solid ‘physiological’ diet, lymph 
samples were collected 5 h after administration of food to the animals in order to fall 
within the period of steady state maximal lipid transport.
The data have shown that the effect of dietary fat saturation on lymph 
apolipoprotein B48/TAG ratio when using a fat load in the form of 2 ml of the tested oils 
instilled intragastrically or when it is administered as solid ‘physiological’ diets enriched 
with the tested oils was similar. Avoiding the disadvantage of electron microscopy, where 
the particles have to be fixed, stained and embedded prior to sectioning and size
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determination, lymph apolipoprotein B48/TAG ratio estimates the average size of the 
TAG-rich lipoprotein particles including both chylomicrons and VLDLs.
Estimation of TAG concentration (Chapter 2) actually measures the number of 
glycerol molecules generated after hydrolyzing fatty acids from the TAG molecules and 
the final results may be expressed as either mg/dl or mmol/L. Such methods are better 
used to determine the molar concentration rather than the mass of TAG of an unknown 
sample since differences in the chain lengths of fatty acids esteiified to the glycerol 
molecule can not be taken into account. Consequently, while the average size of TAG- 
rich lipoprotein particles was estimated in this study, it is also necessary to consider 
differences in the chain lengths of the fatty acids incorporated in these particles. Early 
studies indicated that the composition of TAGs found in chylomicrons closely resemble 
the TAGs present in the intestinal lumen (Whyte, Goodman and Karen, 1965; Zilversmit, 
1965; Feldman et a l, 1983; Levy et a l, 1991; Lambert et a l, 1996). The latter report 
suggests that the major fatty acids of the secreted chylomicrons after coconut oil (86.5% 
SFA; 44.6% lauric acid (C12:0)l olive oil (73.7% MUFA; 72% oleic acid (C18:lj^ and 
sunflower oil (65.7% PUFA; G5»L% linoleic acid (C l8 :2^(See also Table 4.1, chapter 4) 
ingestion were respectively lauric (C12:0), oleic (C18:l), and linoleic (C18:2). Since the 
shortest chain fatty acids are found in the TAG-rich lipoprotein particles secreted after 
coconut oil ingestion compared to olive and sunflower oils, it is tempting to speculate that 
this suggests a smaller average size of the TAG-rich lipoproteins particles after coconut 
feeding compared to olive and sunflower oil. In Table 5.3 we have shown that after 
taking into consideration the chain length of the fatty acid or more properly the average
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molecular mass of the TAG molecules of the administerd fat load (coconut, olive or 
sunflower oil), coconut oil consistently (at 1.5, 3 and 6 hours) resulted in the formation of 
smaller TAG-rich lipoprotein particles. However, sunflower oil and olive oil both 
resulted in the formation of TAG-rich lipoprotein particles of similar sizes. Using electron 
microscopy, Renner et a l  (1986), Levy et a l  (1991) and Kalogeris et a l  (1992) have 
determined the average chylomicron diameter of mesenteric lymph chylomicron collected 
at 25 to 27°C after fat loading. In the above studies the following fat loads were used: 
palmitic (50%) monoolein (50%) emulsion, linoleic (50%) monoolein (50%) emulsion, 
safflower oil, coconut oil, medium chain fatty acids, com oil, olive oil, and butter oil. 
Comparison of ratios of average fatty acids chain length and the corresponding 
chylomicron diameter showed a very high correlation (r = 0.9719) indicating that fatty 
acid chain length of ingested TAG is one of the important factors that determine the size 
of chylomicrons as we have suggested above.
Fat saturation could be an another important factor that should be considered when 
comparing the average sizes of TAG-rich lipoprotein particles secreted during lipid 
absorption using the presently reported method. Unsaturated fatty acid containing TAGs 
have a less ordered stmcture and do not pack together so closely or so compactly as 
saturated fatty acid-containing TAGs (Brown, 1995). This suggests that TAG molecules 
with similar chain length fatty acids tend to occupy a larger volume as the fatty acids in 
the TAG molecules becomes more unsaturated. Consequently, the average size of the 
TAG-rich lipoprotein particles secreted after coconut oil feeding is expected to be the
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smallest (only about 7.6% unsaturated fatty acids), followed by those secreted after olive 
oil feeding and the largest particles would follow sunflower oil feeding.
Since apolipoprotein B48 estimations indicate that similar numbers of 
chylomicrons were secreted after ingestion of coconut, olive, and sunflower oils, it is 
suggested that the average size of TAG-rich lipoprotein particles secreted during the peak 
of lipid absorption depends chiefly on the chain length of the fatty acids in the ingested 
fat, and to a lesser extent on the relative unsaturation of the fatty acids in the ingested fat 
(where both long chain and unsaturated fatty acids lead to the formation of relatively 
larger average size of the TAG-rich lipoprotein particles). There is evidence that 
saturated fatty acids are carried by smaller chylomicrons but are associated with larger 
VLDL particles. Ockner and Jones (1970) and Ockner et al. (1969^ reported that 
saturated fatty acids such as palmitic acid resulted in increased TAG transport in VLDL 
whereas the absorption of unsaturated fatty acids did not significantly change VLDL TAG 
transport. These latter findings (Ockner and Jones, 1970; Ockner et al., 1969^ clearly 
suggest a differential distribution of saturated and unsaturated fatty acids among 
chylomicrons and VLDL resulting in smaller chylomicrons and larger VLDLs with 
saturated fat feeding, rather than simply reflecting the final average size of these particles.
Thus, the present data, suggesting that the average size of the intestinal TAG-rich 
lipoprotein particles is larger after sunflower oil and •„ smaller after coconut oil 
ingestion are in agreement with the reports of Ockner and Jones (1970), Feldman et al.
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(1983), Levy et al. (1991), Kalogeris et al. (1992) and Sakr et al. (1997) but conflict with 
the reports of Zilversmit et al. (1966) and Renner et al. (1986).
Early studies showing that saturated lipid feeding resulted in the secretion of 
smaller TAG-rich lipoproteins when compared to unsaturated lipid feeding used electron 
microscopy of mesenteric lymph lipoprotein particles (Ockner and Jones, 1970; Feldman 
et ah, 1983, Levy et a l, 1991; Kalogeris et al. (1992) as well as showing increased 
TAG transport in smaller VLDL-size particles during saturated fat infusion in the rat 
(Ockner et al., 1969^. Feldman et al. (1983), in their electron microscopic study, utilized
lipoproteins prepared at 27 to avoid the cooling effects upon the fixed TAG-rich 
lipoprotein particle sizes. In contrast to the report of Renner et al. (1986), smaller 
chylomicrons but larger VLDLs were observed when the proportion of dietary saturated 
fatty acid was increased. Similarly, Ockner and Jones (1970) and Ockner et al. (1969p 
demonstrated that saturated fatty acids {e.g. palmitic acid) increased TAG transport in 
VLDL whereas the absorption of unsaturated fatty acids did not affect VLDL TAG 
transport. These reports appear to conflict with the later report of Renner et al (1986). 
Levy et al. (1991) also reported that rats fed a diet rich in safflower oil (PUFA) produced 
chylomicrons of larger size compared to those fed a diet rich in coconut oil (SFA). But it 
is worth mentioning that Levy et al. (1991) observed a significant increase (p<0.05) in 
TAG transport with safflower compared to coconut oil which could have partly accounted 
for the increase in size of chylomicrons in the safflower oil group. Kalogeris et al. 
(1992) observed that both olive oil and sunflower oil have resulted in the formation of 
chylomicrons of similar size but of larger size than chylomicrons from butter oil. Both
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Levy et al. (1991) and Kalogeris et al. (1992) used electron microscopy of lymph sample 
stored at 27°C. Recently, using agarose gel filtration, Sakr et al. (1997) reported that 
chylomicron size depends on the fatty acid composition of ingested fats and the time 
course of digestion, being larger for polyunsaturated fatty acid-rich fats in the early phase 
of digestion (4-6h).
Zilversmit et al. (1966) used phase contrast microscopy in conjunction with 
ultracentrifugation, to determine particle size distribution of lymph chylomicrons but 
found no difference in chylomicrons sizes after feeding with cream or com oil. The 
apparent conflict of the present data with those of Zilversmit et al. (1966) may be due to 
the fact that they used the thoracic duct lymph while in the present, and in all other studies 
cited here, lymph was collected from the intestinal mesenteric lymph duct. Thoracic duct 
lymph, might include lipoprotein particles that are not from intestinal origin. In addition, 
there is no great differences in the average chain length of , in com oil (17.7 carbon) 
and cream (16.3 carbon). Renner et al. (1986) developed a short-term steady state 
infusion model where micellar solutions of linoleate, oleate, or palmitate were infused 
intraduodenally. A  similar TAG transport rate was observed in all infused groups. 
Compositional analysis of the subsequently formed lipoproteins {d < 1.006 g/ml) revealed 
no difference in the ratios of either phospholipid or apolipoprotein A-I (surface) to TAG 
(core) constituents between saturated and unsaturated lipids, suggesting similar particle 
sizes. The similar ratios of phospholipid to TAG (core) observed by Renner et al. (1986) 
and previously by Fraser et al. (1968), when saturated and unsaturated fats are fed, are 
consistent with the data reported here and, it is suggested, do not indicate similar particle
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sizes since the chain lengths of the fatty acids used in both studies were relatively slightly 
shorter in the SFA groups and of course the relative unsaturation of the fatty acids in the 
SFA groups was less. Renner et al. (1986) verified their findings using agarose gel
filtration and electron microscopy carried out at 27 ®C. However, their results conflict 
with those of Sakr et al. (1997) where agarose gel filtration was used and with Feldman 
et al. (1983), Levy et al. (1991) and Kalogeris et al. (1992) where electron microscopy at 
27°C were used.
Renner et al. (1986) used a perfusate containing the tested fatty acid (palmitic or 
linoleic acid) (50%) and monoolein (50%). The estimated diameter in the palmitic and 
linoleic groups were respectively 99.2 nm and 105.8 nm (Renner et al., 1986). This 
minor difference in the estimated chylomicron diameter could be explained by the small 
difference in the average chain length of fatty acid in the perfusate (17 carbon units for 
the palmitic group and 18 carbon for the linoleic group). This is consistent with the high 
correlation observed between fatty acid chain length in the perfusate and estimated 
chylomicron diameter. For instance, if we look at halogens et al. (1992) results, the 
average fatty acid chain length of the perfused oils were: com oil = 17.74 carbon, olive oil 
= 17.76 carbon and butter oil = 15.79 carbon, while the estimated diameters were 
respectively 109.6 nm, 112 nm and 87.4 nm. A greater difference in diameter was 
observed (Kalogeris et a l, 1992) because of the larger difference in average chain length 
of fatty acid in the perfused oils (com oil and olive oil compared to butter oil). Similarly 
in Levy et al. (1991) study, there was a large difference in the average chain length of 
fatty acid in the perfused oils (17.75 carbon for safflower oil and 12.84 carbon for coconut
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oil) and consequently a large difference in the estimated diameter (185.3 nm for safflower 
oil and 140.3 nm for coconut oil).
Surprisingly, Renner et al. (1986) reported increased apolipoprotein B content of 
saturated fat chylomicrons, inferred from higher apolipoprotein B/TAG ratios with 
saturated fatty acids compared to unsaturated fatty acids. This finding could rather 
suggest that smaller sizes and larger numbers of chylomicrons are secreted during 
saturated fat feeding since it is believed that only one apolipoprotein B48 molecule is 
found in each chylomicron particle (Elovson et al. (1988); Martins et al. (1994). The 
results of Renner et al. (1986) appear to be contradictory. A possible explanation of their 
observation could be the method used to estimate apolipoprotein B content in the lymph 
samples. Renner et al. (1986) used a radioimmunoassay method in which the antibody 
recognized both apolipoprotein B48 and apolipoprotein BIOO. Possibly the increased 
apolipoprotein B content observed with saturated fat was due to increased apolipoprotein 
BIOO rather than apolipoprotein B48. This suggestion is supported by their data, 
reporting that approximately one-third of lymph apolipoprotein B was contained in 
particles of d > 1.006 g/ml and their preliminary studies had indicated that these 
apolipoprotein B-bearing particles are mainly IDE and LDL (Renner et al., 1986). Also, 
this is supported by the fact that the same authors reported about 2 fold increase in the 
mass of apolipoprotein B secreted into the mesenteric lymph duct during steady state lipid 
absorption; a much higher value than reported by Krause et al. (1981), Martins et al. 
(1994), and in the present study where an increase of about 1.5 fold was observed.
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The present data show that apolipoprotein B48 output in lymph in the fasted state 
was about 110 qg/h increasing to about 180 p-g/h during steady state maximal lipid 
absorption. These measurements are similar to those reported by Krause et al. (1981) of 
lymphatic concentrations of about 140 pg/h in fasted rats, increasing to about 200 pg/h in 
fat-fed rats. Martins et al. (1994) reported similar relative changes in apolipoprotein B48 
transport in lymph but with lower total mass outputs of about 55 pg/h of apolipoprotein 
B48 output in fasting increasing to about 75 pg/h during fat absorption. Such 
apolipoprotein B output is about half that reported here and also found by Krause et al. 
(1981), possibly because different strains of rats were used (Sprague Dawleys versus 
Wistar rats). Other reports by Renner et al. (1986), using rats, have shown an increase, 
from about 157 pg/h in fasting to 342 pg/h during steady state lipid absorption, in 
apolipoprotein B output. However, Hayashi et al. (1990) indicated that the output of rat 
apolipoprotein B in whole lymph and in the TAG-rich lipoprotein fractions of lymph did 
not change from fasting values (about 140 pg/h) during the absorption of a triolein 
emulsion.
The above findings (Krause et al., 1981; Martins et al. 1994) are consistent with 
the present report, indicating a maximal increase of about 1.5 fold in the number of TAG- 
rich lipoprotein particles secreted from the intestine after a fat load. The small apparent 
increase in TAG-rich lipoprotein particle numbers secreted during lipid absorption makes 
it very unlikely to observe a change in the number of chylomicron secreted with changing 
fat saturation in the diet.
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In conclusion, the data reported here suggest that the increased transport of fat 
following absorption of a dietary fat load, is accommodated chiefly by an increase in the 
average size of the TAG-rich lipoprotein particles with only a small increase in number of 
these particles. The data also show that dietary fat saturation has no effect on the number 
of the TAG-rich lipoprotein particles secreted during acute lipid absorption. However, it 
is suggested that the average particle size may be mainly affected by the chain length of 
the ingested fatty acids.
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6. Dietary Fat Saturation and the Morphology of Triaeylglycerol-Rich 
Lipoproteins Secreted From Rat Small Intestine During Lipid
Absorption
6.1 Introduction
The Western diet currently provides a high proportion (about 40%) of total energy 
intake in the form of fat. It is widely recommended that this be reduced and also the 
proportion of polyunsaturated fat be increased at the expense of saturated fat (Gregory, 
Foster, Tyler and Wiseman, 1990). A consistent finding of most international 
epidemiological studies has been the observation of a positive relationship between 
energy intake deriving from dietary saturated fatty acids, plasma cholesterol 
concentrations, and rates of coronary heart disease mortality.
In man, the ingestion of large amounts of fat is linked to elevated blood 
triacylglycerol concentrations (Connor and Connor, 1990) in turn associated, as with 
elevated blood cholesterol concentrations (Betteridge, 1989), with increased incidence of 
coronary heart disease (CHD).
Saturated fatty acids have, by definition, no double bonds and vary in chain length 
from 4 to 18 carbons. They are not essential fatty acids as they can be synthesized in vivo 
from acetate. The major saturated fatty acids in the diet are lauric (C12:0), myristic
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(C14:0), palmitic (C16:0), and stearic (C18:0) acids. They are abundant in animal 
products (meats and dairy products), hydrogenated vegetable oils, and tropical oils 
(coconut, palm, and palm kernel oils). The intake of saturated fatty acids in the American 
diet, where palmitic acid is the major saturated fatty acid, provides about 13% of total 
energy intake (McNamara, 1995). Various health agencies have recommended that 
saturated fatty acid intake be reduced to less than 10% of total dietary energy (Committee 
on Diet and Health, 1989; Surgeon General's Report, 1988). The recommendation is 
based on epidemiological and metabolic evidence that when dietary energy derived from 
saturated fatty acids is high it is directly related to elevated plasma cholesterol 
concentration and higher incidence of CHD.
Monounsaturated fatty acids are not essential fatty acids since they can be 
synthesized in the body (Connor and Connor, 1982). The primary monounsaturated fatty 
acids in the diet are oleic (C l8:1, n-9) and palmitoleic (C l6:1, n-9) acids. Olive oil, 
rapeseed oil (canola oil), cocoa butter, and beef are excellent sources of oleic acid. A 
typical western diet contains 15-16% of its energy content as monounsaturated fatty acids 
and the dietary recommendation has been to reduce intake from monounsaturated fatty 
acids to 10% of dietary energy (Committee on Diet and Health, 1989; Surgeon General's 
Report, 1988). Conventional wisdom held that monounsaturated fatty acids had a neutral 
effect on fasting plasma cholesterol (Becker et a l, 1983), or triacylglycerol concentrations 
in humans (Mattson and Grundy, 1985; Grundy, 1986). More recently, Grundy (1989) 
reported that monounsaturated fatty acids, when substituted for saturated fatty acids in the 
diet, effectively reduce plasma LDL cholesterol concentrations and might be utilised in
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dietary modifications to lower plasma cholesterol concentration. Hydrogenation of 
polyunsaturated fatty acids of vegetable oils can result in the formation of large quantities 
of rra/25-monounsaturated fatty acids. Elaidic acid (C l8:1, trans n-9) is the major trans­
unsaturated isomer resulting from hydrogenation of polyunsaturated fatty acids 
(McNamara, 1995). Studies by Mensink and Katan (1990) indicated that intake of elaidic 
acid significantly increased plasma LDL cholesterol and apo B levels while lowering 
HDL cholesterol and apo A-I plasma concentrations.
Polyunsaturated fatty acids are "essential" fatty acids as they cannot be synthesized 
in vivo and must be obtained from the diet (Neuringer and Connor, 1986). There are two 
major classes of polyunsaturated fatty acids: co-3 (n-3) fatty acids, such as 
eicosapentaenoic (C20:5, n-3) and docosahexaenoic (C22:6, n-3) acids, found in fish oils 
and as minor constituents of some vegetable oils; and co-6 (n-6) fatty acids, including the 
essential linoleic acid (C l8:2, n-6), found in vegetable oils such as com, sunflower, 
cottonseed, and soybean oils (Connor and Connor, 1990). The average energy intake as 
polyunsaturated fatty acids in the current American diet is 5-7%, although this value has 
increased over the last 20 years due to changes in eating habits (Stephen and Wald, 1990). 
Current dietary recommendations suggest that energy intake from polyunsaturated fatty 
acids should approach 10% of total dietary energy, based on the plasma LDL cholesterol 
lowering effect of n-6 polyunsaturated fatty acids (Committee on Diet and Health, 1989; 
Surgeon General's Report, 1988).
177
Lauric acid (C l2:0), a major fatty acid found in coconut oil (tropical oil), appears 
to have a marked hypercholesterolaemic effect in humans and animals. Early studies of 
the effect of lauric acid intake on plasma cholesterol concentrations have produced 
conflicting data. It has been reported as possessing similar hypercholesterolaemic potency 
to palmitic acid (Keys et a l, 1965) and as having only a minor effect on plasma 
cholesterol (Hegsted et al, 1965). More recent studies in nonhuman primates (Hayes et 
a l, 1991) and in hamsters (Lindsey et al., 1990) compared diets of similar fatty acid 
composition with the primary variable being a shift from lauric to palmitic acid while 
maintaining a constant P:S ratio. Both studies reported reduced plasma total and LDL 
cholesterol concentrations consequent upon change to the palmitic acid-containing diet. 
In the hamster, Lindsey et al. (1990) reported that the shift from lauric acid-rich to a 
palmitic acid-rich diet reduced the LDL:HDL ratio and increased hepatic apolipoprotein 
A-I and LDL receptor mRNA levels. Compared to carbohydrates, monounsaturated fatty 
acids and polyunsaturated fatty acids, palmitic acid is consistently reported to increase 
plasma total and LDL cholesterol (Hayes et al. 1991 ; Lindsey et al. 1990).
Early reports (Ahrens et al., 1957; Hegsted et a l, 1965; Kinsell, Partridge, Boling, 
Margen and Michaels, 1952; Keys et a l, 1957) established the plasma cholesterol- 
lowering effects of n-6 polyunsaturated fatty acids in the diet compared to saturated fatty 
acids. More recent studies (Grundy and Denke, 1990; McNamara, 1987; Kris-Etherton, 
Krummel, Russel, Dreon, Mackey, Beochers and Wood, 1988; Goldberg and Schonfeld, 
1985; Goodnight, Harris, Connor and Illingworth, 1982) investigating dietary fat
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saturation effects on plasma cholesterol levels have not contradicted these original 
observations.
Recent studies have recognized the importance of dietary monounsaturated fatty 
acids, and now it is clear that neither carbohydrates nor monounsaturated fatty acids can 
be considered as being without effect on plasma lipoprotein levels. Mattson and Grundy 
(1985) reported that intake of oleic acid (C l8:1) in normolipidemic patients was as 
effective as linoleic (C l8:2) in reducing LDL cholesterol concentrations, but more 
importantly did not reduce HDL cholesterol concentrations. Studies in 
hypercholesterolaemic subjects (Sirtori et a l, 1986) indicated that a low-fat (28% of 
dietary energy) diet containing either olive oil or com oil had similar effects in reducing 
plasma total and LDL cholesterol and apolipoprotein B concentrations. In the same study, 
Sirtori et al. (1986) observed that an olive oil rich diet was less potent in reducing plasma 
HDL cholesterol and apolipoprotein A-I levels and resulted in an increased plasma 
apolipoprotein A-I:apolipoprotein B ratio, indicative of a less atherogenic lipoprotein 
profile. Many studies have similarly stressed the effectiveness of dietary 
monounsaturated fatty acids in lowering plasma total and LDL cholesterol concentrations 
as compared to saturated fatty acids (Gmndy, 1986; Mensink and
Katan, 1989) and generic low-fat diets (Mensink and Katan, 1987; Mensink, De Groot, 
Van den Brocke, Severijnen-Nobels, Demacker and Katan, 1989; Baggio, Pagnan, 
Muraca, Martini, Opportuno, Bonanome, Ambrosio, Ferrari, Guarini, Piccolo, Manzato, 
Corrocher and Crepaldi, 1988).
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The available data suggest that the hypocholesterolaemic response to dietary 
intake of polyunsaturated fatty acids and monounsaturated fatty acids results primarily 
from alterations in the synthesis and catabolism of the plasma lipoproteins. McNamara 
(1987) and Grundy and Denke (1990) reported that chronic intake of polyunsaturated fatty 
acids-rich diet does not affect endogenous cholesterol metabolism but rather exerts its 
hypocholesterolaemic effect by modifications of both synthesis and catabolism of plasma 
lipoproteins.
Thus, the effects of chronic intake of diets rich in either polyunsaturated fatty 
acids, monounsaturated fatty acids, or saturated fatty acids on plasma lipoproteins levels 
have been extensively studied. Also, a variety of studies have examined the effect of 
saturated and unsaturated lipids on the size of mesenteric lymph lipoprotein. In most 
studies, saturated lipid feeding resulted in the secretion of smaller chylomicrons than 
when unsaturated lipid was fed (Ockner et al., 1969^0ckner et al., 1970; Feldman et al., 
1983; Levy et al., 1991; Kalogeris and Story, 1992; Sakr et al., 1997). However, there are 
no reports of investigations upon long term effects of dietary fat saturation on the size of 
chylomicrons synthesized and secreted from the intestine after acute fat loading. More 
specifically, is there any relationship between dietary habits rich in either saturated or 
unsaturated lipids and size of chylomicrons secreted after ingestion of a fat load, 
especially if it is a saturated lipids (like coconut oil) that results in the formation of small 
chylomicrons? Or, is the size of chylomicrons only dependent on the type of ingested fat 
load regardless of the dietary habit followed? In this study long-term effects of dietary fat
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saturation on blood triacylglycerol and cholesterol concentrations, in addition to the effect 
on mesenteric lymph chylomicron size, were investigated.
6.2 Study Design
Male Sprague Dawley rats weighing 230-250 g (Lebanese American University 
stock) were used in all experiments. Animals were maintained on the same rat chow diet 
until commencement of the dietary intervention when they were randomly allocated to 
three groups each of 7 rats. The animals from each experimental group were caged in 
groups of 3 and 4 and fed the experimental diets for 40 days.
The experimental diet consisted of the commercial rat chow diet to which either 
coconut, olive, or sunflower oil was added to a concentration of 10% (w/w) (see table 
6.1). The rat chow diet originally contained 4-5% (w/w) of fat (Supplier’s data). Thus the 
final fat concentration in the diet was about 14-15% (w/w) of which at least two thirds 
was contributed by the added oils. Animals of all groups received every morning a 
similar mass (45g) of food per kg body weight on the basis of total body mass within each 
cage. The mass of food administered to the animals was based on the initial body mass 
measured at the beginning of the experiment. All administered chow was consumed by 
the next feeding time.
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Dietary composition 2Æ2 Coconut oil grouu Olive oil srouD Sunflower oil sroun
body wei2 ht
Rat chow 40.5 g 40.5 g 40.5 g
Olive oil --- 4.5 g ---
Sunflower oil --- --- 4 .5^
Coconut oil --- —
Table 6.1. Dietary composition of the food administered over the 40 days period.
At the completion of dietary intervention, food was withdrawn from two animals 
per day from each group; the animals were isolated in the afternoon in separate cages, 
with free access to water, until the following morning. Between 8:30 am and 10:30 am, at 
20 minute intervals, one fasted animal from each dietary group received intragastrically 2 
ml of coconut oil using a stomach tube. On the third and last day only, three animals from 
each group were used to complete the investigation in three days.
Four hours after intragastric instillation of the fat load, animals were anaesthetized 
with ether, the abdomen opened, and blood and lymph samples collected as previously 
described (Chapter 2). Concentrations of the following were measured: serum 
triacylglycerol, serum cholesterol, lymph triacylglycerol, lymph cholesterol and lymph
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apolipoprotein B-48. All experimental procedures used in order to determine the above 
parameters were as previously described (Chapter 2). From these data, the ratio lymph 
apolipoprotein B-48(mg) / lymph triacylglycerol (g), assumed to reflect chylomicron size, 
was determined.
6.3 Results
After 40 days of dietary intervention, fasted animals received a similar fat load and 
after 4 hr blood and lymph samples were collected and the following parameters were 
studied.
6 3 . Body weights
Animal body weights at commencement and termination of the study, together 
with the 95% confidence intervals of weight gain on the three diets are shown in Table 6.2 
below.
There were no significant differences in either commencing body weight or weight 
gain over the period of the study.
183
Oil administered Body weight at 
commencement 
(g)
Body weight at 
conclusion
(g)
Weight gain 
(95% Confidence 
interval)
(g)
Monounsaturated fat 236.00 ± 5.80 290.71 ±7.46 52.74 to 56.69
Polyunsaturated fat 239.43 ± 5.26 295.57 ± 7.41 53.73 to 58.56
Saturated fat 238.86 ± 6.34 295.43 ± 7.79 54.51 to 58.63
Table 6.2. Body weight changes over the 40 day dietary intervention. Weight gains are 
estimated on paired commencement and concluding weights (means ± SD, n=7 in each 
group).
6.3.2 Serum cholesterol
The circulating concentrations of serum cholesterol in the three dietary groups are 
shown in Figure 6.1 (See also Appendix VI, Table 6.A). Oneway analysis of variance 
indicated significant differences among the groups (Fs[2,18] = 6.7750; p  = 0.0064) while 
Duncan’s multiple range test (a  = 0.05) showed the mean blood concentration of 
cholesterol to be greater in the coconut oil group compared with the sunflower oil and 
olive oil groups.
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6.3.3 Serum triacylglycerol
The circulating concentrations of serum triacylglycerol in the three dietary groups are 
shown in Figure 6.2 (See also Appendix VI, Table 6.B). Oneway analysis of variance 
indicated no difference among the dietary groups (Fs[2,l 8] = 2.11; NS).
6.3.4 Lymph cholesterol
The cholesterol concentrations of the three groups as determined in the lymph are 
shown in Figure 6.3 (See also appendix 5, Table 5.C). The cholesterol concentrations in 
the lymph after 4 hr of instilling the fat load intragastrically in all experimental groups 
were not affected by the 40 days period of dietary fat manipulation (Fs[2,18] = 0.47; NS).
6.3.5 Lymph triacylglycerol
The triacylglycerol concentrations of the three groups as determined in the lymph 
are shown in Figure 6.4 with the values given in appendix VI, Table 6.D. Animals from 
the three different dietary groups exhibited similar triacylglycerol concentrations in the 
lymph with no significant effect of the 40 days period of dietary fat manipulation on the 
absorption and transport of lipid after 4 hr of introducing the fat load (Fs[2,18] = 0.05; 
NS).
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6.3.6 Lymph apolipoprotein B-48
The apolipoprotein B-48 concentrations of the three groups determined in the 
lymph are shown in Figure 6.5 (See also Appendix VI, Table 6.E). Analysis of these data 
revealed no significant change in the apolipoprotein B-48 concentrations in lymph 
samples collected from the three different dietary groups (Fs[2,18] = 0.04; NS).
6.3.7 Lymph apolipoprotein B-48/triacylglycerol ratio
The lymph apolipoprotein B-48/lymph triacylglycerol ratio in the three dietary 
groups was determined and the data are shown in Figure 6.6 See also Appendix VI, Table 
6.F). The above ratios, assumed to reflect chylomicron sizes, were similar in all groups 
and did not show any significant change among the dietary groups (Fs[2,18] = 0.09; NS).
6.3.8 Blood glucose
The glucose concentrations of the three groups as determined in the blood are 
shown in Figure 6.7 (See also Appendix VI, Table 6.G). No significant differences were 
observed among the groups (Fs[2,18] = 0.71; NS).
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Figure 6.1 Rat serum cholesterol concentrations (mmol/L) as determined after 4 hours 
of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 40 days 
a diet rich in either olive (MONO), coconut (SAT), or sunflower (POLY) 
oil. Mean ± S.E.M. (n = 7). * = SAT vs POLY and MONO groups (p < 
0.05)
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Figure 6.2 Rat serum triacylglycerol (TAG) concentrations (mg/dl) as determined after 4 
hours of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 
40 days a diet rich in either olive (MONO), coconut (SAT), or sunflower 
(POLY) oil. Mean ± S.E.M. (n = 7).
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Figure 6.3 Rat mesenteric lymph duct cholesterol concentrations (mmol/L) as 
determined after 4 hours of instilling intragastrically 2 ml of coconut oil in 
fasted rats fed for 40 days a diet rich in either olive (MONO), coconut 
(SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 7).
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Figure 6.4 Rat mesenteric lymph duct triacylglycerol (TAG) (mg/dl) concentrations as 
determined after 4 hours of instilling intragastrically 2 ml of coconut oil in 
fasted rats fed for 40 days a diet rich in either olive (MONO), coconut 
(SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 7).
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Figure 6.5 Rat mesenteric lymph duct apolipoprotein B-48 (apo B-48) (mg/L) 
concentrations as determined after 4 hours of instilling intragastrically 2 ml 
of coconut oil in fasted rats fed for 40 days a diet rich in either olive 
(MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 
7).
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Figure 6.6 Lymph apolipoprotein B-48 (apo B-48) (mg) / lymph triacylglycerol (TAG) 
(g) concentrations in the rat mesenteric lymph duct as determined after 4 
hours of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 
40 days a diet rich in either olive (MONO), coconut (SAT), or sunflower 
(POLY) oil. Mean ± S.E.M. (n = 7).
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Figure 6.7 Rat blood glucose concentrations (mmol/L) as determined after 4 hours of 
instilling intragastrically 2 ml of coconut oil in fasted rats fed for 40 days a 
diet rich in either olive (MONO), coconut (SAT), or sunflower (POLY) oil. 
Mean ± S.E.M. (n = 7).
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6.4 Discussion
A consistent finding of most international epidemiological studies has been the 
positive correlation between dietary intake of saturated fatty acids, plasma cholesterol 
concentration, and rates of coronary heart disease mortality. The present report extends 
earlier studies and confirms the effect of qualitative dietary fat manipulation over a period 
of 40 days on rat serum cholesterol.
After 40 day of manipulation of dietary fatty acid intake, fasted rats from each of 
the different dietary groups received an isoenergetic fat load, and after 4 h, blood and 
lymph samples were collected. The 4 hr period was chosen because, as shown in the 
previous chapter, this falls within the steady state period of maximal lipid transport. 
Since chylomicrons are small at the beginning and larger during the peak of lipid 
absorption (Martins et ah, 1994), it was necessary that the steady state of maximal lipid 
absorption had been reached to compare properly chylomicrons size between the dietary 
groups.
Serum cholesterol concentrations were highest in the coconut oil fed group. This 
may reasonably be explained as the result of increased saturated fatty acid intake over the 
40 days period rather than a temporary increased secretion from the intestine, since lymph 
cholesterol concentrations in all groups did not differ. Similarly human (Grundy and 
Ahrens, 1970; McNamara et a l, 1987) and animal (Fernandez et a l,  1990) studies have 
shown that fat saturation has no effect on cholesterol absorption Thus, this finding is
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consistent with numerous previous observations of the hypercholesterolaemic effect of 
dietary saturated fatty acid. Studies by Hayes et al. (1991) in non-human primates, and 
Lindsey et al. (1990) in hamsters have shown similar results where intake of saturated 
fatty acids (palmitic or lauric), as compared to monounsaturated fatty acids or 
polyunsaturated fatty acids, were consistently associated with increased total and LDL 
cholesterol. McNamara (1995) reported also that intake of coconut oil in animal models 
had a pronounced hypercholesterolaemic effect in comparison with polyunsaturated fatty 
acid intake. Compared to dietary polyunsaturated fatty acids, intake of monounsaturated 
fatty acids in rats resulted in increased levels of plasma and hepatic cholesterol 
concentrations (Kris-Etherton et a l, 1984; Beynen, Visser, Schouten and Katan, 1987). 
We observed in the present study that the olive oil dietary group showed an insignificant 
increase of about 9 % in the mean serum total cholesterol concentration as compared to 
the sunflower oil dietary group. Numerous mechanisms have been suggested for the 
hypocholesterolaemic action of polyunsaturated fatty acids. The majority of data indicate 
that it is the result of alterations in the synthesis and catabolism of the plasma lipoproteins 
rather than affecting endogenous cholesterol metabolism. Compared to saturated fatty 
acids, intake of polyunsaturated fatty acids have no effect on cholesterol absorption 
(Grundy and Ahrens, 1970; McNamara et a l, 1987; Fernandez et a l, 1990), endogenous 
cholesterol synthesis (Shephered et a l, 1980) or bile acid synthesis (Grundy and Ahrens, 
1970; Shephered et a l, 1980). Thus changes in serum cholesterol concentrations, reported 
here after 40 days of dietary fat saturation manipulation are probably chiefly the longer- 
term effect of the different types of fat on synthesis and catabolism of plasma 
lipoproteins.
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Since there is only one apolipoprotein B-48 molecule per chylomicron particle 
(Elovson et a l, 1988; Martins et a l,  1994) the average size of the tiiacylglycerol-rich 
lipoprotein particles (chylomicrons and VLDL) in the collected lymph samples was 
estimated by determining the concentration ratios of lymph apolipoprotein B- 
48(mg)/lymph tiiacylglycerol(g). The average size estimated using this method would 
then represent both chylomicron and VLDL particles. The mass of apolipoprotein B-48 in 
the lymph can also be used to estimate the number of triacylglycerol-rich lipoprotein 
particles secreted.
After 4 hr of instilling intragastrically 2 ml of coconut oil in all the dietary groups, 
the average size and number of the resulting triacylglycerol-rich lipoprotein 
(chylomicrons and VLDL) particles was estimated. The three groups showed similar 
mean particle size and number indicating that dietary fat saturation manipulation over a 
40 days period had no effect on the size and number of the triacylglycerol-rich lipoprotein 
particles synthesized during acute lipid absorption. Consequently, the size of 
chylomicrons synthesized and secreted from the intestine after acute fat loading appears to 
be depedent only on the type of fat load ingested rather than to be also regulated by 
previous dietary habits relying on fat saturation.
Weintraub et a l  (1988) investigated numbers of postprandial plasma 
chylomicrons formed in normolipidemic men fed 42% energy fat diets with P:S ratios of 
either 1.39 or 0.07. Their data indicated decreased (67%) postprandial chylomicron
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plasma levels with the high polyunsaturated fatty acids diet, and it was suggested that this 
response related more to the chronic intake of polyunsaturated fatty acids than to the fatty 
acid content of the acute fat challenge. The same investigators reported also that 
polyunsaturated fatty acid-containing chylomicrons were more susceptible to lipoprotein 
lipase hydrolysis in vitro, compared to saturated fatty acids-iich particles. They further 
suggested that the effects of fat saturation on chylomicron metabolism differ between 
acute effects, relating to susceptibility of chylomicrons to lipoprotein lipase, and chronic 
effects, directed at the catabolic system. In a previous chapter of the present study, it has 
been shown that qualitative dietary fat manipulation for a period of 40 days had no effect 
on apolipoprotein B-48 content of either enterocytes or mucosal scrapings of fasted rats. 
Similarly, in the present chapter, chronic fat feeding (40 days) did not disclose any effect 
of fat saturation on the size and number of chylomicrons secreted by the intestine 4 h 
after of intragastric instillation of a fat load. These data suggest that if a change in the 
integrated plasma time course of apolipoprotein B-48 (a marker for chylomicrons, and 
atherogenicity) is to be observed with (chronic and acute) dietary fat saturation 
manipulation, the change must be attributed to a decreased clearance of chylomicrons and 
their remnants rather than an increased secretion of these particles from the intestine.
Data from most previously reported human and animal studies are consistent with 
the present findings, suggesting that qualitative dietary fat manipulation may affect the 
catabolism of chylomicrons and their remnant particles rather than alter chylomicron 
synthesis and secretion rates. Studies by Davidson et a l  (1987) using rats fed either 
butter fat or com oil (30-35% by weight) indicated that dietary fat saturation has no effect
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on rate of apolipoprotein B-48 synthesis by the intestine. Similar findings were reported 
by Sorci-Thomas et al. (1989a,b) where intestinal apolipoprotein B mRNA levels of 
African green monkeys were unaltered by changing in dietary fat quality from saturated 
fatty acids to polyunsaturated fatty acids. These reports thus suggest that fat saturation 
has no effect on either apolipoprotein B-48 gene expression (transcription) or translation 
(apolipoprotein B synthesis). Not only is qualitative dietary manipulation without effect 
on apolipoprotein B-48 synthesis rate; Davidson et al. (1986) have shown that neither 
acute nor chronic dietary t a g  augmentation (quantitative manipulation) has a 
regulatory effect on apolipoprotein B48 synthesis rates. Similar studies by Black 
1 et al. (1991) and Black (1992) have shown that despite increased
jejunal mucosal apolipoprotein B content associated with triacylglycerol absorption in the 
newborn piglet, the synthesis rate of the apolipoprotein was unchanged. Thus, a change 
in apolipoprotein B-48 synthesis rate affecting the size and number of the intestinal 
triacylglycerol-rich lipoprotein particles is unlikely to happen following the 40 days 
period of qualitative dietary fat manipulation in the present study. This is also supported 
by our findings in chapter 4 where a 40 days period of dietary fat saturation manipulation 
failed to show any post-translational regulatory effect on apolipoprotein B in the rat 
jejunum.
In conclusion, dietary fat saturation interventions in rats have shown that diets 
containing sunflower oil (rich in polyunsaturated fatty acids) are the most 
hypocholesterolaemic and diets containing coconut oil (rich in saturated fatty acids) are 
the most hypercholesterolaemic. However, long-term dietary fat saturation manipulation
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appears to be without effect on the size of triacylglycerol-rich lipoprotein particles 
secreted in response to a similar fat load. The size of triacylglycerol-rich lipoprotein 
particles seems to be only dependent on the type of ingested lipid regardless of the 
previous dietary habit followed. The present study also suggests that changes in the 
concentrations of apolipoprotein B-48 in the blood in response to a similar fat load, that 
might occur following long term dietary fat saturation interventions should be attributed 
to a change in the catabolism of these particles rather than to a change in the secretion 
profile of those particles from the intestine.
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7. A Study of the Triacylglycerol-Rich Lipoprotein Particles secreted 
by the Intestine of Fat-loaded Rats after 40 Days of Insulin
Administration
7.1 Introduction
Storage and metabolism of ingested metabolic fuels is primarily controlled by 
insulin. Secretion of insulin during and after a meal facilitates the uptake, utilization, and 
storage of glucose, fat, and amino acids. Conversely, reduced insulin secretion leads to 
mobilization of endogenous fuels as well as decreased anabolism of ingested nutrients. 
Thus, carbohydrate, protein, and fat are the major metabolic fuels regulated by insulin in 
three principal tissues: muscle, liver, and adipose tissue.
Insulin accelerates the clearance of circulating triacylglycerol derived from both 
endogenous and exogenous sources. It is known to stimulate both the activity (Cryer, 
Riley, Williams and Robinson, 1976; Eckel, 1987) and the rate of synthesis (Spooner, 
Chemick, Garrison and Scow, 1979) of lipoprotein lipase thereby increasing the rate of 
hydrolysis of plasma lipoprotein triacylglycerols and their subsequent uptake into the 
adipose tissue. In adipose tissue, insulin has an antilipolytic effect, decreasing activity of 
hormone-sensitive lipase (Denton, Brownsey and Belsham, 1981) responsible for lipid 
mobilization from the adipocytes. Insulin also inhibits the outward transport of fatty acids
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across the adipocyte plasma membrane (Abumrad, Perry and Whitesell, 1986). The 
antilipolytic effect occurs at concentrations of insulin below those needed to promote the 
transport of glucose; and this is considered the most sensitive action of insulin (Felig and 
Bergman, 1995).
In summary, insulin has an overall anabolic role in lipid metabolism and this is 
shown in increased hydrolysis of circulating triacylglycerol and their subsequent uptake 
into adipocytes, in the antilipolytic effect in the adipocytes, and in the stimulation of de 
novo lipogenesis pathways in the same cells. Consequently, the net effect of insulin is to 
increase the fat content of adipocytes.
There is evidence (Ruderman, Toews and Shafrir, 1968)
' supporting the view that free fatty acids and ketones, which are derived 
from free fatty acids in insulinopaenic conditions, can sustain basal insulin secretion at 
low blood glucose concentrations, preventing unrestrained fat loss from adipose tissue. A 
bolus injection of acetoacetate induced a small rise in plasma insulin concentration in 
obese subjects, but this was not observed in nonobese subjects (Owen, Reichard and 
Markus, 1973). In general, plasma insulin concentrations in mammals are the net result of 
the effects of a number of different glucoregulatory mechanisms, hi intact animals, 
insulin secretion is regulated by a wide variety of nutrients for example glucose (Depocas, 
1959; Grodsky, Curry, Bennett and Rodrigo, 1968), free fatty acids (Horwitz, 1971; 
Seyfert and Madison, 1967), ketone bodies (Balasse, Couturier and Franckson, 1967; 
Gobema, Tamarit jr, Osorioo, fiissganger, Tamarit and Pfeiffer, 1974), amino acids
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(Basake, Lopez, Viktora and Wolff, 1971; Floyd, Fajans, Conn, Knopf and Rull, 1966), 
intestinal hormones such as pancreozymin (Mahler and Weisberg, 1968), secretin 
(Decker , 1968) and gastrin (Dupré, Curtis, Waddel, Unger and Beck, 1969; Unger, 
Ketterer, Dupre and Eisentraut, 1967), and other hormones such as glucagon (Campbell 
and Rastogi, 1966; Decker;, 1968), and adrenocorticotropic hormone (ACTH) (Sussman, 
Vaughan^ ■ 1967). The islets of Langerhans are provided with a rich
autonomic innervation (Woods and Porte, 1974). Parasympathetic stimulation increases 
insulin secretion (Kajinuma, Kaneto, Kuzuya and Nakao, 1968) while adrenaline (Porte, 
Graber, Kuzuya and Williams, 1966) and noradrenaline (Porte and Williams, 1966; 
Howland and Baroody 1982), secreted at sympathetic nerve terminals, inhibits the 
glucose-induced release of insulin from the beta-cell.
Insulin binds initially to a specific receptor on the cell membrane. The receptor 
has three functions as identified by Kahn and Crettaz (1995): 1) recognition of insulin by 
binding the hormone with high specificity, 2) transmission of a signal which results in 
activation of intracellular metabolic pathways, and 3) endocytosis of the complex leading 
to lysosomal proteolysis of insulin with recycling of receptor subunits to the membrane. 
Thus, after being internalized, most of the receptors are recycled to the membrane 
(Marshall, 1983), and a single receptor can make several cycles before being degraded 
(Marshall and Olfesky, 1983). Degradation of the receptor was found to be enhanced by 
exposure to insulin (Hedo, Kasuga and Van Obberghen, 1981). The number of insulin 
receptors seems to depend on the ambient concentration of insulin. Under conditions of 
hyperinsulinaemia (e.g., obesity), there is reduced expression of insulin receptors ("down
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regulation"), while the contrary ("up regulation") is observed in hypoinsulinaemic 
conditions (e.g., starvation) (Felig and Bergman, 1995).
Insulin resistance is generally characterised by a decreased response to either 
endogenous insulin (e.g. hyperinsulinaemia associated with high blood glucose 
concentrations) or exogenous insulin. Insulin resistance is the result of a change in insulin 
receptors, postreceptor events, or both (Felig and Bergman, 1995). During 
hyperinsulinaemia, a receptor-mediated insulin resistance occurs without a change in the 
maximal response (i.e., maximal rate of glucose utilization is unaffected but requires 
higher insulin concentration to achieve this) and this is termed decreased insulin 
sensitivity. However, when insulin resistance is caused by a post-receptor defect, there is 
reduced maximal tissue response to insulin and this is termed decreased insulin 
responsiveness. The majority of cases of type n  diabetes (or in insulin-resistant obesity) 
are characterized by a mixed type of insulin resistance where decreases in both insulin 
sensitivity and responsivity are observed (Felig and Bergman, 1995).
Insulin half-life is some 6 to 10 min and the major site of insulin degradation is the 
liver, where about 40 to 60 percent of the hormone is removed in a single passage (Felig 
and Bergman, 1995). About 15 to 20 percent of endogenous insulin is removed by the 
kidney. However insulin degradation by this organ becomes more important with 
injection of exogenous insulin subcutaneously which is absorbed via the systemic 
circulation unlike the endogenous insulin released into the portal vein (Felig and 
Bergman, 1995).
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Apolipoprotein B-48 and apolipoprotein B-lOO concentrations are higher in 
diabetic patients compared to non-diabetic subjects in both the fasting and post-prandial 
triacylglycerol -  rich lipoprotein (TRL) samples (Curtin et a l,  1996). The high 
concentrations of fasting TRL, often found in diabetic patients, is associated with 
apolipoprotein B-48 derived from increased intestinal chylomicron production, while the 
post-prandial pattern suggests an abnormality in intestinal production as well as hepatic 
clearance of apolipoprotein B-48 (Curtin et a l, 1996). Earlier studies by Martins et al 
(1994) showed that during lipid absorption, insulin deficiency had no effect on 
triacylglycerol or apolipoprotein B-48 transport in rat lymph and both control and diabetic 
rats showed only small increases in intestinal apolipoprotein B-48 secretion since the 
increased lipid transport was accomplished mostly by increased particle size rather than 
number. In the same study, Martins et al (1994) suggested that each chylomicron 
molecule contained only one apolipoprotein B-48 molecule and that hyperphagia was 
unconnected to the impairment of chylomicron metabolism in insuhn-deficient ra ts .
Levy et a/.(1996b) reported an insulin-stimulated decline in TAG ' and 
chylomicron production and in apolipoprotein B-48 and apolipoprotein-100 secretion in 
cultured jejunal explants from human fetuses. Apolipoprotein B mRNA was not affected 
by the addition of insulin, suggesting co- or post-translational modifications of 
apolipoprotein B (Levy et a l, 1996b). Using cultured hepatocytes from normal rats 
(Jackson, Salhanick, Elovson, Deichman, and Amatruda, 1990), it has been shown that 
the secretion of apolipoprotein B-48 and apolipoprotein B-lOO are inhibited by insulin
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and this inhibition was partly due to enhanced intracellular degradation; however there 
was a second intracellular apolipoprotein B-48 pool which was not regulated or degraded 
by insulin. Insulin decreased incorporation into apolipoprotein B 100 by 42% while 
only a small effect (11%) was observed on apolipoprotein B-48. This was considered to 
be related to the insulin-insensitive apolipoprotein B-48 intracellular pool (Jackson et a l, 
1990).
In view of the observed effects of insulin on lipid metabolism and lipoprotein 
secretion, blood triacylglycerol and cholesterol concentrations, and lymph triacylglycerol- 
rich lipoprotein particle size were measured during lipid absorption in rats following a 40 
days period of insulin administration intended to simulate the hyperinsulinaemia of 
insulin resistance.
7.2 Study Design
Male Sprague Dawley rats weighing 200-250 g (Lebanese American University 
stock) were used in all experiments. Animals were randomly allocated to two groups of 6 
rats and each experimental group was further subdivided in subgroups of 3 animals that 
were caged together. All animals were fed the same diet during the 40 days period of the 
experiment. The diet consisted of rat chow containing 4-5% (w/w) of fat (Supplier’s 
specification) and animals of both groups received 45g of food per kg body weight every 
morning. All diets were consumed by the following morning.
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The insulin group received every other day, at noon, a subcutaneous injection of a 
long-acting human insulin preparation (Insulin Monotard, Novo Nordisk, Denmark) as 8 
LU./250g body weight. The control group received an equivalent volume of sterile 153.8 
mM NaCl solution injected subcutaneously at the same time. At day 40, the last dose was 
administered respectively at 0600 h and 0900 h for the first and second insulin subgroups 
and at 0730 and 1030 the same day for the first and second control subgroups. 12 hours 
after of the last dose had been administered to all experimental groups, food was removed 
and animals had free access to water only. On the second day, 15 hours after food 
removal and consecutively every 30 minutes, one animal at a time received 
intragastrically, using a stomach tube, 2 ml of coconut oil.
After 3 hours following intragastric instillation of the fat load, the animals were 
anaesthetized with ether, the abdomen opened and blood and lymph samples collected (as 
described in Chapter 2). Blood glucose, serum triacylglycerol, serum cholesterol, lymph 
triacylglycerol, lymph cholesterol and lymph apolipoprotein B-48 concentrations were 
assayed using procedures previously described (Chapter 2). From these data the ratio 
lymph apolipoprotein B-48(mg)/lymph triacylglycerol (g), reflecting the chylomicron size, 
was determined.
206
7.3 Results
7.3.1 Body weights
As illustrated in Figure 7.1, there were no mean body weight differences before 
(Fs[l,10] = 0.76; NS) or following (Fs[l,10] = 0.73; NS) 40 days of insulin administration. 
Examination of weight gains on a paired measurement basis (Final body weight - initial 
body weight) likewise revealed no effect of insuhn administration (Fs[l,10] = 0.79; NS).
7.3.2 Serum triacylglycerol
The circulating concentrations of serum triacylglycerol in the two groups are 
shown in Figure 7.2 (see also Appendix VU, Table 7.A). While the mean circulating 
concentration of triacylglycerol of the insulin treated group was about 23% higher than 
that of control group, this did not attain significance (Fs[l,10] = 2.71; NS)
7.3.3 Serum cholesterol
The circulating concentrations of serum cholesterol in the two groups are shown 
in Figure 7.3 (See also Appendix VII, Table 7.B). The circulating concentrations of 
cholesterol were similar in both groups and the 40 days period of hyperinsulinaemia did
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not show any significant effect on the serum cholesterol concentrations (Fs[l,10] = 0.23;
7.3.4 Lymph cholesterol
The lymph cholesterol concentrations of the two groups are shown in Figure 7.4 
(See also Appendix VU, Table 7.C). The cholesterol concentrations in the lymph 3 hr of 
after intragastric instillation of the fat load were not affected by 40 days of insulin 
administration (Fs[l,10] = 0.02; NS)
7.3.5 Lymph triacylglycerol
The lymph triacylglycerol concentrations of the two groups are shown in Figure 
7.5(See also Appendix VU, Table 7.D). Animals from both insulin and the control groups 
exhibited similar triacylglycerol concentrations in the lymph without showing any 
significant effect of the 40 days period of insulin administration (Fs[l,10] = 0.003; NS).
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7.3.6 Lymph apolipoprotein B-48
The lymph apolipoprotein B-48 concentrations of the two groups are shown in 
Figure 7.6 (See also Appendix VII, Table 7.E). The data suggest some reduction (ca 
10%) of lymphatic apolipoprotein B-48 concentration in the insulin-treated group 
compared to the control group. However the apparent difference did not attain 
significance (Fs[l,10] = 1.04; NS)
7.3.7 Lymph apolipoprotein B-48/lymph triacylglycerol ratio
The lymph apolipoprotein B-48/lymph triacylglycerol ratios in the two groups was 
determined and are shown in Figure 7.7 (See also Appendix Vn, Table 7.F). This ratio, 
taken to represent the average triacylglycerol-rich lipoprotein particle size, showed no 
significant difference in the average particle size between the two groups (Fs[l,10] = 0.40; 
NS) although the data suggest a 9% decrease in particles size in the insulin-treated group.
7.3.8 Blood glucose
The blood glucose concentrations of the insulin-treated and control groups are 
shown in Figure 7.8 (See also Appendix VII, Table 7.G). The blood glucose 
concentrations of the insulin-treated group showed much greater variance (SD = 3.11)
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compared to those of the control group (SD = 0.83). However, the mean values in both 
groups were similar showing no significant effect of the 40 days period of insulin 
treatment on blood glucose concentrations (Fs[l,10] = 0.21; NS).
7.4 Discussion
c
Hyperinsulinaemia has been implicated as a risk factor for atherosclerosis, perhaps 
by stimulating vascular smooth muscle proliferation (DeFronzo and Ferrannini, 1991). 
Also, the coexistence of hyperinsulinaemia with hyperglycaemia or normoglycaemia 
suggests that insulin resistance is present. In view of the above effects of 
hyperinsulinaemia and its role in lipid metabolism, it was important to assess the 
potential contribution of the intestine to atherogenesis. A 40 days period of insulin 
treatment intended to induce hyperinsulinaemia was utilised to obtain an appropriate 
animal model upon which to make the assessment. The intestine, a source of 
triacylglycerol-rich lipoprotein particles (chylomicrons and VLDLs), is an important 
contributor to blood apolipoprotein B-48, an obligatory surface component of intestinal 
chylomicrons and VLDLs. Apolipoprotein B-48 is considered as an excellent marker of 
the triacylglycerol-rich lipoprotein particles and their remnants in the blood where an 
increased postprandial concentration of these particles are postulated to be atherogenic 
(Weintraub etal., 1987a,b; M&yer et al., 1996).
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Figure 7.1 Initial and final body mass of rats receiving subcutaneously every other day 
(over a 40 days period) 8 I.U. of insulin /250g body weight (Insulin). 
Control group (Control) was treated similarly but with an equivalent 
volume of sterile 153.8 mM NaCl solution. Means ± SEM (n=6)
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Figure 7.2 Rat serum triacylglycerol (TAG) (mg/dl) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; the serum 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
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Figure 7.3 Rat serum cholesterol (mmol/L) concentrations after 3 hours of instilling 
intragastrically 2 ml of coconut oil in fasted animals; the serum 
collection was done after 30 hours of the last dose of the 40 days period 
of hyperinsulinaemia. Means ± S.E.M. (n = 6).
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Figure 7.4 Rat mesenteric lymph cholesterol (mmol/L) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; lymph 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
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Figure 7.5 Rat mesenteric lymph triacylglycerol (mg/dl) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; lymph 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
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Figure 7.6 Rat mesenteric lymph apolipoprotein B-48 (mg/L) concentrations after 3 
hours of instilling intragastrically 2 ml of coconut oil in fasted animals; 
lymph collection was done after 30 hours of the last dose of the 40 days 
period of hyperinsulinaemia. Means ± S.E.M. (n = 6).
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Figure 7.7 Lymph apolipoprotein B-48 (apo B-48)(mg)/lymph triacylglycerol (TAG) 
(g) ratios of rat mesenteric lymph after 3 hours of instilling intragastrically 
2 ml of coconut oil in fasted animals; lymph collection was done after 30 
hours of the last dose of the 40 days period of hyperinsulinaemia. Means ± 
S.E.M. (n = 6).
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Figure 7.8 Rat blood glucose (mmol/L) concentrations after 3 hours of instilling 
intragastrically 2 ml of coconut oil in fasted animals; the serum collectionwas 
done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
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The possible effects of chronic hyperinsulinaemia upon intestinal secretion of 
apolipoprotein B-4$,indicating potential contributions to atherogenicity, are better studied 
during the peak of lipid absorption. Chylomicrons are small at the beginning and larger 
during the peak of lipid absorption; also apolipoprotein B-48 secretion increases about 1.5 
fold (Martins et ah, 1994; see also Chapter 5 of the present study) under similar 
conditions, indicating proportionate increase in the number of the triacylglycerol-rich 
lipoprotein particles leaving the gut, since there exists only one apolipoprotein B-48 
molecule per particle (Elovson et a l,  1988; Martins et a/., 1994). Insulin is a generic 
promoter of protein synthesis (Fluckey, Vary, Jefferson, Evans and Farrell, 1996; 
Kimball, Jurasinski, Lawrence and Jefferson, 1997; Yogiatzi, Nair, Beckett and Copeland, 
1997), and as such could promote synthesis of enterocyte apolipoprotein B48 in 
hyperinsulinaemic states. Consequently, during peak lipid absorption, hyperinsulinaemia 
could have effect upon the size and number of triacylglycerol-rich lipoprotein particles 
formed by the gut.
While serum triacylglycerol concentrations did not reach significant difference 
when comparing the control and the insulin groups, the mean triacylglycerol 
concentration of the latter group, on initial inspection, was 23% higher. The variances 
associated with the measures were, however, large. Insulin resistance is a frequent, 
concomitant of exogenous hyperinsulinaemia (Felig and Bergman, 1995). Thus, the high 
level of variance observed in the serum triacylglycerol concentrations in the insulin group 
could be because some of the animals in that group became insulin resistant. A  mixed 
type of insulin resistance, with decreased insulin sensitivity and responsivity, occurs in the
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majority of instances of hyperinsulinaemia (Felig and Bergman, 1995). In the present 
study, compared to the mean serum triacylglycerol concentration in the control group, 
some of the animals in the insulin group showed about 50% or more increase in the serum 
triacylglycerol concentrations while other were almost unchanged. The data thus suggest 
that some animals in the insulin group may have developed insulin resistance during the 
40 days period of insulin treatment. The increased serum triacylglycerol concentration 
observed in some animals is also consistent with the effect of insulin on lipid metabolism. 
Insulin is known to stimulate both the activity (Cryer, et a l, 1976; Eckel, 1987) and the 
rate of synthesis (Spooner et al., 1979) of lipoprotein lipase
thereby increasing the rate of hydrolysis of plasma lipoprotein triacylglycerol and their 
subsequent uptake into the adipose tissue where insulin also has an antilipolytic effect 
(Denton et a i, 1981) inhibiting outward movement of fatty acids across the adipocyte 
plasma membrane (Abumrad et al., 1986) hence reducing the plasma triacylglycerol 
concentration.
Blood glucose concentrations in the insulin-treated group did not differ from those 
of the control group, however, they showed much greater variance (Control SD 0.83; 
Insulin treated SD 3.11). The large standard deviation recorded from the insulin-treated 
group could be held to reflect development of insulin resistance in some of the animals 
during 40 days of insulin administration.
Lymph cholesterol concentrations in the control and insulin groups show that the 
40 days period of insulin administration did not affect cholesterol output from the
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intestine. Dietary and biliary cholesterol are the two major sources of cholesterol in the 
intestinal lumen. Although these represent the bulk sources of cholesterol in the 
intestine, the enterocytes express specific receptors for LDL (Pittman et a l, 1982) and is 
also capable of internalizing LDL by non-receptor-mediated pathways (Spady et a l, 
1985). Also, the rat small intestine is very active in cholesterol synthesis and about 25% 
of the total daily synthesis is accounted for by this organ (Tso, Drake, Black and Sabesin, 
1984). Thus, cholesterol output from the intestine has an endogenous (biliary cholesterol, 
internalized LDL cholesterol, and cholesterol synthesis in the small bowel) and exogenous 
(dietary choleste0l) origins. The present study would then suggest that 40 days of insulin 
administration did not produce any specific effect on the net endogenous cholesterol 
contribution of the intestine since both experimental groups (insulin and control groups) 
received a similar fat challenge of 2 ml coconut oil.
The 40 day period of insulin administration was without effect on the serum 
cholesterol concentration. This is in accord with the observed cholesterol output from the 
intestine. This finding also indicates that prolonged insulin treatment has no regulatory 
effect on cholesterol metabolism in normal rats. Studies in non-obese, normolipidemic, 
type n  diabetic patients have shown that, under poor metabolic control, an increased 
cholesterol synthesis can be normalized by insulin therapy (Scoppola, Testa, Fronioni, 
Maddaloni, Gambardella, Menzinger, Lala, 1995). They also showed that insulin therapy 
resulted in an insignificant decrease (9%) in total plasma cholesterol concentrations 
(Scoppola et a l, 1995). This finding is consistent with ours where after 30 hours of the
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last dose of the 40 days period of hyperinsulinaemia only about 4% decrease in total 
plasma cholesterol concentrations was observed.
Triacylglycerol concentrations in lymph from both the control and the insulin 
group showed no effect of prolonged insulin administration. Individual values for 
triacylglycerol concentrations were similar in both experimental and control groups 
reflecting similar triacylglycerol absorption in both groups. Consequently, if any particle 
size difference were the observed with long-term insulin administration, the difference 
should not be attributed to changed lipid absorption kinetics resulting in different 
triacylglycerol-rich lipoprotein particle size. It has already been reported (Chapter 5) that 
3 hours after intragastric instillation of 2 ml coconut oil, the rat small intestine reached a 
steady state of maximal hpid transport.
The mass of apolipoprotein B-48 in the lymph was used to estimate the number of 
triacylglycerol-rich lipoprotein particles secreted from the intestine. The mean 
apolipoprotein B-48 concentration in the lymph appeared not tolMfected by the previous 
40 days period of insulin administration. The above finding would indicate that a similar 
number of triacylglycerol-rich lipoprotein particles was secreted by the intestine in both 
the insulin-treated and the control groups. The mean size of these particles was estimated 
by determining the concentration ratios of lymph apolipoprotein B-48(mg)/lymph 
triacylglycerol(g). After 3 hr following intragastric instillation of 2 ml coconut oil, in 
both experimental groups, the average size of the resulting triacylglycerol-rich lipoprotein 
(chylomicrons and VLDL) particles was apparently similar.
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Using cultured human foetal jejunal explants, Levy et ah (1996tj reported an 
insulin stimulated decline in triacylglycerol and chylomicron production as well as in 
apolipoprotein B-48 and apolipoprotein B-lOO secretion. These authors suggested that 
insulin may induce co- or post-translational modifications of apolipoprotein B since 
apolipoprotein B mRNA was not affected by insulin addition. Similarly, Jackson et al. 
(1990) using cultured rat hepatocytes demonstrated an inhibitory effect of insulin on 
apolipoprotein B-48 and apolipoprotein B-lOO secretion due partly to enhanced 
intracellular degradation However, insulin had less effect on apolipoprotein B-48 which 
was found to have an another, insulin-independent, intracellular pool. The same study 
reported respectively about 42% and 11% decrease of incorporation into 
apolipoprotein B-lOO and apolipoprotein B-48 in the presence of insulin. This difference 
was attributed to the presence of an insulin-insensitive apolipoprotein B-48 intracellular 
pool. Thus, the above findings suggest a modest inhibitory effect of insulin on 
apolipoprotein B-48 secretion and that intracellular apolipoprotein B-48 modification is 
mainly the result of a post-translational modification due partly to intracellular 
degradation. These findings also appear consistent with data from the present study 
where, in the absence of a direct effect of exogenous insulin, the 40 days period of insulin 
administration indicated , albeit statistically unsupported, of only about 9%
change in triacylglycerol-rich lipoprotein particle size. Another study (Martins et al. 
1994) reported that insulin deficiency resulted only in a very small increase in rat 
intestinal apolipoprotein B-48 secretion in both fasted and lipid-absorbing states. This 
can be also considered as consistent with the lack of effect of the 40 days period of insulin
223
administration on average triacylglycerol-rich lipoprotein particle size in the present 
study.
Finally, in the present study previous investigations have been extended by 
studying possible long-term effects of insulin upon apolipoprotein B-48 secretion. After 
40 days of insulin treatment of normal {i.e. non-diabetic) rats there was no change in the 
size of triacylglycerol-rich lipoprotein particles secreted from the intestine during lipid 
absorption. The data also suggest that, following long-term insulin administration, a 
significant proportion of animals so treated are likely to have developed insulin resistance.
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8. General Discussion
The primary purpose of this study was to examine, first, whether dietary fats and 
dietary habits, in terms of both fat saturation and dietary load, have any effect upon 
apolipoprotein B48 concentrations within isolated rat jejunal enterocytes and in mucosal 
scrapings. Second, the average size and number of the triacylglycerol-rich lipoprotein 
particles secreted from the intestine were examined in terms of dietary fat saturation and 
load. Third, the effects of chronic dietary fat saturation manipulation upon size of 
triacylglycerol-rich lipoprotein particles secreted into the mesenteric lymph were studied 
in the fat-fed states. Finally, in view of the liporegulatory role of insulin, especially with 
reference to the hyperinsulinaemia of obesity and non-insulin dependent diabetes mellitus, 
the effect of chronic insulin administration upon triacylglycerol-rich lipoprotein particle 
size during lipid absorption has been investigated.
The present data indicate that acute fat feeding produces a 2 to 2.4 fold increase in 
the concentration of apolipoprotein B in both jejunal enterocytes and mucosal scrapings 
consistent with earlier reports. Using jejunal mucosal scrapings, Schonfeld et a l, (1978) 
and Alpers et a l, (1985) using the rat model and Black and Rhower-Nutter, (1991) and 
Black (1992) using neonatal piglets reported similar magnitudes of increase in 
apolipoprotein B content during lipid absorption. However, previous reports lack 
consistency when isolated enterocytes are considered. Lipid feeding has been variously 
reported as leading either to severe apolipoprotein B depletion in human (Rachmilewitz et 
a l, 1976) and inconsistent depletion in the rat (Davidson et al. 1986) enterocytes. 
Conversely, apolipoprotein B enrichment has been reported in both human (Glickman et 
a l, 1979; Green et a l, 1982) and rat (Glickman et a l,  1978; Schonfeld et a l, 1978; 
Alpers é ta l,  1985) enterocytes.
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Rachmilewitz et al. (1976) reported that 45 minutes after intraduodenal instillation 
of a fat load to human subjects, apolipoprotein B content in the jejunal enterocytes was 
reduced by about 77%. However (Glickman et a l, 1978; Green et a l,  1982), using 
human subjects, an increased enterocyte apolipoprotein B content was observed 
consequent upon lipid feeding. The depletion observed by Rachmilewitz et a l  (1976) 
contradicts previous report suggesting that rat enterocytes contain a large intracellular 
pool of apolipoprotein B and that lipid absorption mobilizes only a small fraction of the 
intracellular apolipoprotein B pool (Magun et a l, 1988). Also, studies on neonatal piglets 
showed that after 24 hours of lipid absorption, apolipoprotein B content in the jejunal 
mucosal scrapings increased some 2.4 fold relative to the fasted state (Black and Rhower- 
Nutter, 1991). The present data indicate that net apolipoprotein B secretion from the rat 
intestine into the mesenteric lymph duct increased about 1.4 to 1.6 fold in steady-state 
lipid absorption for up to 6 hours (the maximum time used in this study). This finding is 
consistent with earlier studies by Krause et al. (1981) and Martins et al. (1994). These 
consistent data cast doubt upon the very marked enterocyte apolipoprotein B depletion 
reported to occur during lipid absorption in human subjects (Rachmilewitz et al. (1976). 
The latter claimed depletion could be the result of an incomplete recovery of the different 
apolipoprotein B pools within the enterocyte since they reported (Rachmilewitz et a l, 
1976) that their method failed to recover 25-30% of a known amount of apolipoprotein B 
added to the cell homogenate.
In the second study (Davidson et al. 1986) using the rat model, pulse radiolabeling 
for 9 minutes was used to estimate apolipoprotein B content in jejunal enterocytes. This 
technique chiefly estimates newly synthesized apolipoprotein B molecules and fails to 
take the previously existing large intracellular apolipoprotein B pool into account (Magun 
et a l, 1988). The pulse radiolabeling method is more appropriate to studies upon
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synthesis rate, rather to estimate enterocyte apolipoprotein B content. For example. Black 
and Rhower-Nutter (1991) used a pulse radiolabeling procedure to determine 
apolipoprotein B synthesis rate and competitive enzyme-linked immunosorbent assay 
(E l is a ) to estimate apolipoprotein B content in intestinal mucosal scrapings. Thus, the 
inconsistent depletion in enterocyte apolipoprotein B reported during acute lipid 
absorption (Davidson et a l, 1986) does not exclude the possibility of an overall increase 
in apolipoprotein B content as reported here.
The increased apolipoprotein B content here reported in rat jejunal enterocytes and 
mucosal scrapings during lipid absorption is probably not the result of increased synthesis 
rate since lipid feeding appears to be without effect upon apolipoprotein B synthesis in 
rat (Davidson et a l, 1986, Hayashi et a l,  1990) and in the neonatal piglet (Black, 1992). 
Three possible explanations can be advanced for the increase in apolipoprotein B content 
reported here in jejunal enterocytes and mucosal scrapings during lipid absorption. First, 
lipid absorption may result in a reduced rate of intracellular apolipoprotein B degradation. 
This possibility is supported by studies on cultured hepatocytes (Borchardt et a l, 1987) 
and Hep G2 cells (Bostrom et a l, 1988) indicating that significant amounts of newly 
synthesized apolipoprotein B undergo intracellular degradation. Increased co- 
translational lipidation of apolipoprotein B during lipid absorption, a step mediated by 
MTP, protect the protein from early intracellular degradation and results in the formation 
of a primordial intracellular lipoprotein (Hussain et a l  1996; Innerarity et a l, 1996). 
Studies on HepG2 cells have shown MTP to increase 3-5 fold after treating the cells with 
oleic acid, and under the same conditions MTP-apolipoprotein B interaction was also 
increased (Wu et a l, 1996). Such an increased interaction protects apolipoprotein B from 
intracellular degradation (Sakata et a l, 1993). Thus, protection of apolipoprotein B from 
rapid intracellular degradation occurs mainly via an increase in both the degree and the 
duration of association between MTP and apolipoprotein B.
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It was shown in Chapter 5 of the present study that increased lipid transport is 
accomplished chiefly by increased size of the triacylglycerol-rich lipoprotein particles, 
with only about 50% to 60% increase in number, consistent with studies by Martins et a l 
(1994) and Krause et al. (1981). The increased size of the triacylglycerol-rich lipoprotein 
particles during lipid absorption suggests a longer intracellular residence of the particles 
for packaging, and secretion from within the enterocytes, with their surface apolipoprotein 
B48. Also, the increased secretion (about 50% to 60%) of apolipoprotein B48 during 
lipid absorption may result from increased mobilization of the particles in the enterocytes, 
hence being incorporated into triacylglycerol-rich lipoprotein particles rather than 
undergoing intracellular degradation. In this way increased mobilization of 
apolipoprotein B48 particles and the formation of large triacylglycerol-rich lipoprotein 
particles would also, in part, explain the increased apolipoprotein B48 content in the 
jejunal enterocytes and mucosal scrapings observed during lipid absorption.
Studying the effects of manipulating dietary fat saturation over a 40 day period 
revealed no effect upon apolipoprotein B48 content in fasted jejunal enterocytes and 
mucosal scrapings. The absence of a fat saturation effect upon apolipoprotein B48 
content in the fasted jejunal enterocytes and mucosal scrapings observed is consistent 
with studies conducted by Davidson et al. (1987) and Sorci-Thomas et al. (1989a,b) 
demonstrating respectively that dietary fat saturation has no effect upon apolipoprotein B 
translation (apolipoprotein B synthesis) or transcription (apolipoprotein B gene 
expression). The present study further extends these earlier investigations and indirectly 
confirms that fat saturation has no effect on co- and post-translational regulatory 
mechanism affecting the apolipoprotein B48 content of jejunal enterocytes and mucosal 
scrapings. The data reported in Chapter 5 of this study are also consistent with the above- 
mentioned findings. In Chapter 5, acute fat feeding with different fat types resulted in
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similar apolipoprotein B48 secretion into the mesenteric lymph duct, hence suggesting a 
similar mobilization of apolipoprotein B48 particles with feeding differently saturated 
fats. Thus, it would be unlikely that any change would be anticipated in apolipoprotein 
B48 content of fasted rat jejunal enterocytes and mucosal scrapings when consuming 
different fats of different degrees of saturation.
Dietary studies reported here have shown that increasing the dietary fat energy 
ratio in the different test diets, from 5% to 20 %, resulted in a about 40% increase in 
apolipoprotein B content in the enterocytes of all 20% groups. The observed increase in 
apolipoprotein B content in the fasted jejunal enterocytes of rats fed the 20 % fat energy 
diet is most likely to be the result of a posttranslational regulatory effect since neither 
acute nor chronic dietary triacylglycerol augmentation appear to have a regulatory 
function on rat apolipoprotein B48 synthesis rate (Davidson et a l,  1986). The increased 
apolipoprotein B48 content might be attributable to reduced intracellular degradation of 
this apolipoprotein associated with increasing the dietary fat energy ratio from 5% to 
20%.
The upward trend in apolipoprotein B content observed in jejunal enterocytes from 
fasted animals with increased percentage fat content in the diet, is drastically reduced and 
is not significant in any of the dietary groups when apolipoprotein B content is estimated 
in jejunal mucosal scrapings from fasted animals. It is reasonable to speculate that this is 
caused by apolipoprotein B48 secretion into the intercellular spaces in the absence of an 
exogenous fat load and which is estimated together with enterocyte apolipoprotein B48 
when examining jejunal mucosal scrapings.
Thus enterocyte apolipoprotein B48 content is considered mainly to reflect the 
regulatory effects and changes modifying and determining the final mass of
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apolipoprotein B48 available in these cells. Apolipoprotein B48 content in the intestinal 
mucosal scrapings, on the other hand, reflects the content in the enterocytes together with 
the newly secreted apolipoprotein B48 particles in the intercellular spaces. Consequently, 
determining apolipoprotein B48 content only in the enterocytes cannot give any idea 
about newly secreted apolipoprotein B48 particles that are considered to be the principal 
contributor to atherogenicity. Similarly determining apolipoprotein B content in mucosal 
scrapings may mask regulatory changes affecting the actual apolipoprotein B availability 
in the enterocytes. Thus, it was necessary to assay apolipoprotein B content in both 
jejunal enterocytes and mucosal scrapings. Some post-translational changes, influencing 
enterocyte apolipoprotein B content, appeared to be taking place with changing dietary fat 
energy ratio, but not with changing dietary fat type. However, the actual number of 
apolipoprotein B particles secreted from the enterocytes seems not to be modified. This 
would then indicate a neutral effect in terms of the intestinal contribution to blood 
apolipoprotein B48 in the fasted state after following a 40 day period of dietary fat 
manipulation in terms of both fat energy ratio and fat saturation .
Further studies on dietary habits have shown that in response to a similar fat load a 
40 day period of dietary fat manipulation of fat saturation failed to show any effect on the 
average size of the triacylglycerol-rich lipoprotein particle secreted at peak lipid 
absorption. In the same study, the mean concentration of apolipoprotein B48 in the lymph 
samples collected during the steady state of maximal lipid absorption was unaffected by 
the immediately previous dietary history. Results from earlier studies, showing that 
dietary fat saturation has no effect on either apolipoprotein B synthesis rate (Davidson et 
a l, 1987) or gene expression (Sorci-Thomas et a l, 1989a,b), together with the present 
data, strongly suggest that dietary fat saturation has no effect on co- and post-translational 
regulatory mechanisms affecting apolipoprotein B48 content in jejunal enterocytes or 
mucosal scrapings of fasted animals. Our study is consistent with the above studies and
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further suggest that the size of triacylglycerol-rich lipoprotein particles seems to be only 
dependent on the type of ingested lipid regardless of the previous dietary habit followed. 
This indicates that dietary habits relying on fat type seems-wife Improve {i.e. reduce apo 
B48 secretion via formation of large triacylglycerol-rich lipoprotein particles) the 
intestinal contribution to blood apolipoprotein B48 during lipid absorption (as in the fed 
state). Consequently, any increased blood apolipoprotein B48 concentrations, in either 
fasted or fat fed states, occurring when following a particular dietary regime should be
attributed to decreased clearance of chylomicrons and their remnants from the blood
rather than to increased intestinal output. Dietary habits, then, seem to have a minor or no 
role in increasing the intestinal contribution to elevated serum apolipoprotein B48. 
Hence it appears that further investigations of the effects of dietary fat saturation upon the 
metabolism of intestinal triacylglycerol-rich lipoproteins and their clearance from the 
blood are required.
On the other hand, the present data indicate that dietary fat type influences serum 
cholesterol concentration. A diet rich in saturated fatty acids was the most
hypercholesterolaemic while the polyunsaturated fatty acid diet was the most
hypocholesterolaemic. These findings are consistent with studies on non-human primates 
(Hayes et al., 1991) and hamsters (Lindsey et al., 1990). The difference in mean serum 
cholesterol concentration observed among the three dietary habits is considered to be 
chiefly the result of an effect of fat type on the synthesis and catabolism of plasma 
lipoproteins since polyunsaturated fatty acid intake compared to saturated fatty acid 
intake, has no effect on cholesterol absorption (Grundy and Ahrens, 1970; McNamara et 
a l, 1987; Fernandez et al., 1990), endogenous cholesterol synthesis (Grundy and Ahrens, 
1980; Shephered et a l, 1980), or bile acid synthesis (Grundy and Ahrens, 1970; Shepherd 
e ta l,  1980).
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The present data show an increase of about four fold in the size of triacylglycerol- 
rich lipoprotein particles secreted during the steady state of maximal lipid absorption 
compared with the fasting state. This finding is supported by previous reports showing 
lipid absorption to be mainly accommodated by increased chylomicron particle size 
(Green and Glickman, 1981; Bisgaier and Glickman, 1982; Martins et a l, 1994). The 
present study has also shown a 1.45 to 1.6 fold increase in triacylglycerol-rich lipoprotein 
particle numbers in the mesenteric lymph, when compared to the fasting state, during lipid 
absorption. The small increase in particle number observed during lipid absorption is 
corroborated by similar studies in rats (Krause et a l, 1981; Martins et a l,  1994) where 
about 1.5 fold increase was reported. Thus, the present findings confirm that the intestine 
accommodates the absorption and secretion of a fat load chiefly by increasing 
triacylglycerol-rich lipoprotein size with only a small increase in number. This 
mechanism allows the transport of a large mass of triacylglycerol with only small increase 
in the number of surface constituents such as apolipoprotein B48 particles. This 
conservation of apolipoprotein B48 is obviously of metabolic value. Any sudden larger- 
than-usual increases in fat intake can be accommodated without any adaptation of 
biosynthetic mechanisms - in other words, it is functionally more rapid and metabolically 
more efficient.
Maximal lipid absorption was reached three hours after intragastric instillation of 
2 ml of olive, sunflower, or coconut oil. The lymph apolipoprotein B48/triacylglycerol 
ratio, here used to estimate the average size of the triacylglycerol-rich lipoprotein particles 
(chylomicrons and VLDLs) secreted from the intestine during steady state maximal lipid 
absorption, was unaffected by the type of fat used. However, taking into account the 
chain length of the fatty acids of the triacylglycerol molecules incorporated into the 
triacylglycerol-rich lipoprotein particles, as shown in Chapter 5 of this study (Table 5.3),
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the average size of the triacylglycerol-rich lipoprotein particles secreted during the peak of 
lipid absorption was smaller with coconut oil compared to olive and sunflower oil.
During lipid absorption, the average size of the TAG-rich lipoprotein particles 
depends primarily on the rate of triacylglycerol transport, being larger with increased 
triacylglycerol transport rates. When comparing the effect of different fat type upon the 
average size of triacylglycerol-rich lipoprotein particles, the average chain length of fatty 
acids of the fat ingested should also be taken into consideration. This is shown in table 5.3 
and supported by studies using electron microscopy (Renner et a l, 1986; Levy et a l, 
1991; Kalogeris et a l, 1992) where the ratios of average fatty acids chain length and the 
corresponding chylomicron diameter showed a very high correlation (r = 0.9719) 
indicating that fatty acid chain length of ingested fat is one of the important factors that 
determine the size of chylomicrons. In our study, intragastric instillation of either coconut 
oil, olive oil or sunflower oil showed similar triacylglycerol transport rates. Then, the 
difference of TAG-rich lipoprotein particle size resides in the large difference of average 
fatty acid chain length between coconut oil (12.8 carbon units) and olive (17.8 carbon 
units) or sunflower (17.8 carbon units) oils. This is consistent with the fact that the 
composition of TAGs found in chylomicrons closely resemble the TAGs present in the 
intestinal lumen (Whyte, Goodman and Karen, 1965; Zilversmit, 1965; Feldman et a l, 
1983; Levy et a l,  1991; Lambert et a l, 1996). Thus, a larger mass of TAG is actually 
transported by a certain number of TAG-rich lipoprotein particles when olive oil or 
sunflower oil are ingested compared to coconut oil. Consequently, for a certain mass of 
fat to be completely absorbed and transported, a larger number of TAG-rich lipoprotein
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particles is needed if the fat is coconut oil compared to olive or sunflower oil. Although, 
the rate of TAG-rich lipoprotein particles secretion was similar in the present study for 
coconut, olive and sunflower oil, the final number of particles needed to absorb all the 
administered fat load can not be determined. The six hour used as the maximun study 
period is not enough to allow absorption of the large fat load instilled intragastrically, and 
this is apparent since at 6 hours the rate of triacylglyceerol transport was still maximal. 
Since the number of TAG-rich lipoprotein particles secreted at the beginning and at the 
peak of lipid absorption was the same for all three oils while the size is bigger for olive 
and sunflower oil, we expect that both latter oils are absorbed more rapidly by the 
intestine compared to coconut oil. This is supported by studies showing that saturated 
fatty acid-containing fats are absorbed less efficiently than those with predominantly 
unsaturated fatty acid and must traverse a longer length of the intestine before absorption 
(Ockner, Pittman and Yager, 1972; Bergstedt, Hayashi, Kritchevsky and Tso, 1990). 
Consequently, it is more likely that the difference in particle number appears at the late 
phase of coconut oil digestion and absorption where both olive and sunflower oil are 
completely absorbed.
Recently, it has been shown that particle number and size are determinants of the 
rates of plasma clearance of the TAG-rich lipoproteins (Martins, Mortimer, Miller and 
Redgrave, 1996). The same study also showed that particle number is more important 
than size and higher number of particles markedly affect the clearance of TAG-rich 
lipoproteins. The increased atherogenicity of coconut oil compared to sunflower oil and 
olive oil seems to reside in having smaller average fatty acid chain length, hence forming
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smaller average TAG-rich lipoprotein particle size which necessitate an increased number 
of TAG-rich lipoproteins particles for complete absorption. Thus, our study suggest that 
not all saturated fatty acids have equal atherogenic effect, in term of increasing the 
number of chylomicron remnants in the blood. It is tempting to suggest that saturated 
fatty acids such as stearic acid (C l8:0) is expected to result in a similar number of 
chylomicron remnants as olive and sunflower oils, while lauric (C12:0) and myristic 
(C14:0) acids are expected to increase the number of chylomicron remnants in the blood, 
consequently being more atherogenic. Numerous epidemiological studies demonstrate a 
positive relationship between saturated fat intake and incidence of CHD mortality
(McGee et a l,  1985; Kushi et a l, 1985). This could partly be related to the 
nature of saturated fat that tend to have smaller average fatty acid chain length (coconut 
oil, beef tallow, butter oil, palm kernel) compared to unsaturated fat (olive oil, sunflower 
oil, com oil, safflower oil). The importance of fatty acid chain length has been previously 
reported. Diets rich in stearic acid (C l8:0), when used isoenergetically to replace PUFAs 
or carbohydrates in the diet, did not raise plasma cholesterol levels to the same extent as 
lauric (C l2:0), myristic (C14:0) and palmitic (C l6:0) acids (Key et a l, 1965; Hegsted et 
a l, 1965). In non-human primates (Hayes et a l, 1991) and hamsters (Lindsey et a l, 
1990) the intake of palmitic acid (C l6:0) was not as hypercholesterolaemic as lauric 
(C12:0) and myristic (C14:0) acids. Also, Bonanome and Grundy (1988) reported that 
stearic or oleic (C l8:1) intake showed similar LDL and HDL cholesterol levels that were 
both significantly lower compared to subject fed palmitic acid (C l6:0) at the same energy 
level. All these reports suggest that fatty acids with small average fatty acid chain length 
tend to be more hypercholesterolaemic. Recently, it has been shown that chylomicroi^and
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their remnants impede the normal lipolytic degradation of hepatic VLDL and could 
thereby be indirectly implicated in the generation of atherogenic remnant lipoproteins 
(Bjorkegren, Packard, Hamsten, Bedford, Caslake, Foster, Shephered, Stewart, Karpe, 
1996). Since dietary fatty acids of small chain length (about 12 to 14 carbon units) 
necessitates a larger number of TAG-rich lipoprotein particles to be absorbed compared to 
long chain fatty acids of similar mass, it is tempting to suggest that dietary fat rich in such 
short chain fatty acids result in impedance of the normal lipolytic degradation of hepatic 
VLDL and its atherogenic remnant lipoproteins that are rich in cholesterol, hence partly 
resulting in increased serum cholesterol levels.
The data presented here, suggesting that the average size of intestinal 
triacylglycerol-rich lipoprotein particles is the largest following sunflower, and smallest 
following coconut, oil ingestion are concordant with studies by Ockner and Jones (1970), 
Feldman et a l  (1983), Levy et a l  (1991), Kalogeris et a l  (1992) and Sakr et a l  (1997) 
but contradict studies by Zilversmit et a l  (1966) and Renner et a l  (1986). The difference 
in results observed by Zilversmit et a l  (1966) could be explained by the fact that there 
was no great difference in the average fatty acid chain length of ingested fat, and that 
thoracic duct lymph was used while in the present and all of the other studies above, 
mesenteric lymph duct lymph was collected. Intestinal lymph represents a combination of 
plasma filtrate from the capillaries and also the material released by the enterocytes 
(Hayashi et a l, 1990). Thus, collecting lymph from the thoracic duct could be a much 
greater source of plasma filtrate contamination compared to the mesenteric duct lymph in 
term of plasma lipoprotein.
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The data of Renner et al. (1986) should not be considered as contradictory to 
studies by Ockner and Jones (1970), Feldman et al. (1983), Levy et al. (1991), Kalogeris 
et al. (1992) and Sakr et al. (1997). Renner et al. (1986) used a perfusate containing the 
tested fatty acid (palmitic or linoleic acid) (50%) and monoolein (50%). The estimated 
diameter in the palmitic and linoleic groups were respectively 99.2 nm and 105.8 nm 
(Renner et ah, 1986). The average chain length of fatty acid in the perfusate was 17 
carbon units for the palmitic group and 18 carbon units for the linoleic group. The ratios 
of average fatty acid chain length and estimated diameter in Renner et al. (1986) study are 
respectively 0.944 and 0.937. Thus, this is consistent with the high correlation observed 
between fatty acid chain length in the perfusate and estimated chylomicron diameter 
(Levy et al., 1991; Kalogeris et a l, 1992). The lack of effect of saturated fatty acid on the 
TAG-rich lipoprotein particle size in Renner et a l  (1986) study may then be attributed to 
the small difference in average fatty acid chain length of the palmitic and linoleic groups.
The present study suggests that if different fasting and postprandial apolipoprotein 
B48 plasma concentrations were observed with changing fat saturation in the diet, the 
difference in apolipoprotein B48 concentrations should be attributed to a change in the 
number of apolipoprotein B48 particles secreted from the intestine. Also, the differences 
in average particle sizes, that depend partly on chain length of the incorporated fatty acids, 
seems to be of particular importance since it seems to decide the hyper- or hyposecretion 
of apolipoprotein B48. Another factor that could be of importance along with the fatty 
acid chain length is the rate at which a certain fat load is absorbed. The rate of lipoprotein 
lipase hydrolysis of different types of triacylglycerol forming the bulk of the 
triacylglycerol-rich lipoprotein particles, in generating chylomicron remnant particles is 
also an important issue. Evidence for a contributory role of lipoprotein lipase may be 
adduced from studies of human subjects deficient in this enzyme. Lipoprotein lipase- 
deficient humans have a much slower (about 8 hr) clearance of apolipoprotein B48 from
237
blood compared to 15 min in human subjects who are not lipoprotein lipase deficient 
(Stalenhoef, Mallay, Kane and Havel, 1984). This indicates that chylomicron remnant 
clearance rate depends partly on the metabolism of chylomicrons by lipoprotein lipase. 
Thus, studying the effect of dietary fat composition on the activity of lipoprotein lipase 
may be an area worthy of investigation to aid understanding of other mechanisms leading 
to an increased concentrations of chylomicron remnant particle in blood.
After 40 days of insulin administration, normal rats received intragastric fat load 
of 2 ml of coconut oil; three hours later the average size of the triacylglycerol-rich 
lipoprotein particles secreted from the intestine was compared with that of the control 
group. The results cited in this study show that previous chronic insulin administration 
was without effect on either lymphatic apolipoprotein B48 concentration or average size 
of triacylglycerol-rich lipoprotein particles secreted following a fat load. The insulin- 
treated group showed only about 10% reduction in the lymph apolipoprotein B48 
concentration and about 9% increase in the average size of the triacylglycerol-rich 
lipoprotein particle although these apparent changes did not attain significance. This is 
consistent with work on cultured rat hepatocytes (Jackson et al., 1990) indicating that 
insulin has a lesser inhibitory effect on apolipoprotein B48 (11%), compared to that on 
apolipoprotein B-lOO (42%), synthesis.
The 40 days of insulin treatment showed also an evident tendency towards 
increased serum triacylglycerol concentration (23%) although again statistical significance 
was not attained. However, some individual animals showed more than 50% increase in 
serum triacylglycerol concentration compared to the mean value of the control group. The 
insignificant increase in the mean serum triacylglycerol concentration in the insulin- 
treated group could be attributedtsome animals becoming insulin resistant. Certainly
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insulin resistance is a frequent concomitant of exogenous hyperinsulinemia (Felig and 
Bergman, 1995).
Thus, dietary habits relying on fat manipulation in terms of both fat energy ratio 
and fat saturation have neutral effect in terms of the intestinal contribution to blood 
apolipoprotein B48 in the fasted state, one of the factors considered an indicator of high 
risk of coronary artery disease. Dietary fat saturation interventions have shown that diets 
containing sunflower oil (rich in polyunsaturated fatty acids) are the most 
hypocholesterolaemic and diets containing coconut oil (rich in saturated fatty acids) are 
the most hypercholesterolaemic. However, long-term dietary fat saturation manipulation 
appears to be without effect on the size of triacylglycerol-rich lipoprotein particles 
secreted in response to a similar fat load. The size of triacylglycerol-rich lipoprotein 
particles seems to be only dependent on the type of ingested lipid regardless of the 
previous dietary habit followed. Dietary habits, then, seem to have a minor or no role in 
increasing the intestinal contribution to elevated serum apolipoprotein B48. Any change 
in the concentrations of apolipoprotein B-48 in the blood in response to a similar fat load, 
that might occur following long term dietary fat saturation interventions should be 
attributed to a change in the catabolism of these particles rather than to a change in the 
secretion profile of those particles from the intestine. Our study also suggest^ that not all 
saturated fatty acids have equal atherogenic effect, in terms of increasing the number of 
chylomicron remnants in the blood after ingestion of a fat load. The average chain length 
of fatty acid seems to be inversely proportional to triacylglycerol-rich particle size but 
directly proportional to number. Consequently, fatty acid average chain length would be 
inversely proportional to atherogenicity. A relationship is also suggested between 
increased triacylglycerol-rich particle number that occurs with coconut oil and the 
hypercholesterolaemic effect of that oil. We have shown that chronic hyperinsulinemia, 
that is common in obese and type H diabetic patients, tend to increase the mean serum
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triacylglycerol concentration because of insulin resistance, an indication of increased 
atherogenicity.
In conclusion, the present study has confirmed an increase of about 2 to 2.5 fold in 
apolipoprotein B content in the jejunal enterocytes and mucosal scrapings after lipid 
feeding with no prior dietary intervention. Manipulation of dietary fat quantity showed a 
modest increase in the apolipoprotein B48 content of fasted jejunal enterocytes but not of 
mucosal scrapings as the dietary fat energy ratio increased from 5% to 20%. 
Manipulation of dietary fat saturation showed no effect on apolipoprotein B48 content of 
fasted jejunal enterocytes or mucosal scrapings. The size of the triacylglycerol-rich 
lipoprotein particles secreted in the mesenteric lymph duct in response to a fat load was 
also unaffected by previous chronic dietary fat saturation manipulation. However, the 
present results confirm that when dietary fat is predominantly sunflower oil (rich in 
polyunsaturated fatty acids) the experimental animals are relatively hypocholesterolaemic. 
When dietary fat consists predominantly of coconut oil (rich in saturated fatty acids) the 
animals are markedly hypercholesterolaemic. The present studies have also shown that 
increased transport of fat, after digestion and absorption of a dietary fat load, is 
accommodated chiefly by increased (about 4 fold) size of triacylglycerol-rich lipoprotein 
particles with only a small increase in number (about 1.45-1.6 fold) of these particles. It 
has also been demonstrated that dietary fat saturation has no effect on the number of 
triacylglycerol-rich lipoprotein particles secreted during the studied period of lipid 
absorption. However, it is suggested that by the end of the absorption period of the 
administered fat load the absolute number of triacylglycerol-rich lipoprotein particle 
secreted is more for coconut oil compared to olive and sunflower oils. The actual 
physical size of the triacyglycerol-rich lipoprotein particles depend upon chain length of 
the ingested fatty acids and rate of triacyglycerol transport. Both factors are directly 
proportional to the average size of the particles. Finally, we have shown that after 40 days
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of insulin treatment of normal rats, there was no change in the average triacylglycerol-rich 
lipoprotein particle size secreted from the intestine during lipid absorption It was 
suggested that some of the animals had developed insulin resistance as a result of chronic 
administration of insulin.
In order to elucidate further the mechanism behind the differential effect of fatty 
acid chain length upon blood cholesterol levels, it would be useful to relate changes of 
fatty acid chain length of a fat load and the concentration of blood apo B-lOO that reflect 
hepatic VLDL and its remnants that are rich in cholesterol. Such an assessment might 
provide greater insight into the mechanism by which chylomicrons from different fat type 
impede the normal lipolytic degradation of VLDL and its remnants.
In an attempt to establish the importance of fatty acid chain length as determinant 
of atherogenicity, it would be useful to study the lipolysis of chylomicrons derived from 
different fats by lipoprotein lipase in vitro by determining the release of [3H]stearate from 
their triacylglycerol after being subjected to rat post-heparin lipoprotein lipase. Such a 
study, indicate^ about the possibility of differential metabolism of chylomicrons containing 
fatty acid of different chain length.
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A ppendix  I 
General reagents
Acetic acid (BDH, Poole, UK).
Acrylamide, electrophoresis grade (Sigma, USA).
Ammonium persulphate, electrophoresis grade (Sigma, Poole, UK).
Benzamidine (Sigma, Poole, UK).
Bovine serum albumin (Sigma, Poole, UK).
Bromophenol blue (Sigma, Poole, UK).
Calcium chloride (Merck, Germany).
Coomassie blue R-250 (Sigma, Poole, UK).
Copper sulphate (BDH, Poole, UK).
Diethyl ether (Fluka, Switzerland).
Disodium ethylenediamine tetraaceticacid (Merck, Germany).
Dithiothreitol (Sigma, Poole, UK).
Folin-Ciocalteu phenol reagent (Sigma, Poole, UK).
Gelatin (Merck, Germany).
Glycerol (Sigma, Poole, UK).
Glycine (Merck, Germany).
Horse radish peroxidase (Boehringer, Lewes, UK).
Human serum albumin (sigma, Poole, UK).
Hydrochloric acid (BDH, Poole, UK).
Magnesium chloride (Merck, Germany).
Mercaptoethanol (Sigma, USA).
Methanol (BDH, Poole, UK).
Myosin, molecular weight marker from rabbit muscle for SDS-PAGE (Sigma, Poole, 
UK).
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N, N'-bis-methylene acrylamide, electrophoresis grade (Sigma, USA).
Nunc Maxisorp microtitre plates (Nunc, Roskilde, Denmark). 
Phenylmethyl-sulfonylfluoride (Sigma, Poole, UK).
Potassium bicarbonate (Merck, Germany).
Potassium dihydrogen phosphate (Merck, Germany).
Potassium hydrogen phosphate (Merck, Germany).
Sodium bicarbonate (Merck, Germany).
Sodium carbonate (Merck, Germany).
Sodium chloride (Merck, Germany).
Sodium deoxycholate (Sigma, Poole, UK).
Sodium dodecyl sulphate (SDS), electrophoresis grade (Sigma, USA)
Sodium hydroxide (Merck, Germany).
Sodium oleate (Sigma, USA).
Sodium pentobarbital (Ceva, France).
Sucrose (Merck, Germany).
3,3',5,5'-tetramethylbenzidine (TEMED), electrophoresis grade (Sigma, USA). 
Triton X-100 (Sigma, Poole, UK).
Tris (hydroxymethyl) methylamine (BDH, Poole, UK).
Tween 80 (Sigma, USA).
Tween 20 (Sigma, Poole, UK).
Urea (Sigma, USA).
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A p p e n d ix  II
Appendix II includes results from chapter 2: Materials and Methods.
Table 2.A Apolipoprotein B content of jejunal mucosal scrapings without
flushing (n = 5) and following flushing with PBS (n = 5) or isotonic 
sucrose (n = 5). Data presented as mean ± SEM.
AVBmGE 0.278 0.278 0.294
S E M  0.02 0.02 0.0125
Table 2.B Triacylglycerol concentrations in lymph samples collected from the 
mesenteric lymph duct of the same animals with and without cannula and 4 
h after intragastric instillation of 2 ml olive oil (values denote mean ± 
S.E.M. (n = 5)).
AVERAGE 2957.4 3011.4
SEM 232.6 236.8
Table 2.C Cholesterol concentrations in lymph samples collected from the mesenteric 
lymph duct of the same animals with and without cannula and 4 h after 
intragastric instillation of 2 ml olive oil (values denote mean ± S.E.M. (n =5)).
C E o W e m *  (iurig I /L )
AVERAGE 1.03 1.02
SEM 0.086 0.087
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Table 2.D Apolipoprotein B concentrations in lymph samples collected from the 
mesenteric lymph duct of the same animals with and without cannula and 4 
h after intragastric instillation of 2 ml olive oil (values denote mean ± 
S.E.M. (n =5)).
AVERAGE 71.12 71.78
2.56 3.02
Figure 2.E Apohpoprotein B-48(mg)/TAG (g) ratios determined in lymph samples 
collected from the mesenteric lymph duct of the same animals with and 
without a cannula 4 hours after intragastric instillation of 2 ml of olive 
oil (values denote mean ± S.E.M. (n = 5)).
/  C ^ )
AVERAGE 2.44 2.40
0.128 0.0949
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A p p e n d ix  III
Appendix III includes results from chapter 3: Fat Loading and Apolipoprotein B Content 
of Rat Jejunal Enterocytes and Mucosal Scrapings
Table 3.1 Apolipoprotein B content of jejunal mucosal scrapings {In vitro study) after 
2 h of incubation in either a modified tinger solution (control) or an oleic 
acid emulsion (oleic acid) in modified Ringer solution. Mean ± S.E.M. 
(n=7).
AVERAGE 0.36 0.88
0.019 0.067
Table 3.2 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
90 minutes of instilling intragastiically 2 ml of either 153.8 mM NaCl or olive 
oil. Mean ± S.E.M. (n = 5).
................................................................................................................
AVERAGE 0.34 0.28 0.61
0.028 0.024 0.030
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Table 3.3 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting and 
after 90 minutes of instilling intragastrically 2 ml of either 153.8 mM NaCl or 
olive oil. Mean ± S.E.M. (n = 5).
AVERAGE 0.37
0.033
0.34
0.018
0.76
0.092
Table 3.4 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
3 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl or olive 
oil. Mean ± S.E.M. (n = 5).
AVERAGE
SEM
0.34
0.028
0.34
0.029
0.73
0.054
Table 3.5 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting and 
after 3 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl or 
olive oil. Mean ± S.E.M. (n = 5).
AVERAGE 0.37 0.30 0.82
SEM 0.033 0.020 0.051
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Table 3.6 Apolipoprotein B content of fasted jejunal enterocytes after fasting and after 
90 minutes of instilling inU*aduodenally 4 ml of either 153.8 mM NaCl or 
oleic acid emulsion. Mean ± S.E.M. (n = 5).
a a
AVERAGE 0.34 0.24 0.52
SEM 0.028 0.020 0.028
Table 3.7 Apolipoprotein B content of fasted jejunal mucosal scrapings after fasting and 
after 90 minutes of instilling intraduodenally 4 ml of either 153.8 mM NaCl 
or oleic acid emulsion. Mean ± S.E.M. (n = 5).
AVERAGE 0.37 0.32 0.61
S i m 0.033 0.022 0.062
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Appendix IV includes results from chapter 4: Long-Term Dietary Fat-Loading. Fat Type 
and Intestinal Apoliporotein B Content.
Table 4.1 Fasted rat jejunal enterocytes apolipoprotein B content after 40 days of feeding 
on a 20% fat energy diet rich in either coconut (20% SAT), olive (20%
MONO) or sunflower (20% POLY) oil. Means ± SEM. (n = 7).
M M #
AVERAGE 0.41 0.44 0.44
SEM 0.033 0.020 0.026
Table 4.2 Apolipoprotein B content in fasted rat jejunal mucosal scrapings after 40 days 
of feeding on a 20% fat energy diet rich in either coconut (20% SAT), olive 
(20% MONO) or sunflower (20% POLY) oil. Mean ± SEM. (n = 7).
AVERAGE 0.41 0.43 0.42
SEM  0.021 0.032 0.022
293
Table 4.3 Fasted rat jejunal enterocytes apolipoprotein B content after 40 days of feeding 
on a 5% fat energy diet rich in either coconut (5% SAT), olive (5% MONO) 
or sunflower (5% POLY) oil. Means ± SEM. (n = 7).
AVERAGE 0.33 0.32 0.32
SEM  0.032 0.028 0.026
Table 4.4 Apolipoprotein B content in fasted rat jejunal mucosal scrapings after 40 days 
of feeding on a 5% fat energy diet rich in either coconut (5% SAT), olive (5% 
MONO) or sunflower (5% POLY) oil. Mean ± SEM. (n = 7).
.............
AVERAGE 0.37 0.40 0.38
$mm  0.021 0.019 0.022
Table 4.5 Fasted rat jejunal enterocytes apolipoprotein B content after 40 days of feeding 
on either a 5% or 20% fat energy diet rich in either coconut (5% or 20%
SAT), olive (5% or 20% MONO) or sunflower (5% or 20% POLY) oil. 
Means ± SEM. (n = 7).
AVERAGE 0.33 0.41 0.32 0.44 0.32 0.44
SEM 0.032 0.033 0.028 0.020 0.026 0.026
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Table 4.6 Fasted rat jejunal mucosal apolipoprotein B content after 40 days of feeding on 
either a 5% or 20% fat energy diet rich in either coconut (5% or 20% SAT), 
olive (5% or 20% MONO) or sunflower (5% or 20% POLY) oil. Means ± 
SEM. (n = 7).
q27 0.41 0.40 0.43 0.38 0.42
SIM 0.021 0.021 0.019 0.0316 0.22 0.022
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Appendix V includes results from chapter 5: Effects of Dietary Fat Saturation upon Size 
And Number Of Tag-Rich Lipoprotein Particles Secreted During Lipid Absorption.
Table 5.A Rat serum cholesterol concentrations (mmol/L) after 0, 1.5, 3, and 6 hours of 
instilling intragastrically 2 ml of either 153.8 mM NaCl (CONTROL) or oil 
in fasted rats (MONO = olive oil, SAT = coconut oil, POLY = sunflower 
oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for MONO, SAT and POLY 
groups)
EXPERIMENTAL GROUT
CONTROL (O hr) 2.32 0.122
CONTROL 0*5 br) 2.27 0.116
CONTROL (3 hr) 2.36 0.185
CONTROL (6 hr) 2.37 0.126
MONO (1*5 hr) 2.03 0.137
MONO (3 hr) 2.02 0.111
MONO (6 hr) 2.14 0.080
SAT a  J  hr) 2.06 0.086
SAT (3 hr) 2.07 0.083
SAT (6 hr) 2.14 0.056
POLY 0*5 hr) 2.05 0.090
POLY (3 hr) 2.06 0.108
POLY (6 hr) 2.16 0.069
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Table 5.B Rat serum triacylglycerol (TAG) concentrations (mg/dl) after 0, 1.5, 3, and 6 
hours of instilling intragastrically 2 ml of either 153.8 mM NaCl 
(CONTROL) or oil in fasted rats (MONO = olive oil, SAT = coconut oil, 
POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for 
MONO, SAT and POLY groups)
E X P E R IM E N T A L .......
GROU P
CONTROL CO hr) 24.9 2.53
CONTROL 0^5 hr) 24.8 3.67
MONOCLSfer) 34.7 2.31
SAT(L5hr) 35.5 2.72
POLYCLShr) 35.6 2.08
CONTROL 0  hr) 28.7 2.63
MONO {3 hr) 48.9 3.80
SAT (3 for) 45.3 3.52
POLY (3 hr) 44.0 3.48
CONTROL (6 hr) 25.9 4.53
MONO 0  hr) 42.8 2.89
SAT (6 hr) 41.5 2.37
POLY <6 hr) 43.1 3.09
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Table 5.C Rat mesenteric lymph duct cholesterol concentrations (mmol/L) after 0, 1.5, 
3, and 6 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl 
(CONTROL) or oil in fasted rats (MONO = olive oil, SAT = coconut oil, 
POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for 
MONO, SAT and POLY groups)
EXPERIMENTAL 
GROUP
CO NTROL (O h r) 1.60 0.096
CONTROL CL5 h r) 1.63 0.122
MONO (W hr) 1.20 0.036
S K T ih S h r } 1.15 0.048
POLY ( I S  h r) 1.13 0.038
CONTROL {3 hr) 1.75 0.127
MONO (3 h r) 0.93 0.077
SAT <3 h r ) 0.92 0.044
POLY <3 h r ) 0.87 0.043
CONTROL <6 h r ) 1.52 0.097
MONO (6 h r) 1.07 0.046
SAT (6 h r ) 1.13 0.046
POLY {6 hr) 1.09 0.053
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Table 5.D Cholesterol output (pmol/h) in the rat mesenteric lymph duct after 0, 1.5, 3, 
and 6 hours of instilling intragastrically 2 ml of either 153.8 mM NaCl 
(CONTROL) or oil in fasted rats (MONO = olive oil, SAT = coconut oil, 
POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for 
MONO, SAT and POLY groups)
EXPERIMENTAL
G ROU P
CONTROL (Ofer) 2.41 0.217
CONTROL CLS hr) 2.48 0.220
M ONO (1 5  h r) 2.66 0.081
SAT (1*5 hr) 2.60 0.133
POLY (IS hr) 2.59 0.146
CONTROL (3 h r ) 2.48 0.187
MONO 0  hr) 2.52 0.212
SAT (3 hr) 2.36 0.087
POLY{3hr) 2.29 0.157
CONTROL (6 hr) 2.26 0.109
MONO 0  hr) 2.23 0.058
SAT (6 hr) 2.36 0.109
POLY 0  h r ) 2.26 0.192
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Table 5.E Rat mesenteric lymph duct triacylglycerol (TAG) concentrations (mg/dl) after 
0, 1.5, 3, and 6 hours of instilling intragastrically 2 ml of either 153.8 mM 
NaCl (CONTROL) or oil in fasted rats (MONO = olive oil, SAT = coconut 
oil, POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for 
MONO, SAT and POLY groups)
EXPERIM ENTAL
GROUP
CONTROL (O hr) 557.6 69.0
CONTROL (L 5 h r ) 600.0 71.7
MONO (15 hr) 2026 124
SAT (15 hr) 2086 127
POLY (IS hr) 2061 106
CONTROL (3 hr) 602.4 80.4
MONO <3 hr) 2781 202
SAT {3 hr) 2908 191
POLY (3 h r ) 2870 144
CONTROL (6 hr) 628.6 80.3
MONO <6 hr) 3939 219
SAT 0  h r) 3732 235
POLY (6 hr) 3717 283
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Table 5.F Triacylglycerol (TAG) output (mg/hr) in the rat mesenteric lymph duct after 0, 
1.5, 3, and 6 hours of instilling intragastrically 2 ml of either 153.8 mM 
NaCl (CONTROL) or oil in fasted rats (MONO = olive oil, SAT = coconut 
oil, POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n = 6 for 
MONO, SAT and POLY groups)
EXPERIM ENTAL
GROUP
CO NTROL (O h r) 8.13 0.52
CONTROL (1 5  h r ) 8.80 0.78
M O N O C LShr) 45.4 3.76
SAT (1 5  h r) 47.3 3.14
POLY 0*5 h r ) 47.4 2.99
CONTROL (3 h r) 9.04 0.98
MONO (3 h r ) 74.6 3.67
SAT 0  h r) 74.4 2.78
P 0 1 Y (3 h r ) 74.7 2.31
CONTROL 0  h r) 8.53 0.59
MONO <6 h r ) 81.8 1.83
SAT 0  h r) 77.6 2.56
POLY 0  h r) 75.8 3.24
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Table 5.G Rat mesenteric lymph duct apolipoprotein B48 (apo B-48)concentrations 
(mg/L) after 0, 1.5, 3, and 6 hours of instilling intragastrically 2 ml of either
153.8 mM NaCl (CONTROL) or oil in fasted rats (MONO = olive oil, SAT 
= coconut oil, POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n 
= 6 for MONO, SAT and POLY groups)
EXPERIMENTAL
GROUP
CO N TRO L (G h r) 77.5 3.52
CONTROL (1*5 hr) 75.0 3.47
MONO (LS hr) 75.9 3.02
S A T d J h r ) 75.7 2.92
POLY (L5 hr) 71.6 3.45
CONTROL (3 hr) 76.3 4.10
MONO 0  h r ) 68.9 3.91
SAT <3 hr) 71.5 5.08
POLY (3 hr) 68.3 1.66
C O N T K O L 0 h r) 77.2 3.63
MONO (6 hr) 88.1 3.03
SAT 0  hr) 86.3 2.98
POLY 0  hr) 85.4 4.72
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Table 5.H Apolipoprotein B48 (apo B-48) output (p-g/hr) in the rat mesenteric lymph 
duct after 0, 1.5, 3, and 6 hours of instilling intragastrically 2 ml of either
153.8 mM NaCl (CONTROL) or oil in fasted rats (MONO = olive oil, SAT 
= coconut oil, POLY = sunflower oil). Mean ± S.E.M. (n = 5 for C group; n 
= 6 for MONO, SAT and POLY groups)
EXPERIMENTAL
GROUP
CONTROL (O hr) 112.6 6.09
CONTROL (15 W 113.2 4.08
MONO 115 hr) 169.3 8.32
SAT (15 hr) 170.8 4.01
POLY (15 hr) 163.5 5.10
CONTROL (3 hr) 107.4 2.26
MONO (3 hr) 180.1 5.27
SAT {3 hr) 183.2 8.20
POLY (3 hr) 178.2 1.94
CONTROL 0  hr) 108.2 3.60
MONO 0  hr) 184.0 5.58
SAT (6 hr) 181.9 3.92
POLY 0  hr) 174.7 4.66
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Table 5.1 Lymph flow rate (ml) in the rat mesenteric lymph duct after 0,1.5, 3, and 6
hours of instilling intragastrically 2 ml of either 153.8 mM NaCl (CONTROL) 
or oil in fasted rats (M = olive oil, S = coconut oil, P = sunflower oil). Mean 
± S.E.M. (n = 5 for C group; n = 6 for M, S and P groups).
i ..:... :............................:.............
w i m m m m A L
GROUP
CONTROL CO hr) 1.50 0.090
CONTROL (15 hr)' 1.52 0.080
MONO (15 hr) 2.23 0.080
B A T i t S h t } 2.27 0.070
POLY (15 hr) 2.30 0.080
CONTROL (3 hr) 1.42 0.060
MONO <3 hr) 2.70 0.080
SAT <3 hr) 2.58 0.070
POLY (3 hr) 2.62 0.060
CONTROL 0 W 1.40 0.090
MONO 0  hr) 2.10 0.090
SAT 0  hr) 2.10 0.070
POLY 0  hr) 2.07 0.080
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Table 5.J Lymph apolipoprotein B-48 (apo B-48) (mg) /  lymph triacylglycerol (TAG) (g) 
in the rat mesenteric lymph duct after 0,1.5, 3, and 6 hours of instilling 
intragastrically 2 ml of either 153.8 mM NaCl (CONTROL) or oil in fasted 
rats (MONO = olive oil, SAT = coconut oil, POLY = sunflower oil). Mean 
± S.E.M. (n = 5 for C group; n = 6 for MONO, SAT and POLY groups)
EXPERIMENTAL
GROUP
CONTROL (O hr) 14.2 1.3
CONTROL 0,5 hr) 12.9 0.91
MONOClShr) 3.8 0.24
SAT(LShr) 3.7 0.30
POLY (W hr) 3.51 0.20
CONTROLOhr) 13.3 1.28
MONO 0  hr) 2.50 0.13
SAT 0  hr) 2.46 0.05
POLY 0  hr) 2.4 0.09
CONTROL 0  hr) 12.8 1.12
MONO 0  hr) 2.25 0.1
SAT 0  hr) 2.33 0.07
POLY 0  hr) 2.31 0.07
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Table 5.K Rat serum cholesterol (mmol/L) concentrations as collected after fasting or 
after 5 hours of feeding on a sohd physiological diet rich in either olive 
(MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 
6).
cmomwmmt
AVERAGE 2.32 1.96 1.73 1.60
SEM  0.122 0.169 0.099 0.080
Table 5.L Rat serum triacylglycerol (TAG) (mg/dl) concentrations as collected after
fasting or after 5 hours of feeding on a solid physiological diet rich in either 
olive (MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. 
(n = 6).
T A G im m y
AVERAGE 24.9 60.8 64.3 57.63
2.53 6.93 8.94 7.1
Table 5.M Rat mesenteric lymph duct cholesterol (mmol/L) concentrations as collected 
after fasting or after 5 hours of feeding on a solid physiological diet rich in 
either olive (MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± 
S.E.M. (n = 6).
CHOLESTEROL
(m io o iiL )
AVERAGE 1.60 0.74 0.80 0.89
0.096 0.12 0.097 0.12
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Table 5.N Rat mesenteric lymph duct triacylglycerol (TAG) (mg/dl) concentrations as
collected after fasting or after 5 hours of feeding on a solid physiological diet 
rich in either olive (MONO), coconut (SAT), or sunflower (POLY) oil.
Mean ± S.E.M. (n = 6).
TAG ( m g / #
AVERAGE 557.6 4454 4010 3850
69.0 486 558 371
Table 5.0 Rat mesenteric lymph duct apolipoprotein B-48 (apo B-48) (mg/1)
concentrations as collected after fasting or after 5 hours of feeding on a 
solid physiological diet rich in either olive (MONO), coconut (SAT), or 
sunflower (POLY) oil. Mean ± S.E.M. (n = 6).
;............. ....................................................................
APOE^#(m#)
AVERAGE 77.5 90.0 86.6 82.7
SEM  3.52 5.13 5.42 6.42
Table 5.P Lymph apolipoprotein B-48 (apo B-48) (mg) /  lymph triacylglycerol (TAG)
(g) in the rat mesenteric lymph duct as collected after fasting or after 5 hours 
of feeding on a solid physiological diet rich in either olive (MONO), coconut 
(SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 6).
LYMPH APO E-^ 48 (mg)/ 
LYMPH TAG (g)
AVERAGE 14.2 2.1 2.34 2.21
SEM 1.3 0.22 0.27 0.17
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A p p e n d ix  V I
Appendix VI includes results from chapter 6: Dietary Fat Saturation and the Morphology 
of Triacylglycerol-Rich Lipoproteins Secreted From Rat Small Intestine During Lipid 
Absorption
Table 6.A Rat serum Cholesterol concentrations (mmol/L) as determined after 4 hours 
of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 40 days 
a diet rich in either olive (MONO), coconut (SAT), or sunflower (POLY) oil. 
Mean ± S.E.M. (n = 7).
CHOLESTERO L im m m .}
AVERAGE 2.02 1.59 1.70
0.093 0.090 0.073
Table 6.B Rat serum triacylglycerol (TAG) concentrations (mg/dl) as determined after 4 
hours of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 
40 days a diet rich in either olive (MONO), coconut (SAT), or sunflower 
(POLY) oil. Mean ± S.E.M. (n = 7).
TAG (m g/# — — — —
AVERAGE 29.2 35.2 41.6
SEM 4.16 4.36 4.28
Table 6.C Rat mesenteric lymph duct Cholesterol concentrations (mmol/L) as 
determined after 4 hours of instilling intragastrically 2 ml of coconut oil in 
fasted rats fed for 40 days a diet rich in either olive (MONO), coconut 
(SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 7).
CHOLESTEROL (mmul/L)
AVERAGE 0.918 0.838 0.880
SEM 0.064 0.052 0.054
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Table 6.D Rat mesenteric lymph duct triacylglycerol (TAG) (mg/dl) concentrations as 
determined after 4 hours of instilling intragastrically 2 ml of coconut oil in 
fasted rats fed for 40 days a diet rich in either olive (MONO), coconut 
(SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 7).
TAG (mg/di)
AVERAGE 2911 2947 2825
SEM  366 192 246
Table 6.E Rat mesenteric lymph duct apolipoprotein B-48 (apo B-48) (mg/L) 
concentrations as determined after 4 hours of instilling intragastrically 2 ml 
of coconut oil in fasted rats fed for 40 days a diet rich in either olive 
(MONO), coconut (SAT), or sunflower (POLY) oil. Mean ± S.E.M. (n = 
7).
APO B«45{mg/ï)
AVERAGE 74.6 76.3 45.8
SEM  4.84 3.00 4.37
Figure 6.F Lymph apolipoprotein B-48 (apo B-48) (mg) / lymph triacylglycerol (TAG) 
(g) concentrations in the rat mesenteric lymph duct as determined after 4 
hours of instilling intragastrically 2 ml of coconut oil in fasted rats fed for 40 
days a diet rich in either olive (MONO), coconut (SAT), or sunflower 
(POLY) oil. Mean ± S.E.M. (n = 7).
LYM PH APO (mg) /
LYMPH TA G  (g)
AVERAGE 2.67 2.65 2.77
SEM 0.19 0.20 0.20
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Table 6.G Rat blood glucose concentrations (mmol/L) as determined after 4 hours of 
instillingintragastrically 2 ml of coconut oil in fasted rats fed for 40 days a 
diet rich in either olive (MONO), coconut (SAT), or sunflower (POLY) oil. 
Mean ± S.E.M. (n = 7).
GLtlCOSlCmmel/L)
AVERAGE 11.9 9.70 9.90
1.67 1.14 1.57
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A ppendix  v u
Appendix VII includes results from chapter?: A Study of the Triacylglycerol-Rich 
Lipoprotein Particles secreted by the Intestine of Fat-loaded Rats after 40 Days of Insulin 
Administration.
Table 7.A Rat serum triacylglycerol (TAG) (mg/dl) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; the serum 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
TAG {rngm i
AVERAGE 44.9 55.5
s m L 6.7 14.2
Table 7.B Rat serum cholesterol (mmol/L) concentrations after 3 hours of instilling 
intragastrically 2 ml of coconut oil in fasted animals; the serum collection 
was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
CH OLESTEROL
AVERAGE 1.97 1.89
GEM 0.054 0.15
Table 7.C Rat mesenteric lymph cholesterol (mmol/L) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; lymph 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
CHOLESTEROL
AVERAGE 1.24 1.21
0.17 0.16
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Table 7.D Rat mesenteric lymph triacylglycerol (mg/dl) concentrations after 3 hours of 
instilling intragastrically 2 ml of coconut oil in fasted animals; lymph 
collection was done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
TAG (mgûl)
AVERAGE 2209 2187
248 314
Table 7.E Rat mesenteric lymph apolipoprotein B-48 (mg/L) concentrations after 3 
hours of instilling intragastrically 2 ml of coconut oil in fasted animals; 
lymph collection was done after 30 hours of the last dose of the 40 days 
period of hyperinsulinaemia. Means ± S.E.M. (n = 6).
■AFO'MBtiiig/l)...................
AVERAGE 68.0 61.3
jSEM 4.92 4.33
Table 7.F Lymph apolipoprotein B-48 (apo B-48)(mg)/lymph triacylglycerol (TAG) (g) 
ratios of rat mesenteric lymph after 3 hours of instilling intragastrically 2 ml 
of coconut oil in fasted animals; lymph collection was done after 30 hours of 
the last dose of the 40 days period of hyperinsulinaemia. Means ± S.E.M. (n 
= 6).
L V M m W G R W # # /—
LVMFHTAG(g)
AVERAGE 3.26 2.97
m M 0.37 0.28
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Table 7.G Rat blood glucose (mmol/L) concentrations after 3 hours of instilling 
intragastrically 2 ml of coconut oil in fasted animals; the serum 
collectionwas done after 30 hours of the last dose of the 40 days period of 
hyperinsulinaemia. Means ± S.E.M. (n = 6).
GLUCOSE (mmoW
AVERAGE 11.0 11.6
0.34 1.3
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